Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
HTR1A	"5-HT1A, ADRB2RL1, ADRBRL1"	ENSG00000178394	"5-hydroxytryptamine receptor 1A"	P08908	5	63960356-63962507	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 21.5;ovary: 10.4"	"Group enriched"	"Detected in some"	32	"NTERA-2: 5.3;SCLC-21H: 4.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 14.7;cerebral cortex: 10.7;hippocampal formation: 21.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018073	Uncertain									"HPA018073: AB_1856704"					"unprognostic (1.81e-1)"													0.2	0.4	14.7	0.2	1.0	0.2	0.2	0.1	10.7	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.5	21.5	2.4	0.2	0.2	0.3	0.2	0.7	2.7	10.4	0.2	0.2	0.1	0.2	0.9	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.6	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	1.0	0.1	10.7	21.5	2.4	0.7	2.7	0.9	0.0
WFIKKN2	"WFDC20B, WFIKKNRP"	ENSG00000173714	"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2"	Q8TEU8	17	50834650-50842348	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 89.1;ovary: 56.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;T-47d: 3.7;U-87 MG: 3.8"	"Group enriched"	"Detected in some"	5	"glioma: 0.7;testis cancer: 2.2"	"Region enriched"	"Detected in some"	10	"pons and medulla: 89.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted in other tissues"	1700000	1700000				"unprognostic (7.31e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.54e-3)"		"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.14e-1)"	0.1	0.5	0.2	0.1	0.3	0.0	0.0	0.8	0.5	0.2	0.3	6.8	0.0	0.1	0.7	0.4	0.2	0.6	0.2	0.3	9.1	0.2	0.1	0.0	1.0	0.0	0.4	0.0	56.4	0.3	0.1	0.8	0.0	89.1	0.3	0.1	4.5	0.1	0.5	1.3	0.6	0.1	0.2	0.3	0.1	0.1	1.6	0.5	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.5	9.1	0.2	0.4	0.0	89.1	0.5
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138670772-138780348	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	15	"brain: 23.0;kidney: 8.0;ovary: 19.3"	"Cell line enhanced"	"Detected in some"		"AF22: 6.2;SCLC-21H: 2.4;SiHa: 6.0;U-2 OS: 9.9;U-251 MG: 3.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"pons and medulla: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"					"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6.0	0.6	0.3	0.0	0.0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8.0	0.3	0.3	0.2	2.4	2.0	19.3	0.2	0.4	0.4	0.4	23.0	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	2.4	1.6	6.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2.0	23.0	0.8
KLHDC8A	FLJ10748	ENSG00000162873	"Kelch domain containing 8A"	Q8IYD2	1	205336065-205357090	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	12	"ovary: 93.4"	"Cell line enhanced"	"Detected in some"		"AF22: 5.5;HAP1: 11.3;NTERA-2: 2.7;SCLC-21H: 11.5"	"Cancer enhanced"	"Detected in many"		"glioma: 45.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.92e-1)"	"unprognostic (8.37e-3)"	"unprognostic (7.39e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.84e-7)"	"unprognostic (4.53e-3)"	"unprognostic (5.83e-2)"	"prognostic favourable (8.01e-4)"	"unprognostic (1.20e-2)"	0.3	8.0	2.2	0.4	6.0	2.3	0.5	7.8	2.4	0.7	0.5	2.3	0.1	0.6	1.2	1.7	1.4	5.7	0.5	0.4	3.6	5.0	0.3	0.3	0.4	0.3	2.2	1.8	93.4	1.1	0.3	6.5	0.3	8.0	0.4	0.5	3.0	2.2	0.3	0.3	0.5	0.5	1.2	1.3	0.4	1.4	1.8	0.8	0.0	1.5	1.7	1.4	0.3	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	11.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	11.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	6.0	7.8	2.4	3.6	5.0	2.2	1.8	8.0	0.8
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 312.0;ovary: 80.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 79.9;RPTEC TERT1: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;T-cells: 4.6"	"Group enriched"	"Detected in many"	4	"amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3"	"Low region specificity"	"Detected in all"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"				"Actin filaments, Focal adhesion sites"	"Actin filaments, Focal adhesion sites"	"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	8.3	9.8	1.5	5.7	3.6	1.5	8.9	0.8	5.6	16.3	10.5	1.4	5.1	6.0	14.8	12.1	9.2	6.8	16.5	312.0	2.5	0.4	5.5	7.8	2.1	2.7	0.9	3.0	80.7	1.6	0.2	4.1	16.7	1.1	12.8	7.4	18.5	6.2	8.7	9.4	5.6	16.9	11.9	0.8	3.9	12.7	13.4	0.7	3.1	6.6	16.9	5.1	18.1	7.6	1.4	1.3	7.8	0.8	1.5	4.6	2.6	22.5	5.3	3.1	0.1	10.1	12.8	29.6	42.8	11.3	27.5	33.1	9.5	35.3	0.0	3.6	52.1	7.0	4.6	38.9	31.4	0.9	3.5	15.8	6.5	7.1	40.0	0.0	3.5	26.6	21.4	43.3	28.8	56.0	4.1	1.3	79.9	0.8	3.6	0.1	6.5	16.7	0.0	4.8	0.6	73.7	16.0	0.1	1.0	16.0	7.2	11.1	9.0	0.5	26.9	20.0	20.3	22.1	34.4	0.4	0.0	0.1	31.9	0.0	20.6	7.8	0.8	1.0	2.2	0.4	1.5	1.1	1.8	3.6	0.7	1.4	1.4	2.9	4.5	1.5	0.3	1.3	4.6	2.6	1.5	3.6	0.8	5.6	2.5	0.4	0.9	3.0	1.1	0.7
UCMA	C10orf49	ENSG00000165623	"Upper zone of growth plate and cartilage matrix associated"	Q8WVF2	10	13221767-13234334	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 6.2;heart muscle: 3.2;ovary: 5.4;pituitary gland: 2.4"	"Cell line enhanced"	"Detected in single"		"THP-1: 3.5"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Group enriched"	"Detected in some"	6	"amygdala: 6.2;basal ganglia: 3.7;cerebral cortex: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046718	Uncertain				"Secreted to extracellular matrix"					"HPA046718: AB_2679771"															"unprognostic (4.25e-1)"			0.0	0.0	6.2	0.2	3.7	0.0	0.0	0.2	6.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	3.2	0.7	0.2	0.0	0.1	0.5	0.0	0.1	0.9	5.4	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.7	0.2	6.1	0.7	0.2	0.1	0.9	0.0	0.0
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6"	"Cell line enhanced"	"Detected in some"		"BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA028338	Enhanced									"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	3.2	0.1	0.4	0.0	0.2	0.5	24.5	0.0	31.0	0.0	0.0	0.2	0.1	0.0	0.1	23.0	0.1	0.0	0.0	9.6	0.1	0.0	1.6	0.2	1.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.1	1.1	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	2.3	0.1	0.4	1.0	1.3	0.3	0.0	0.1	0.0	0.3	2.3	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.3	1.8	0.1	1.0	0.0	0.1	0.0	3.0	1.1	0.0	0.2	0.4	0.0	0.0	0.2	0.9	0.0	0.0	2.0	1.2	0.7	0.0	0.0	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.3
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007299-54018186	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 64.2;lung: 16.1;ovary: 20.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 3.6;Hep G2: 14.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.1	0.1	0.0	0.0	0.6	2.1	0.4	64.2	1.1	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	20.5	0.1	0.0	1.5	0.1	0.2	0.5	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.8	4.8	0.0	0.0	0.7	0.5	2.1	0.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	3.6	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.8	14.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.3	0.0	0.1	1.0	0.0	0.8	0.1	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"lymphoid tissue: 11.3;ovary: 36.6"	"Cell line enriched"	"Detected in some"	15	"HEL: 15.0"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	0.4	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.1		36.6	1.1	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.3	0.1	11.3	1.8	0.5			0.0		0.0	0.3	0.0	0.6	0.5	2.6	3.3	0.8	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.2	15.0	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.4	0.2	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.2	0.5	1.0	2.6	0.1	3.3	0.1	0.5	0.2	0.1	0.5	0.6	0.1	0.2	1.4	0.8	3.3	0.3	0.0	0.3										
STAR	"StAR, STARD1"	ENSG00000147465	"Steroidogenic acute regulatory protein"	P49675	8	38143649-38151265	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 311.3;ovary: 124.6"	"Cell line enriched"	"Detected in some"	5	"K-562: 99.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Region enriched"	"Detected in some"	8	"basal ganglia: 10.6"	"Cell type enriched"	"Detected in single"	11	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023644, HPA027318, CAB032598"	Enhanced									"CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574"	"unprognostic (1.60e-4)"	"unprognostic (3.20e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.12e-5)"	"unprognostic (3.30e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.77e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.75e-9)"	"unprognostic (1.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.16e-2)"	0.2	311.3	0.5	0.3	10.6	0.3	0.0	0.0	1.0	0.0	0.0	11.6	0.0	0.0	0.1	0.8	0.2	0.4	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.3	0.2	0.9	124.6	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.4	0.0	0.0	29.5	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.1	5.7	0.1	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.4	0.1	1.3	0.3	1.0	0.0	3.4	0.0	0.0	0.0	0.0	99.5	0.0	0.0	0.0	0.0	11.7	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	11.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	5.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.1	0.5	10.6	0.0	1.0	0.3	0.5	0.2	0.9	1.2	0.1
UTF1		ENSG00000171794	"Undifferentiated embryonic cell transcription factor 1"	Q5T230	10	133230274-133231558	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ovary: 22.9;testis: 23.4"	"Group enriched"	"Detected in some"	18	"NTERA-2: 10.9;RPMI-8226: 3.9"	"Cancer enriched"	"Detected in single"	243	"testis cancer: 49.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"																		"unprognostic (9.19e-2)"					"unprognostic (1.95e-1)"	"unprognostic (8.57e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-1)"		0.2	0.3	0.4	0.1	0.2	0.5	0.1	0.3	0.3	0.1	0.1	0.0	0.0	0.1	0.3	0.8	0.1	0.7	0.1	0.9	0.2	0.2	0.1	0.2	0.6	1.6	0.1	0.0	22.9	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.4	3.1	0.2	23.4	0.0	1.1	0.1	0.1	0.5	0.1	0.0	0.5	0.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.2	0.3	0.3	0.2	0.2	0.1	0.0	0.1	0.0
VWC2	"PSST739, UNQ739"	ENSG00000188730	"Von Willebrand factor C domain containing 2"	Q2TAL6	7	49773661-49921950	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.0;heart muscle: 12.8;ovary: 12.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA055243	Approved				"Secreted to extracellular matrix"					"HPA055243: AB_2682755"	"unprognostic (3.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.90e-4)"	"unprognostic (8.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.56e-3)"		"unprognostic (3.41e-2)"		"unprognostic (4.11e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.69e-4)"	"unprognostic (1.60e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.70e-3)"	0.5	0.3	3.6	0.4	3.9	0.4	0.5	17.0	6.9	0.6	0.5	1.4	0.0	0.5	1.9	0.4	0.5	0.8	0.5	12.8	1.7	2.8	0.4	0.3	0.6	0.4	2.1	1.8	12.5	0.3	0.3	0.2	0.3	3.8	0.4	0.5	0.6	0.4	0.5	0.4	1.2	0.7	1.5	0.8	0.6	0.4	0.5	0.8	0.0	0.4	0.0	0.3	0.4	0.2	0.1	0.0	0.9	0.4	1.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.9	1.0	0.2	0.0	0.0	0.0	3.6	3.9	17.0	6.9	1.7	2.8	2.1	1.8	3.8	0.8
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 17.6;HHSteC: 7.6;HSkMC: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"									"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	Cytosol	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.5	1.5	0.2	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652668-63679020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;RH-30: 2.6;SH-SY5Y: 3.6"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.2"	"HPA043322, HPA058399"	Enhanced									"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.1	26.6	0.0	73.9	0.0	0.0	0.6	0.3	0.0	0.0	29.5	0.0	0.0	0.0	18.5	0.1	0.0	1.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.5	0.5	0.0	0.0	0.0	0.3	0.2	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.4	2.6	0.2	0.2	0.4	0.3	3.6	0.1	0.4	0.0	0.1	0.3	0.0	0.7	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0
INHA		ENSG00000123999	"Inhibin alpha subunit"	P05111	2	219569162-219575713	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;CAPAN-2: 4.3;HEL: 5.6;SK-BR-3: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000047, HPA019141"	Enhanced		Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"CAB000047: AB_322161, HPA019141: AB_1851789"	"unprognostic (8.90e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (9.61e-3)"	"unprognostic (4.15e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.73e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (4.03e-5)"	"unprognostic (4.85e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.43e-2)"	0.5	24.2	0.8	0.5	8.4	0.0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0.0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0.0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	2.5	0.8	0.2	4.6	0.5	0.4	0.7	0.2	0.3	4.3	0.0	0.3	1.0	2.7	0.3	0.7	0.0	0.0	0.8	5.6	2.0	3.0	0.4	0.0	0.0	1.0	1.3	0.0	0.7	0.0	3.4	0.0	0.1	3.1	0.0	0.2	1.7	1.1	0.1	0.2	0.0	0.7	0.3	0.5	1.1	1.6	13.0	0.4	0.8	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5
LHX9		ENSG00000143355	"LIM homeobox 9"	Q9NQ69	1	197911902-197935478	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ovary: 22.1;retina: 24.3;testis: 17.5"	"Cell line enriched"	"Detected in some"	10	"fHDF/TERT166: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"hippocampal formation: 6.9;midbrain: 20.7;thalamus: 13.3"	"Group enriched"	"Detected in many"	5	"midbrain: 38.1;pons and medulla: 11.9;thalamus: 24.4"	HPA009695	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA009695: AB_1079251"	"unprognostic (8.05e-2)"	"unprognostic (1.18e-1)"		"unprognostic (1.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.62e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.42e-1)"		"unprognostic (1.88e-1)"	0.3	0.2	1.7	0.1	1.0	0.1	0.1	0.1	0.5	1.1	0.3	0.7	0.4	0.2	0.8	4.1	0.1	0.4	0.2	1.5	0.7	2.6	0.1	1.2	2.7	0.1	0.8	0.0	22.1	0.1	0.1	1.4	0.1	3.1	0.1	0.2	24.3	0.1	0.2	0.9	0.1	0.2	0.1	0.5	0.1	0.1	17.5	0.5	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.2	2.1	0.1	0.0	0.0	0.0	0.0	77.1	0.0	1.9	0.0	0.6	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.3	2.3	0.8	0.0	0.0	0.0	1.8	0.0	0.7	0.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.1	0.5	0.7	2.6	0.8	0.0	3.1	0.5
LRRTM3		ENSG00000198739	"Leucine rich repeat transmembrane neuronal 3"	Q86VH5	10	66926006-67099830	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 7.3;brain: 29.1;ovary: 8.0;pituitary gland: 26.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;Daudi: 2.2;HAP1: 10.6;NTERA-2: 2.3;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA070444, HPA078598"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA070444: , HPA078598: "					"unprognostic (1.21e-2)"					"unprognostic (4.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.02e-2)"		"unprognostic (1.15e-4)"	"unprognostic (8.11e-2)"		"unprognostic (4.77e-1)"	0.9	7.3	12.9	1.0	18.7	0.9	0.9	19.7	29.1	1.7	0.9	3.2	0.0	1.0	1.2	0.9	1.4	0.9	0.9	0.9	7.0	6.5	1.0	0.9	1.4	0.9	3.7	16.0	8.0	3.7	0.9	26.6	0.9	4.5	1.2	0.9	0.0	1.0	1.2	1.0	0.9	1.1	1.0	2.8	0.9	0.9	1.9	5.9	0.0	0.9	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.4	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	18.7	19.7	21.3	7.0	6.5	3.7	16.0	4.5	5.9
PCDH11X	"PCDH-X, PCDH11, PCDHX, PPP1R119"	ENSG00000102290	"Protocadherin 11 X-linked"	Q9BZA7	X	91779261-92623230	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 7.0;ovary: 12.6;parathyroid gland: 5.2"	"Group enriched"	"Detected in some"	5	"AF22: 4.2;AN3-CA: 6.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077495	Approved									"HPA077495: "	"unprognostic (4.22e-3)"	"unprognostic (1.16e-1)"		"unprognostic (1.39e-4)"	"unprognostic (1.18e-1)"			"unprognostic (8.20e-3)"		"unprognostic (6.32e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.19e-2)"		"unprognostic (4.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.86e-1)"	0.0	0.3	2.6	0.1	7.0	0.0	0.2	0.0	4.8	1.7	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	4.2	0.0	0.0	0.0	0.2	1.3		12.6	0.0	5.2	0.3	1.2		0.0	0.0		0.0	0.4	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0			0.1		0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein (gene/pseudogene)"	Q9H310	1	156369212-156385219	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 23.2;kidney: 16.9;ovary: 5.9"	"Group enriched"	"Detected in some"	65	"CACO-2: 4.7;Hep G2: 5.6;RT4: 9.7"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in some"	15	"cerebellum: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favourable (8.06e-4)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	23.2	0.1	0.3	0.3	0.0	1.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.1	16.9	3.3	0.1	0.0	0.1	0.1	5.9	0.2	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.3	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	1.1	1.2	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.2	0.1	0.1	0.1	0.1	0.1	1.5	0.0
SGCZ	ZSG1	ENSG00000185053	"Sarcoglycan zeta"	Q96LD1	8	14089864-15238339	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.2;ovary: 11.3;pituitary gland: 7.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;REH: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 5.6;basal ganglia: 9.5;cerebellum: 21.2;cerebral cortex: 6.8;pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA017585	Uncertain									"HPA017585: AB_1856799"					"unprognostic (3.83e-1)"						"unprognostic (1.41e-1)"			"unprognostic (5.87e-4)"	"unprognostic (1.21e-1)"			1.1	0.4	5.6	0.5	9.5	0.6	2.6	21.2	6.8	0.8	0.7	0.0	0.0	0.7	0.9	1.4	0.4	0.5	0.7	0.5	1.4	2.2	1.0	0.7	0.4	0.4	1.3	2.3	11.3	0.7	0.4	7.3	0.5	5.3	0.8	0.5	0.1	0.4	0.6	0.4	0.9	0.5	0.9	3.2	0.5	0.7	1.4	1.1	0.0	0.4	0.0	0.5	1.5	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	9.5	21.2	6.8	1.4	2.2	1.3	2.3	5.3	1.1
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	"Calcium/calmodulin dependent protein kinase IG"	Q96NX5	1	209583717-209613938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.4;ovary: 29.2"	"Cell line enhanced"	"Detected in some"		"BJ: 2.0;hTEC/SVTERT24-B: 12.1;NTERA-2: 1.9;SK-MEL-30: 3.6;U-138 MG: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.17e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-3)"	"unprognostic (8.55e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.43e-2)"	0.7	3.5	7.5	0.9	34.4	1.0	0.7	1.3	27.8	1.1	0.8	0.7	1.2	0.8	1.8	6.1	0.6	0.9	1.5	0.6	10.9	9.2	6.9	0.9	1.2	0.8	3.6	17.7	29.2	1.3	0.6	2.0	2.8	3.9	4.6	0.8	0.6	0.6	7.4	0.6	0.6	0.8	2.3	0.9	6.1	0.7	1.4	2.7	0.0	0.7	0.0	0.8	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.0	0.3	0.8	0.3	0.0	0.2	0.0	0.0	0.8	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	12.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.2	2.1	0.2	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	34.4	1.3	27.8	10.9	9.2	3.6	17.7	3.9	2.7
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124501	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"ovary: 17.7"	"Cell line enriched"	"Detected in single"	19	"HEL: 15.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	"Plasma membrane,Intermediate filaments,Cytokinetic bridge"				"Plasma membrane, Intermediate filaments"	"Plasma membrane, Intermediate filaments"	"HPA041269: AB_2732491, HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.2	0.2	4.2	0.2	2.0	2.3	0.2	0.0	2.5	0.2	0.2	0.3	0.0	0.4	0.2	0.2	0.3	0.3	0.2	0.6	2.1	4.3	0.2	0.2	0.2	0.2	4.0	1.6	17.7	0.2	0.2	0.4	0.5	1.9	2.0	0.2	2.1	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.2	0.5	1.4	0.5	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.2	2.0	0.0	2.5	2.1	4.3	4.0	1.6	1.9	0.5
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795926-138904070	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 8.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain									"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0.0	0.2	0.6	7.7	1.0	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0.0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0.0	0.4	0.0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0.0	0.2	0.1	0.2	0.8	0.0	0.4	1.2	0.0	0.0	0.1	0.1	0.8	0.8	0.8	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.5	2.7	0.2	0.0	0.1	0.9	0.4	1.3	0.9	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.6	1.0	0.6	0.6	0.5	0.3	0.2	0.0	0.6	2.8	0.6	0.2	0.7	0.4	0.3	1.1	0.0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.7	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0.0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0.0	8.1	0.8
LEFTY2	"EBAF, LEFTA, LEFTYA, TGFB4"	ENSG00000143768	"Left-right determination factor 2"	O00292	1	225936598-225941489	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"endometrium 1: 61.1;ovary: 80.0"	"Group enriched"	"Detected in some"	5	"NTERA-2: 24.7;RPMI-8226: 26.6"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 41.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"											"CAB025801, HPA047883, HPA056210"	Approved				"Secreted in other tissues"					"CAB025801: , HPA047883: AB_2680200, HPA056210: "	"unprognostic (3.78e-2)"	"unprognostic (4.10e-3)"	"unprognostic (5.79e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.75e-4)"	"unprognostic (2.91e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.90e-4)"	"unprognostic (1.64e-3)"	0.5	0.4	0.1	0.3	0.2	0.0	0.5	0.1	0.2	15.2	0.5	0.7	0.1	0.0	61.1	4.5	0.2	1.1	0.1	0.8	0.4	0.0	0.4	0.1	0.7	0.1	0.2	0.1	80.0	0.1	0.0	8.5	16.3	0.6	0.9	0.0	0.9	0.1	4.4	0.2	0.0	0.2	14.7	0.1	0.1	0.0	1.8	0.1	0.3	0.1	0.1	0.1	0.3	0.5	0.5	0.0	0.9	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	24.7	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	1.4	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.7	0.8	0.1	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.2	0.4	0.0	0.2	0.1	0.6	0.1
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451200-110457354	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"ovary: 107.6;testis: 52.8"	"Cell line enriched"	"Detected in some"	11	"ASC diff: 23.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.7"	"Region enriched"	"Detected in single"	9	"basal ganglia: 4.9"	"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.5;NK-cell: 1.0"	"Group enriched"	"Detected in many"	8	"NK-cells: 1.0;T-cells: 1.5"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (2.66e-1)"	"unprognostic (2.71e-2)"		"unprognostic (1.30e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	0.8	2.8	0.1	0.1	4.9	0.0	1.2	0.1	0.3	3.4	0.2	0.2	0.5	0.0	0.3	1.5	0.3	1.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	107.6	0.1	0.0	0.1	18.0	0.5	3.6	0.0	0.1	0.1	4.0	0.2	0.4	0.1	0.1	0.4	0.3	0.0	52.8	0.1	0.1	0.2	0.2	0.1	1.5	6.8	0.1	0.0	0.0	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	23.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	4.9	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.1
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798857	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 69.1;brain: 137.3;epididymis: 44.5;ovary: 42.7"	"Cell line enhanced"	"Detected in many"		"BJ: 27.1;RPTEC TERT1: 35.8"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA042380	Uncertain									"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	3.0	69.1	61.2	2.7	48.6	2.5	3.0	33.5	137.3	5.9	3.0	50.4	1.8	3.0	6.7	44.5	3.7	9.3	5.1	3.5	49.6	43.4	15.4	2.3	7.5	2.3	58.2	36.3	42.7	18.1	2.2	6.9	4.4	42.0	6.9	3.0	6.3	5.6	12.4	1.7	4.8	3.7	6.2	57.1	3.0	4.3	14.8	43.4	1.2	16.4	0.0	3.0	3.8	2.0	0.9	1.3	3.0	1.2	2.0	7.2	1.8	4.4	2.8	14.5	7.4	8.0	5.2	0.3	27.1	13.4	11.9	9.2	0.3	0.7	8.8	9.5	5.6	7.9	4.2	3.0	15.0	1.7	1.9	0.4	3.5	0.4	1.2	3.9	2.9	4.1	12.2	2.4	2.1	19.0	0.6	1.1	6.2	1.7	16.0	0.9	1.1	1.9	13.7	8.6	6.9	35.8	4.4	8.1	4.6	4.5	0.4	2.6	0.6	2.0	23.3	12.8	7.5	4.8	7.3	2.5	1.0	0.9	6.2	4.1	3.6	3.0	1.2	0.4	7.2	0.5	4.6	0.5	1.7	4.3	0.5	0.9	1.5	5.1	2.0	2.0	0.9	1.3	0.4	1.8	61.2	48.6	33.5	41.2	49.6	43.4	58.2	36.3	42.0	43.4
TRABD2A	"C2orf89, TIKI1"	ENSG00000186854	"TraB domain containing 2A"	Q86V40	2	84821650-84907008	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HDLM-2: 18.3;HSkMC: 13.0;hTEC/SVTERT24-B: 10.7;SiHa: 10.4"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 14.4;stomach cancer: 3.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 29.3"	"Lineage enriched"	"Detected in many"	17	"T-cells: 29.3"									HPA045817	Approved				"Intracellular and membrane"					"HPA045817: AB_2679460"	"unprognostic (7.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-5)"	"unprognostic (2.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.47e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.37e-1)"	1.8	0.5	0.7	24.7	1.6	2.1	6.3	0.6	3.7	0.5	23.2	0.9	0.0	2.4	0.5	0.4	0.5	1.3	0.2	0.7	0.9	0.8	0.9	0.9	3.0	11.3	0.9	3.1	23.7	0.4	0.4	0.6	2.0	0.2	0.5	26.6	1.2	3.3	0.0	0.3	1.2	9.3	1.8	0.9	3.1	0.6	0.6	0.0	6.4	0.7	0.0	6.3	0.7	0.7	1.7	0.6	0.5	0.1	1.3	29.3	5.3	0.7	0.6	0.2	0.1	7.2	7.8	24.3	1.2	1.9	3.5	6.4	0.3	2.7	0.0	0.3	3.8	0.0	1.7	0.3	5.2	18.3	0.4	0.0	5.1	0.0	0.8	0.0	0.0	13.0	0.0	10.7	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.1	0.2	3.4	0.4	0.0	1.2	2.2	0.0	0.0	3.0	2.0	0.0	0.0	0.1	0.0	3.3	0.1	4.0	0.3	13.1	5.0	0.6	1.7	29.3	18.2	0.5	1.3	0.0	0.6	8.5	5.3	0.7	1.6	0.6	3.7	0.9	0.8	0.9	3.1	0.2	0.0
WASF1	"KIAA0269, SCAR1, WAVE, WAVE1"	ENSG00000112290	"WAS protein family member 1"	Q92558	6	110099819-110180004	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.3;ovary: 17.7;testis: 55.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"memory B-cell: 3.9;naive B-cell: 5.9;plasmacytoid DC: 10.7"	"Group enriched"	"Detected in many"	10	"B-cells: 5.9;dendritic cells: 10.7"	"Low region specificity"	"Detected in all"							"HPA004105, CAB022161"	Approved	Supported								"CAB022161: , HPA004105: AB_1080583"	"unprognostic (8.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.30e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.82e-8)"	"unprognostic (9.20e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.38e-1)"	5.4	7.6	19.8	3.4	44.3	7.1	5.5	18.0	63.3	5.4	3.9	10.9	0.5	2.3	9.9	5.1	6.1	4.9	6.6	1.8	43.8	10.3	6.5	4.6	2.6	3.3	10.6	26.7	17.7	4.6	4.1	5.8	2.8	17.0	4.3	3.5	0.9	3.3	4.3	1.3	4.3	2.7	10.5	12.8	2.4	3.0	55.4	9.3	1.0	2.3	0.6	3.4	4.6	2.8	5.9	10.7	0.1	0.8	0.6	0.3	0.5	3.3	3.8	20.2	16.4	8.7	11.3	2.2	7.1	8.2	6.1	10.7	6.5	3.2	19.3	4.6	11.1	3.8	31.4	9.7	10.6	0.3	14.8	37.7	7.4	5.9	15.7	2.2	5.8	8.9	13.8	8.4	41.8	9.2	14.2	4.5	7.0	2.8	19.8	0.6	18.2	5.0	18.3	7.4	0.7	9.8	3.9	16.3	25.3	5.0	3.7	4.6	4.7	9.7	6.8	5.6	5.8	16.4	9.5	0.1	3.0	16.9	6.3	16.3	4.1	0.0	0.7	0.0	0.1	0.2	0.3	3.9	0.3	0.0	0.8	5.9	0.1	0.1	0.1	0.6	0.8	10.7	0.0	0.5	19.8	44.3	18.0	48.9	43.8	10.3	10.6	26.7	17.0	9.3
ABCA10	EST698739	ENSG00000154263	"ATP binding cassette subfamily A member 10"	Q8WWZ4	17	69147214-69244846	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.7;HSkMC: 3.7;HUVEC TERT2: 3.6;RT4: 3.5;U-2197: 5.4"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.8"									HPA014535	Uncertain									"HPA014535: AB_1844426"	"unprognostic (1.45e-4)"	"unprognostic (3.17e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.91e-1)"	"unprognostic (2.70e-4)"	"unprognostic (5.23e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.86e-3)"	4.6	0.5	0.0	0.0	0.2	0.0	10.4	5.0	0.4	1.6	1.7			0.6	2.7	2.4	1.1	6.3	3.1	2.7	0.1	0.2	0.5	2.7	2.5	0.1	0.1		11.6	1.3	0.1	1.3	0.0		0.8	3.8		2.6	0.2	3.5	4.1	1.4	1.7	0.2	0.3	1.0	1.6			3.1		0.3	1.3	1.9	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.2	0.0	1.7	0.3	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.8	0.0	0.0	0.0	1.4	0.0	1.0	0.0	0.0	3.7	0.5	0.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC011043.2		ENSG00000278198			Unmapped	173872-179372	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 1.2;skin 1: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 6.3;NB-4: 5.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1		0.0		0.0	0.0		0.5	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0	0.0	0.0	0.0			1.2	1.0	0.0		0.1		1.1	0.3		0.9	0.2	0.1	1.8	0.3	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.2	0.1	0.0	0.0	0.5	0.7	0.0	6.3	0.4	1.8	2.4	0.5	0.1	1.7	0.8	0.5	0.7	1.4	2.6	0.6	0.1	0.3	0.1	1.9	1.7	0.5	1.9	1.4	2.0	1.2	1.7	2.5	0.1	2.5	2.7	0.0	0.8	0.6	1.2	0.3	0.5	2.1	0.9	0.4	0.5	5.4	1.1	0.1	0.1	0.4	0.0	0.3	0.3	0.6	0.3	0.3	0.2	1.2	0.1	1.2	0.1	1.2	0.5	0.4	1.2	0.6	0.5	0.1	0.6	1.8	1.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0										
AC011455.2		ENSG00000269547			19	38915404-38949855	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.6;ovary: 3.0"	"Cell line enhanced"	"Detected in some"		"A-431: 3.7;A549: 5.1;T-47d: 4.3;U-251 MG: 6.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA052730, HPA056957"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA052730: AB_2681929, HPA056957: AB_2683286"										"unprognostic (6.10e-2)"			"unprognostic (3.79e-2)"					1.3	2.6	0.3	1.7	0.3	0.0	0.1	0.4	1.1	0.3	0.1			0.0	1.2	0.5	0.1	0.4	0.8	1.1	0.1	0.1	1.6	1.1	0.2	0.0	0.2		3.0	0.6	0.0	0.1	0.5		0.2	0.0		0.1	0.0	0.2	0.2	0.2	0.0	0.3	0.1	0.1	0.5			0.1		0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.1	0.0	2.8	0.9	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.5	0.3	1.1	0.5	1.1	0.3	1.9	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	4.3	0.2	0.0	1.4	1.3	0.0	6.3	0.0	0.5	0.0	2.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC011841.1		ENSG00000273496			Unmapped	99351-104855	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 1.2;skin 1: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 6.3;NB-4: 5.4"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1		0.0		0.0	0.0		0.5	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0	0.0	0.0	0.0			1.2	1.0	0.0		0.1		1.1	0.3		0.9	0.2	0.1	1.8	0.3	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.2	0.1	0.0	0.0	0.5	0.7	0.0	6.3	0.4	1.8	2.4	0.5	0.1	1.7	0.8	0.5	0.7	1.4	2.6	0.6	0.1	0.3	0.1	1.9	1.7	0.5	1.9	1.4	2.0	1.2	1.7	2.5	0.1	2.5	2.7	0.0	0.8	0.6	1.2	0.3	0.5	2.1	0.9	0.4	0.5	5.4	1.1	0.1	0.1	0.4	0.0	0.3	0.3	0.6	0.3	0.3	0.2	1.2	0.1	1.2	0.1	1.2	0.5	0.4	1.2	0.6	0.5	0.1	0.6	1.8	1.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0										
AC233723.1		ENSG00000262165			17	4801159-4807013	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 4.7;pancreas: 3.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.7;SCLC-21H: 14.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.6"																"unprognostic (3.93e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	0.3	0.9	0.3	0.3	0.3	0.0	0.8	0.3	1.4	0.8	0.3	0.3	0.3	0.0	0.4	0.3	0.3	1.5	0.3	1.0	0.3		0.5	0.3	0.5	0.3	0.3	0.3	4.7	3.4	0.0	0.3	0.3	0.3	1.1	0.0	0.3	0.4	0.5	1.0	2.3	0.3	0.5	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.8	0.7	1.2	1.9	0.3	2.4	1.1	0.4	0.9	0.0	4.7	0.7	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.0	0.0	0.7	1.5	1.3	0.5	1.0	0.0	1.3	0.5	0.7	0.0	0.8	0.7	1.3	0.1	0.2	0.0	1.4	0.0	14.7	0.8	0.0	0.0	0.3	0.0	0.0	2.0	0.2	0.5	0.3	0.1	0.2	0.0	0.5	0.4	0.0	0.2	0.0	1.9	0.0	1.1	0.0	1.8	1.4	1.0	0.1	0.7	1.8	1.7	2.4	1.2	0.3	1.6	0.1	0.4	1.1										
ACSM3	"SA, SAH"	ENSG00000005187	"Acyl-CoA synthetase medium chain family member 3"	Q53FZ2	16	20610243-20797581	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6;ovary: 47.7;pancreas: 46.6"	"Cell line enhanced"	"Detected in some"		"HEL: 19.9;HMC-1: 84.0;K-562: 59.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 18.3;T-cells: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041013	Uncertain									"HPA041013: AB_10671693"	"unprognostic (1.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.14e-3)"	"prognostic favourable (1.97e-4)"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-3)"	"prognostic favourable (9.88e-6)"	"unprognostic (1.27e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-2)"	2.1	1.8	0.3	3.7	1.0	3.4	18.6	0.4	0.4	10.9	7.0	0.5	4.3	1.7	10.4	5.3	2.9	11.2	5.0	4.0	0.3	0.3	33.1	58.6	6.4	3.7	0.4	0.3	47.7	46.6	5.1	1.0	1.8	0.7	9.6	7.2	1.4	3.6	6.5	1.0	2.0	3.1	3.2	0.5	1.3	10.9	14.7	0.3	1.5	1.5	1.6	1.8	3.9	6.6	2.2	1.9	18.3	2.9	1.9	7.4	2.3	0.2	2.7	0.5	0.1	0.8	0.5	0.3	0.0	0.2	0.0	0.2	0.2	3.9	0.3	4.4	0.0	0.3	0.0	0.4	0.3	0.9	1.4	19.9	0.0	1.5	0.2	2.2	84.0	0.8	0.4	0.1	0.3	0.0	59.1	3.3	0.0	0.3	0.1	0.7	0.1	0.7	0.6	0.0	4.2	4.0	0.2	0.1	0.1	0.0	1.1	0.0	1.3	0.1	0.3	0.2	0.2	0.2	0.1	4.8	3.7	0.2	0.2	1.5	0.1	2.3	1.6	18.3	3.3	1.0	3.8	1.4	4.1	3.0	0.2	2.2	6.5	7.4	0.5	1.9	2.9	1.9	4.6	2.3	0.3	1.0	0.4	0.4	0.3	0.3	0.4	0.3	0.7	0.3
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835747-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 112.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.9;BJ: 71.0;hTEC/SVTERT24-B: 49.0;hTERT-HME1: 44.6;RPTEC TERT1: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdTCR: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 9.0;T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016394, HPA031498"	Uncertain		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	1900000	1900000	"Plasma membrane"	"Plasma membrane"	"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	70.6	13.4	8.2	18.7	14.0	0.7	29.0	6.3	9.2	22.0	18.2	9.5	4.8	3.3	27.7	25.8	30.0	45.8	62.3	40.9	7.6	4.8	15.4	22.8	25.0	10.9	12.7	3.7	112.8	9.3	6.3	7.6	56.8	13.2	23.3	16.5	7.8	5.8	8.1	25.7	6.1	16.2	46.4	10.2	7.2	16.8	12.8	11.4	0.0	14.3	18.1	2.7	32.7	45.3	0.0	0.0	0.0	0.0	9.0	8.0	1.4	0.0	0.0	1.1	0.0	60.9	15.1	3.7	71.0	24.8	12.3	8.1	0.0	0.0	0.0	4.9	22.5	1.3	0.8	3.6	21.7	0.0	22.6	0.0	7.4	0.0	11.7	2.8	0.0	16.9	0.0	49.0	44.6	5.0	1.2	0.0	36.4	0.0	0.3	0.0	4.0	2.8	0.0	28.1	0.2	41.6	4.0	0.0	5.5	3.3	0.0	0.3	0.1	0.7	5.1	17.5	0.9	27.2	10.5	0.1	0.0	0.0	14.4	0.0	5.3	0.0	0.0	0.0	8.0	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.0	1.5	0.0	9.0	0.0	0.0	0.0	1.4	8.2	14.0	6.3	9.2	7.6	4.8	12.7	3.7	13.2	11.4
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;ovary: 16.3"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 6.2;U-2 OS: 4.9;U-2197: 9.1;U-87 MG: 4.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;cerebral cortex: 5.2"	"Cell type enriched"	"Detected in single"	10	"NK-cell: 3.6"	"Lineage enriched"	"Detected in single"	10	"NK-cells: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"			"Nuclear membrane, Mitochondria"	"Nuclear membrane, Mitochondria"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	7.4	0.4	1.8	0.5	2.8	0.6	1.0	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11.0	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0.0	0.5	0.2	2.2	0.7	0.4	0.0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0.0	0.0	0.8	0.0	0.1	3.4	1.5	0.2	0.1	0.3	0.0	3.6	0.2	0.0	2.6	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.2	3.3	0.0	0.2	0.0	0.0	0.8	0.1	1.6	0.1	3.9	0.1	0.0	0.3	0.1	0.0	0.0	6.2	0.2	0.0	0.8	0.4	1.2	0.1	0.1	0.3	1.7	2.5	0.5	3.3	0.2	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	3.3	4.9	9.1	2.1	0.5	0.2	0.1	4.7	0.1	0.4	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0.0	0.0	0.0	0.0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0.0
ADRB3		ENSG00000188778	"Adrenoceptor beta 3"	P13945	8	37962991-37966965	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 23.9;ovary: 15.7;smooth muscle: 10.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.3;Karpas-707: 1.0;U-2 OS: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"amygdala: 1.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA061969	Uncertain									"HPA061969: AB_2732674"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.64e-3)"	"unprognostic (5.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.07e-1)"		"unprognostic (1.14e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.10e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.06e-3)"	0.4	0.1	1.3	1.9	0.3	0.3	0.3	0.0	0.8	1.6	2.3	0.0	0.0	0.4	0.9	1.9	1.7	5.3	23.9	0.1	0.2	0.1	0.1	0.0	0.2	1.2	0.0	0.0	15.7	0.0	0.0	0.0	4.7	0.0	4.1	0.4	0.0	0.0	0.1	0.0	0.1	0.9	10.8	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.1	9.9	1.5	0.9	0.2	1.2	0.4	0.8	0.5	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.0	2.3	0.4	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.4	0.3	0.4	1.3	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.0	0.3	0.3	0.1	0.1	0.4	0.7	0.2	0.1	0.0	0.9	0.2	0.2	1.2	0.8	0.4	0.2	0.5	0.0	1.3	0.3	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0
AJAP1	"MOT8, SHREW-1, SHREW1"	ENSG00000196581	"Adherens junctions associated protein 1"	Q9UKB5	1	4654732-4792534	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;ovary: 13.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.9;EFO-21: 6.0;hTERT-HME1: 3.5;RPTEC TERT1: 22.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"eosinophil: 4.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.1;granulocytes: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.11e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.58e-1)"	"prognostic favourable (1.89e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.49e-2)"	1.4	1.8	18.9	1.1	9.9	0.9	1.1	3.8	18.0	3.0	1.2	4.7	1.6	1.4	2.8	2.5	1.3	2.4	1.2	0.8	10.8	6.0	8.2	1.0	1.2	1.2	6.3	13.4	13.1	3.1	0.9	0.7	1.5	5.5	2.3	1.1	2.2	1.3	6.7	1.3	1.2	1.2	1.6	4.1	3.2	1.3	2.6	7.2	0.0	1.2	0.0	1.2	1.3	1.1	0.0	2.1	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	2.9	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.0	0.0	0.0	0.7	22.2	0.0	1.1	0.6	0.0	2.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	18.9	9.9	3.8	14.9	10.8	6.0	6.3	13.4	5.5	7.2
AL035425.2		ENSG00000260548			X	108722070-108732687	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 13.0;pituitary gland: 7.4;thyroid gland: 8.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 18.6;NTERA-2: 2.6;RT4: 4.8;WM-115: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	2.9	0.0			0.0	3.9	0.9	0.0	0.5	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.5		13.0	0.9	0.0	7.4	0.0		0.1	0.0		0.0	0.7	0.0	1.1	0.0	1.5	0.1	0.0	0.4	0.0			8.9		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.1;ovary: 38.2;testis: 15.2"	"Group enriched"	"Detected in some"	18	"HEL: 27.6;K-562: 15.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"hippocampal formation: 14.3"	"HPA060228, HPA069636"			Approved	"Nucleoplasm,Vesicles,Centriolar satellite,Cytosol"				Vesicles	Vesicles	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.3	27.1	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.6	0.4	0.2	0.4	0.8	0.2	0.0	0.2	1.1	0.3	0.2	0.2	0.2	38.2	8.8	0.1	0.2	0.2	0.3	0.4	0.0	0.2	0.2	0.2	2.5	0.0	0.4	0.5	0.2	3.7	0.3	15.2	0.2	0.2	0.2	0.5	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	27.6	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079951	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.9;fHDF/TERT166: 42.2;LHCN-M2: 42.2;RT4: 57.8;U-2 OS: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		160000	160000	"Golgi apparatus, Plasma membrane"	"Golgi apparatus, Plasma membrane"	"HPA054004: AB_2682339, HPA059601: AB_2684078"	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	5.6	11.9	5.4	4.0	8.8	1.4	14.5	1.6	6.5	18.3	20.3	3.5	1.9	1.6	19.7	12.4	3.1	21.2	12.4	3.4	2.7	7.5	4.3	2.9	11.9	6.7	2.9	5.1	43.4	2.3	2.0	9.5	7.6	16.2	12.8	5.6	6.7	3.1	7.1	1.5	2.3	7.1	21.0	3.0	9.8	3.5	13.1	3.6	1.6	2.5	4.1	4.5	16.6	15.1	2.8	7.4	0.1	0.2	6.6	14.2	4.3	9.7	24.1	1.5	0.0	0.6	0.0	3.9	3.3	9.1	1.1	0.9	0.0	43.9	0.0	11.0	42.2	14.6	0.0	27.0	1.3	1.9	0.1	0.0	2.4	0.0	0.9	0.2	0.4	0.2	4.8	28.9	14.3	3.5	1.8	0.0	42.2	0.4	0.7	0.0	1.0	6.1	0.0	10.9	0.0	12.5	57.8	4.4	0.0	17.4	2.1	0.1	2.6	0.2	0.9	0.6	35.0	0.4	26.9	0.4	0.0	0.0	2.3	0.7	0.6	0.0	0.1	0.0	4.0	0.2	5.4	2.8	6.2	6.2	0.6	1.3	14.2	11.1	0.1	6.6	0.0	7.4	3.6	4.3	5.4	8.8	1.6	6.5	2.7	7.5	2.9	5.1	16.2	3.6
ANGPTL5		ENSG00000187151	"Angiopoietin like 5"	Q86XS5	11	101890674-101916522	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.4;ovary: 24.9"	"Group enriched"	"Detected in some"	6	"ASC diff: 7.7;ASC TERT1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA038516	Uncertain				"Secreted in other tissues"					"HPA038516: AB_10672749"	"unprognostic (8.28e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.23e-2)"		"unprognostic (2.18e-1)"		"unprognostic (4.88e-2)"	"unprognostic (6.74e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-8)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-3)"	9.4	0.3	0.2	0.0	0.3	0.0	6.4	0.2	0.7	1.3	0.3	0.0	0.6	0.1	0.1	5.0	1.0	0.4	0.3	3.7	0.2	0.2	0.1	0.2	1.0	0.1	2.0	0.5	24.9	0.0	0.0	0.3	0.1	0.8	1.4	0.2	0.0	0.5	0.3	1.9	3.5	0.5	1.3	1.7	0.0	0.2	6.2	0.3	0.2	2.4	2.9	0.0	1.8	1.1	0.7	1.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	7.7	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.9	0.0	1.0	0.0	0.0	0.2	0.3	0.2	0.7	0.2	0.2	2.0	0.5	0.8	0.3
ANKRD66		ENSG00000230062	"Ankyrin repeat domain 66"	B4E2M5	6	46746917-46759506	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	6	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																	"unprognostic (1.67e-3)"	"unprognostic (2.52e-1)"			"unprognostic (2.44e-2)"		"unprognostic (2.03e-2)"		"unprognostic (9.36e-2)"		"unprognostic (4.30e-3)"	"unprognostic (2.19e-1)"			0.1	0.2	2.0	0.2	4.3	0.1	0.2	0.0	0.6	1.7	0.1	5.9	0.0	0.1	0.9	12.1	0.1	36.0	0.1	0.1	3.0	3.0	0.1	0.1	7.1	0.2	0.0	0.0	11.1	0.1	0.1	0.5	0.2	15.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.9	1.9	0.0	0.2	0.1	0.2	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.3	0.0	0.6	3.0	3.0	0.0	0.0	15.0	1.9
ANKUB1	C3orf16	ENSG00000206199	"Ankyrin repeat and ubiquitin domain containing 1"	A6NFN9	3	149761100-149968385	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 12.2;lung: 11.9;ovary: 10.4"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.2"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.8"					"Low region specificity"	"Detected in many"			HPA053749	Uncertain									"HPA053749: AB_2682248"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-9)"	"unprognostic (3.06e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.07e-4)"	0.0	0.0	0.8	0.2	1.2	0.6	0.0	0.0	0.3	2.1	0.0	1.8	0.0	0.2	0.9	0.1	0.0	12.2	0.1	0.0	1.5	1.7	0.0	0.0	11.9	0.1	0.0	0.0	10.4	0.1	0.0	1.1	0.1	5.2	0.1	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.3	0.2	0.3	2.2	0.8	0.0	0.0	0.6	0.1	0.1	0.0	0.4	0.3	4.8	0.4	0.2	0.3	0.0	0.6	0.8	0.8	0.3	0.0	0.1	0.6	0.3	0.0	0.1	0.0	1.2	1.2	1.1	0.2	0.0	1.8	0.5	0.6	0.2	0.6	0.4	1.1	2.5	0.5	0.0	0.5	0.9	0.2	0.0	0.0	0.1	0.0	0.6	1.0	0.0	0.4	0.7	1.1	0.5	0.6	1.1	0.8	0.7	0.0	1.1	0.7	0.1	0.5	0.6	0.0	1.0	0.3	0.0	0.7	0.6	0.3	0.4	0.7	0.5	1.0	0.5	1.0	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0.0	0.8	1.2	0.0	0.3	1.5	1.7	0.0	0.0	5.2	0.8
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.2;ovary: 58.7;skeletal muscle: 16.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;PC-3: 6.0;THP-1: 2.5;U-266/70: 12.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 9.5;basal ganglia: 6.7;cerebral cortex: 25.2;hippocampal formation: 10.4;olfactory region: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.5	0.5	9.5	0.5	6.7	0.5	0.7	0.3	25.2	0.5	1.1	1.9	0.0	2.9	0.5	1.8	0.5	1.1	0.5	0.5	10.4	2.6	0.6	0.5	0.8	0.5	0.9	17.1	58.7	2.7	4.4	0.5	0.5	0.0	0.7	1.1	0.0	0.5	0.5	16.9	0.5	1.0	0.5	0.3	0.6	4.9	13.6	3.1	0.0	0.5	0.5	0.8	0.5	0.5	0.0	0.1	0.6	0.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	6.0	0.6	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.5	2.5	0.0	0.0	0.2	0.0	0.0	12.8	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	9.5	6.7	0.3	25.2	10.4	2.6	0.9	17.1	0.0	3.1
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5;HSkMC: 5.3;U-698: 3.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.3	0.8	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.5	0.1	2.4	0.5	0.6	0.3	0.0	0.0	0.0	0.1	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.3	0.0	0.0	0.0	0.0	1.2	2.0	0.0	0.7	0.5	3.4	0.0	1.3	0.7	0.6	2.9	0.0	0.2	0.6	0.6	0.0	0.4	3.8	0.6	0.4	0.7	1.2	1.2	0.2	0.6	0.8	0.7	3.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369796-382116	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1;ovary: 18.6"	"Cell line enhanced"	"Detected in many"		"AF22: 19.7;NTERA-2: 17.6;SCLC-21H: 21.9;SH-SY5Y: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053126	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Mitotic spindle"	"Intracellular and membrane"			"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	1.6	2.5	20.6	2.8	16.7	1.2	3.5	26.5	35.1	5.9	2.0	8.6	0.8	2.4	8.6	2.4	1.8	8.7	2.1	1.4	17.6	16.8	1.2	1.1	1.3	1.6	11.5	14.9	18.6	1.8	6.3	6.1	1.1	13.0	3.8	1.6	2.3	4.0	3.7	1.1	3.8	2.9	3.1	8.3	1.5	1.5	1.8	11.0	0.0	1.1	0.0	1.7	1.3	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	19.7	11.3	0.0	0.0	4.6	3.5	0.9	1.6	0.5	2.0	0.0	0.0	2.6	0.4	0.7	2.6	4.7	0.5	0.0	6.7	0.0	6.2	6.1	0.2	0.0	4.8	0.3	2.8	0.1	2.1	0.2	6.0	0.0	0.0	5.8	0.2	0.0	17.6	7.7	0.0	0.0	2.6	0.2	0.0	21.9	26.7	1.3	0.9	0.2	7.7	0.0	4.8	1.1	6.3	1.9	0.2	0.0	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	16.7	26.5	21.2	17.6	16.8	11.5	14.9	13.0	11.0
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677342-28682939	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 46.8;seminal vesicle: 52.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.8;SK-MEL-30: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"				Vesicles	Vesicles	"HPA010819: AB_2668371, HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favourable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	2.0	24.7	6.7	1.8	6.9	3.0	13.6	2.2	6.3	3.9	2.3	12.9	15.5	1.1	10.1	2.0	1.1	2.8	3.0	22.8	6.7	6.4	11.2	12.9	5.7	3.1	12.0	2.9	46.8	3.9	7.4	4.5	20.9	10.5	6.5	2.8	30.4	3.8	52.4	1.2	2.7	1.1	12.7	10.8	9.0	2.3	4.8	7.9	0.1	0.6	2.1	1.3	13.8	11.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.2	10.8	1.1	0.6	1.3	0.0	6.5	2.6	0.9	4.2	2.7	42.8	4.5	0.1	1.6	1.9	3.2	2.6	0.4	1.9	2.6	6.0	10.1	1.6	16.2	1.5	0.6	13.4	1.0	0.6	2.8	0.4	0.6	5.7	4.9	0.8	17.8	0.0	0.7	19.6	2.7	0.1	2.0	0.9	3.4	10.4	1.8	1.4	3.5	20.8	51.1	6.1	0.7	0.0	2.8	2.1	4.5	1.3	0.1	3.7	0.0	0.2	2.3	17.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.7	6.9	2.2	4.8	6.7	6.4	12.0	2.9	10.5	7.9
BLID	BRCC2	ENSG00000259571	"BH3-like motif containing, cell death inducer"	Q8IZY5	11	122115354-122116215	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 1.4"	"Cell line enhanced"	"Detected in some"		"BJ: 2.5;hTEC/SVTERT24-B: 3.0;hTERT-HME1: 2.6;LHCN-M2: 4.1;U-87 MG: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0			0.0	0.1	1.1	0.3	0.8	0.3	1.1	0.5	0.2	0.4	0.5	0.2	0.0	0.2		1.4	0.0	0.0	0.2	0.1		0.5	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7			0.7		0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.0	0.7	0.9	0.0	2.5	1.5	0.7	0.5	0.0	0.1	0.0	0.1	1.1	0.1	0.0	1.5	1.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	3.0	2.6	0.4	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.8	0.1	0.3	1.2	0.0	0.0	0.0	5.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BNC2	"BSN2, FLJ20043"	ENSG00000173068	"Basonuclin 2"	Q6ZN30	9	16409503-16870843	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.8;ovary: 37.0"	"Cell line enhanced"	"Detected in many"		"HSkMC: 18.1;Karpas-707: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"gdTCR: 5.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018525, HPA059419"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018525: AB_1845402, HPA059419: AB_2732637"	"unprognostic (2.68e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.14e-3)"	4.3	1.0	0.5	5.1	0.7	0.3	4.3	0.5	0.7	19.8	7.6	1.8	2.9	0.8	35.8	5.5	3.8	14.3	9.3	3.8	1.2	0.5	7.6	0.4	2.6	0.9	0.9	0.5	37.0	0.5	2.7	1.5	2.2	2.3	6.4	2.1	11.0	1.3	4.8	7.6	2.9	2.8	23.1	2.0	0.5	3.0	4.7	1.0	0.9	1.7	3.6	1.3	8.5	9.0	0.1	0.0	0.0	0.0	1.0	5.8	3.2	0.1	0.9	0.7	0.0	9.9	12.2	1.5	6.1	10.8	4.4	3.6	0.0	0.0	0.0	2.0	4.2	0.0	2.9	0.0	4.5	0.1	1.1	0.1	2.9	0.0	7.6	0.0	0.2	18.1	0.0	9.3	0.0	9.8	0.0	22.1	6.2	0.0	0.0	1.5	3.6	5.6	0.0	6.9	14.8	3.3	0.2	0.1	0.5	0.0	0.0	10.5	0.0	0.0	9.6	10.4	7.6	8.3	11.2	0.1	0.0	0.0	4.2	1.3	1.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	1.0	0.0	0.0	0.0	3.2	0.5	0.7	0.5	0.7	1.2	0.5	0.9	0.5	2.3	1.0
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405648	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 101.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA017060	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA017060: AB_1845467"	"prognostic favourable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	29.6	72.2	8.4	31.1	9.8	13.6	27.9	2.5	7.6	14.4	12.0	5.6	24.8	6.9	13.4	36.7	8.6	26.8	30.1	13.9	7.9	4.9	24.7	30.8	44.9	16.6	10.0	5.2	101.0	6.9	0.3	8.6	31.5	8.8	15.6	4.8	8.4	11.4	17.5	6.0	3.2	14.0	11.3	9.0	32.9	12.3	8.5	9.4	10.3	10.3	5.9	12.3	14.0	42.4	26.2	74.1	35.8	66.4	57.9	32.6	54.5	39.2	0.0	0.1	18.1	0.0	0.1	6.2	0.1	3.0	58.0	78.1	18.4	35.4	30.4	42.9	24.2	0.1	26.4	2.9	1.8	33.5	0.2	0.4	63.6	17.9	33.2	14.3	38.6	0.1	0.0	19.1	0.0	14.7	17.3	75.8	0.0	10.7	6.8	25.1	19.9	50.8	12.8	0.1	63.5	13.8	0.1	0.0	0.1	40.1	1.5	48.2	30.4	20.3	0.1	0.2	1.4	0.0	0.4	39.1	51.0	20.1	0.1	56.7	0.2	35.8	61.6	21.0	32.6	66.4	30.8	21.0	27.5	30.2	50.7	26.2	22.5	25.6	20.3	57.9	59.3	74.1	24.8	54.5	8.4	9.8	2.5	7.6	7.9	4.9	10.0	5.2	8.8	9.4
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"		11	43942505-43944338	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ovary: 152.0"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Focal adhesion sites, Cytosol"	"Nucleoplasm, Focal adhesion sites, Cytosol"	"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavourable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	68.2	81.2	4.9	23.4	17.4	3.4	42.6	2.6	10.5	39.7	32.2	3.3	6.6	12.4	35.1	41.5	16.3	69.3	70.0	34.3	8.8	7.9	17.9	67.7	61.9	4.9	7.6	4.7	152.0	18.1	3.8	14.2	14.6	32.8	28.6	6.2	7.6	2.3	12.8	38.2	10.1	17.2	22.9	15.3	12.7	31.3	41.7	4.2	0.0	16.7	14.0	2.3	62.9	32.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	1.9	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.4	0.7	0.0	0.0	0.0	0.7	0.8	0.5	0.3	3.2	0.2	1.4	0.0	0.0	0.7	63.8	0.0	0.0	5.9	0.0	0.6	0.8	3.1	1.2	0.7	0.0	7.4	0.0	0.9	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	17.4	2.6	7.1	8.8	7.9	7.6	4.7	32.8	4.2
C20orf203	FLJ33706	ENSG00000198547	"Chromosome 20 open reading frame 203"	Q8NBC4	20	32631652-32673941	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.2;ovary: 2.1"	"Cell line enhanced"	"Detected in some"		"HEL: 7.5;HMC-1: 5.2;NB-4: 2.2;U-266/70: 1.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	13	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 4.2"																				"unprognostic (6.24e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.25e-10)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-5)"	0.1	0.0		0.0		0.3	0.3		1.1	0.2	0.0			0.0	1.0	1.1	0.4	1.1	0.0	0.5			0.0	0.0	0.0	0.4			2.1	0.0	0.0		0.0		0.0	0.0		1.0	0.5	0.0	0.8	0.0	0.0		0.3	0.0	0.3			0.0		0.0	0.0		0.0	0.0	4.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.0	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	2.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	1.1	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0										
C21orf62	"B37, C21orf120, PRED81"	ENSG00000205929	"Chromosome 21 open reading frame 62"	Q9NYP8	21	32793564-32813743	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 13.4;kidney: 18.2;ovary: 16.2;pituitary gland: 38.6"	"Group enriched"	"Detected in some"	11	"AF22: 7.0;RPTEC TERT1: 4.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 11.0"	"Region enriched"	"Detected in many"	4	"pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016899	Enhanced				"Secreted - unknown location"					"HPA016899: AB_1845704"	"unprognostic (1.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.37e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	2.2	0.4	1.6	1.1	2.1	0.3	0.3	0.3	2.4	0.1	0.3	3.9	0.0	0.1	0.2	8.4	0.3	1.2	0.4	0.4	3.0	2.4	18.2	0.3	0.2	0.2	1.5	1.0	16.2	5.6	0.1	38.6	0.1	13.4	4.1	0.1	0.0	0.3	0.3	0.3	0.3	0.6	0.3	1.8	0.2	0.3	0.4	3.1	0.0	0.2	0.0	1.1	0.2	0.3	0.0	0.4	1.1	0.0	0.0	1.7	0.1	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.4	1.7	0.1	1.6	2.1	0.3	2.4	3.0	2.4	1.5	1.0	13.4	3.1
C7		ENSG00000112936	"Complement C7"	P10643	5	40909252-40982939	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 199.9"	"Group enriched"	"Detected in some"	9	"ASC diff: 37.6;HHSteC: 49.7;HSkMC: 68.4;SH-SY5Y: 46.4"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001465	Approved				"Secreted to blood"	67000000000	67000000000			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favourable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	54.4	99.5	0.8	7.4	1.6	0.0	10.5	1.1	1.0	30.2	34.7	3.1	14.8	2.5	36.8	48.6	55.3	47.7	48.2	79.7	0.9	0.3	81.3	41.0	29.1	69.0	3.9	1.5	199.9	32.4	3.0	5.2	55.4	3.7	52.5	4.8	1.4	5.1	17.5	1.9	1.8	17.0	43.3	3.2	33.6	17.9	44.6	0.7	3.1	32.4	1.1	7.2	39.9	29.6	0.7	0.4	1.6	0.3	1.5	0.4	0.0	0.0	0.0	0.0	0.0	37.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.2	0.0	0.7	0.3	0.4	1.1	1.5	0.3	0.4	0.0	0.0	0.8	1.6	1.1	1.0	0.9	0.3	3.9	1.5	3.7	0.7
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430940-59697380	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 28.0"	"Cell line enhanced"	"Detected in some"		"BJ: 26.2;BJ hTERT+: 26.9;BJ hTERT+ SV40 Large T+ RasG12V: 25.2;HBF TERT88: 30.2;hTERT-HME1: 40.9;LHCN-M2: 45.9;TIME: 24.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 10.0"	"Group enriched"	"Detected in some"	7	"basophil: 9.6;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	10.0	12.6	2.4	3.8	1.1	0.4	3.5	0.4	2.0	16.8	15.8	0.6	8.2	0.8	12.1	2.8	2.3	6.9	6.9	2.1	10.0	0.5	3.1	4.3	16.5	3.6	0.4	2.1	28.0	0.8	0.4	2.6	0.3	1.7	3.0	2.3	9.1	1.0	3.5	10.6	3.3	3.0	4.9	0.3	0.3	1.7	2.1	1.3	0.2	1.0	0.0	0.7	2.9	5.1	0.8	0.4	9.6	0.3	0.8	0.3	0.2	5.1	0.4	0.0	0.0	4.1	12.9	8.0	26.2	26.9	19.1	25.2	0.0	0.1	0.1	0.0	10.4	0.5	0.0	16.9	30.2	0.1	0.1	0.0	0.1	0.1	9.5	0.1	0.0	8.6	0.7	14.9	40.9	0.9	0.0	0.1	45.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.5	0.1	0.2	0.0	0.0	0.2	0.0	0.1	24.7	0.0	2.6	3.9	0.0	0.1	0.0	0.0	1.3	0.1	0.6	9.6	0.3	0.8	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.8	0.3	0.3	2.7	0.8	0.2	0.4	0.2	0.2	2.4	1.1	0.4	2.0	10.0	0.5	0.4	2.1	1.7	1.3
CCDC194		ENSG00000269720	"Coiled-coil domain containing 194"	A0A1B0GVG4	19	17390509-17394158	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"ovary: 2.3;placenta: 1.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.4;PC-3: 2.2;U-266/70: 2.2;U-266/84: 1.6"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (1.50e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.87e-4)"	"unprognostic (2.75e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.22e-14)"	"unprognostic (1.04e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.86e-2)"	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.1	0.0	0.4	0.2	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.8	0.7	0.9	0.8	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.6	1.4	0.8	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.4	2.2	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.6	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0										
CCDC8	"3M3, DKFZp564K0322, PPP1R20"	ENSG00000169515	"Coiled-coil domain containing 8"	Q9H0W5	19	46410372-46413584	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.4"	"Cell line enhanced"	"Detected in many"		"AF22: 11.9;AN3-CA: 14.2;HSkMC: 13.0;K-562: 12.4;RH-30: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041993	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041993: AB_10795388"	"unprognostic (3.05e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.72e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (5.43e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.18e-3)"	2.7	13.3	3.0	2.1	3.8	0.6	7.6	0.9	2.3	18.9	2.4	5.1	6.2	0.8	15.5	17.3	2.9	19.0	9.7	18.9	3.1	2.3	7.9	0.7	7.1	0.9	2.4	2.9	39.4	19.2	8.5	9.9	5.6	4.6	12.1	1.1	10.0	8.7	7.5	3.0	2.2	1.6	6.7	2.0	1.8	1.7	9.0	2.6	4.2	11.8	2.6	1.4	4.8	5.8	0.4	0.3	3.6	0.4	0.2	0.2	0.1	1.1	0.1	11.9	14.2	3.2	4.0	5.8	6.1	0.0	1.4	0.6	0.0	0.1	0.1	8.1	4.8	0.1	0.1	9.5	0.6	0.0	6.0	0.0	0.1	0.6	10.6	0.0	0.1	13.0	0.0	3.3	9.9	0.0	12.4	0.0	4.3	0.0	0.0	0.8	8.6	0.0	0.4	16.1	0.0	10.4	0.0	1.9	0.1	0.0	0.0	0.0	0.1	2.9	1.1	0.8	3.2	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.6	0.2	0.3	0.3	0.1	0.1	3.0	3.8	0.9	2.3	3.1	2.3	2.4	2.9	4.6	2.6
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ovary: 16.6;retina: 50.2"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.4;PC-3: 29.6;U-2 OS: 8.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	27	"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.7"					"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	1.7	2.9	0.4	0.5	0.6	0.0	1.4	0.4	0.9	2.8	0.8	0.9	1.0	0.4	0.8	2.3	1.1	1.9	1.3	3.3	0.6	0.0	1.5	0.4	1.2	4.1	1.2	0.4	16.6	0.4	5.9	13.6	0.4	3.3	1.3	8.7	50.2	1.0	0.4	0.4	1.4	0.7	1.6	0.8	0.4	0.6	1.5	0.6	0.8	0.8	0.8	0.9	1.0	3.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	6.7	0.0	0.0	0.7	0.9	0.0	0.3	3.1	2.7	5.7	0.3	1.9	0.0	4.6	2.6	1.2	0.1	0.0	3.8	0.0	0.6	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.3	10.4	0.1	0.0	5.1	0.0	2.0	0.7	0.0	0.0	6.4	29.6	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	5.0	8.4	2.7	1.7	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.4	0.9	0.6	0.0	1.2	0.4	3.3	0.6
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347355	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.3;lymphoid tissue: 77.8;ovary: 35.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 68.2;REH: 20.2;U-698: 54.2;WM-115: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"memory B-cell: 29.8;naive B-cell: 39.3"	"Lineage enriched"	"Detected in many"	28	"B-cells: 39.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002418, HPA024353"	Enhanced									"CAB002418: AB_563529, HPA024353: AB_10600695"	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	2.1	1.0	5.5	57.9	6.8	3.1	0.5	0.7	3.2	1.4	1.0	0.9	0.5	0.4	1.4	0.9	4.4	7.9	2.9	0.8	9.9	4.2	1.4	0.6	5.5	52.6	9.8	0.5	35.4	0.5	0.0	0.7	1.0	0.9	2.8	1.5	1.1	5.9	1.1	0.5	0.0	11.6	2.0	13.5	64.1	1.4	1.2	0.6	5.0	1.1	2.3	77.8	4.3	0.9	39.3	1.3	0.3	0.3	0.0	0.0	1.4	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.2	68.2	1.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	20.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	54.2	0.5	0.2	12.4	0.0	0.0	0.0	0.0	0.3	0.0	29.8	0.0	0.0	1.3	39.3	0.0	0.0	0.3	0.0	0.2	1.1	0.0	1.4	5.5	6.8	0.7	3.2	9.9	4.2	9.8	0.5	0.9	0.6
CDH11	"CAD11, OB"	ENSG00000140937	"Cadherin 11"	P55287	16	64943753-65126112	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 71.0"	"Cell line enhanced"	"Detected in many"		"BJ: 47.1;fHDF/TERT166: 64.3;HSkMC: 44.3;PC-3: 55.3;U-2197: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013072	Enhanced					70000	70000			"CAB013072: AB_2533068"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.93e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.75e-2)"	"prognostic unfavourable (2.48e-9)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.07e-3)"	8.1	3.6	5.5	9.2	12.1	0.3	6.1	5.5	8.8	24.1	4.3	7.5	2.4	2.7	25.9	5.9	3.0	6.8	22.4	4.6	7.3	5.1	4.8	1.0	20.8	5.9	7.8	8.5	71.0	1.7	1.2	6.0	44.2	8.3	8.0	4.9	22.2	7.3	9.7	2.5	5.7	3.4	20.5	10.6	35.1	5.1	4.0	5.4	0.1	4.8	1.9	4.9	18.4	11.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.2	0.0	7.3	15.9	0.0	47.1	27.3	12.1	6.9	0.8	0.0	0.0	0.0	64.3	0.0	0.0	0.3	8.7	0.0	0.4	0.0	0.2	0.0	6.0	0.0	2.8	44.3	0.0	14.8	3.0	3.4	0.0	0.0	6.4	0.0	0.0	0.0	3.7	55.3	0.1	7.3	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	3.4	37.8	13.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	12.1	5.5	8.8	7.3	5.1	7.8	8.5	8.3	5.4
CDHR3	"CDH28, FLJ23834, FLJ44366"	ENSG00000128536	"Cadherin related family member 3"	Q6ZTQ4	7	105876796-106033773	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 51.9;lung: 28.9;ovary: 22.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;Daudi: 9.9;WM-115: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 15.9"	"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8"	"Group enriched"	"Detected in many"	6	"B-cells: 6.9;granulocytes: 1.8"	"Low region specificity"	"Detected in many"							HPA011218	Approved		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA011218: AB_1078886"	"unprognostic (4.38e-4)"	"unprognostic (9.18e-2)"	"unprognostic (8.16e-3)"	"unprognostic (8.08e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.51e-3)"	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12.0	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.7	1.4	2.7	2.6	0.2	0.7	0.6	0.3	0.2	0.0	0.1	9.9	0.0	0.5	0.1	1.8	0.0	0.3	0.8	1.2	0.0	0.2	0.7	0.0	0.1	0.4	0.9	0.3	0.5	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.1	1.7	0.6	0.0	0.0	0.4	0.1	0.1	0.6	2.8	0.0	0.7	0.5	0.0	0.0	0.4	1.4	0.5	1.5	0.0	0.0	0.0	3.2	0.2	0.3	6.7	0.1	0.1	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.2;ovary: 9.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HBF TERT88: 18.2;HMC-1: 34.4;LHCN-M2: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	52	"basophil: 3.5;eosinophil: 6.9"	"Lineage enriched"	"Detected in single"	69	"granulocytes: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	1.3	0.2	0.1	5.2	0.1	0.0	3.7	0.3	0.1	3.4	2.3	0.1	0.1	0.3	4.1	20.2	1.1	1.0	4.2	0.3	0.1	0.0	0.4	0.1	3.3	0.1	0.1	0.1	9.8	0.2	0.0	0.5	0.1	0.1	2.0	0.7	1.4	0.6	0.3	0.7	1.1	3.0	3.9	0.1	0.1	1.1	2.5	0.1	0.1	0.2	1.2	1.2	1.6	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.7	0.0	3.1	14.6	5.5	11.9	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.2	0.0	34.4	2.0	0.0	1.5	0.7	0.0	0.0	0.0	10.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CILP2	MGC45771	ENSG00000160161	"Cartilage intermediate layer protein 2"	Q8IUL8	19	19538248-19546659	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 9.4;testis: 10.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;HEK 293: 5.1;NB-4: 3.8;THP-1: 4.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA041847	Uncertain				"Secreted to extracellular matrix"	11000000	11000000			"HPA041847: AB_10795599"	"unprognostic (6.51e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.42e-4)"	"prognostic unfavourable (3.22e-6)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.13e-3)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.41e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.59e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.36e-2)"	2.8	0.1	0.9	1.1	1.0	3.1	3.6	0.3	1.1	3.1	0.7	0.0	0.8	0.1	0.7	1.1	0.8	0.9	5.6	1.0	0.8	1.4	0.2	0.7	0.9	2.5	0.3	0.0	9.4	0.2	1.4	0.9	2.4	0.4	1.2	0.2	3.0	2.8	0.9	4.0	0.7	0.3	0.5	0.1	0.7	0.2	10.1	0.0	0.0	7.8	0.4	1.8	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.3	0.2	8.7	0.3	1.2	1.1	0.0	0.5	0.1	2.3	0.9	0.1	2.2	0.4	1.0	0.2	0.0	0.1	0.6	5.1	0.0	0.2	0.3	0.3	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.7	0.0	3.8	3.2	1.6	0.6	0.0	0.0	0.1	0.0	0.1	2.2	0.5	2.7	0.3	0.5	4.9	0.0	0.1	1.1	0.4	0.2	0.7	1.9	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	0.3	1.1	0.8	1.4	0.3	0.0	0.4	0.0
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418865-170454733	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;ovary: 47.7;testis: 86.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 56.4;ASC TERT1: 71.2;EFO-21: 42.2;HUVEC TERT2: 60.9;TIME: 96.3"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favourable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	8.2	1.9	14.1	2.0	40.6	1.7	6.3	3.5	50.3	1.9	3.4	85.9	0.5	2.2	2.7	4.6	4.6	4.2	18.9	4.0	28.7	13.0	3.2	2.8	2.8	2.1	59.5	17.1	47.7	2.1	1.8	5.5	4.2	37.3	5.1	2.5	0.6	4.7	4.2	1.7	3.6	2.6	2.8	80.6	2.6	2.5	86.1	47.9	0.0	2.0	0.9	2.0	6.3	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	56.4	71.2	0.0	0.7	3.6	4.6	7.7	0.0	9.4	0.0	42.2	5.7	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	3.2	17.4	0.0	0.0	26.0	0.0	25.3	0.0	60.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	96.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.1	40.6	3.5	25.0	28.7	13.0	59.5	17.1	37.3	47.9
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;ovary: 59.4"	"Cell line enhanced"	"Detected in some"		"AF22: 5.7;SCLC-21H: 16.1;THP-1: 10.1"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		9100	9100	Vesicles	Vesicles	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	14.2	5.0	4.9	1.0	9.8	0.8	8.5	1.5	19.7	4.1	1.8	2.4	0.3	1.2	5.2	1.8	1.6	3.6	2.6	5.9	15.4	4.0	4.5	1.5	1.7	2.8	4.1	14.3	59.4	2.0	1.5	1.3	1.5	23.7	5.4	1.4	3.0	1.6	1.8	1.9	2.1	1.5	6.6	1.4	0.8	1.4	1.9	0.5	0.0	2.9	0.5	1.0	1.9	4.7	0.3	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	5.7	0.0	2.5	0.6	0.1	0.7	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	2.3	0.0	0.0	0.0	2.4	10.1	0.0	1.2	0.5	1.6	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	4.9	9.8	1.5	19.7	15.4	4.0	4.1	14.3	23.7	0.5
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel alpha 4"	Q8IV77	11	6234765-6244429	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 8.0;fallopian tube: 22.5;ovary: 9.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.5;CAPAN-2: 2.6;HaCaT: 2.2;HMC-1: 3.3"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.2	0.3	1.5	0.3	2.0	0.6	0.2	0.6	1.1	1.0	0.4	1.9	0.1	0.5	1.2	8.0	0.4	22.5	0.3	0.1	1.7	1.4	0.3	0.2	6.6	0.4	1.0	0.1	9.1	0.3	0.3	2.3	0.2	3.3	0.3	0.2	0.3	0.2	0.8	0.1	0.4	0.3	0.3	1.3	0.3	0.3	7.4	1.4	0.1	0.3	0.1	0.3	0.2	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.7	2.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.7	0.3	0.0	2.2	0.1	0.5	0.0	1.6	0.3	0.0	0.4	0.1	0.1	0.2	3.3	1.6	1.2	0.2	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.3	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.2	0.6	0.0	1.1	0.6	0.0	0.7	0.3	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.6	1.1	1.7	1.4	1.0	0.1	3.3	1.4
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 29.2;BJ: 16.8;BJ hTERT+: 22.6;RH-30: 24.8;U-2197: 18.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	"Plasma membrane"	"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.7	2.2	0.2	29.2	16.8	22.6	6.3	2.5	0.7	0.3	0.0	1.6	9.2	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	9.2	0.0	24.8	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.9	1.2	18.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1
CSDC2	PIPPin	ENSG00000172346	"Cold shock domain containing C2"	Q9Y534	22	41560763-41577741	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 84.8;ovary: 48.5"	"Group enriched"	"Detected in some"	6	"HeLa: 7.9;U-2 OS: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003073, HPA076549"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA003073: AB_1078578, HPA076549: AB_2686807"	"unprognostic (9.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.52e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.72e-1)"	"prognostic favourable (6.42e-4)"	"unprognostic (8.86e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.09e-3)"	2.5	39.0	4.7	2.1	9.6	1.1	1.2	30.5	15.3	16.8	2.6	2.7	5.5	1.6	18.4	2.0	2.2	4.1	2.6	84.8	6.0	8.5	9.9	1.2	2.8	1.1	9.0	6.0	48.5	25.5	1.1	4.1	1.3	17.7	5.3	1.4	5.6	1.4	11.7	1.5	1.1	1.5	9.1	10.5	1.2	1.6	11.1	3.4	0.0	1.1	0.3	1.0	5.8	6.2	1.0	1.0	1.7	1.1	0.4	1.6	0.7	0.0	0.1	1.0	0.1	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	3.1	0.1	0.0	0.0	0.0	0.0	2.0	0.0	7.9	0.9	2.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.1	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	29.0	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	1.0	1.0	1.7	1.3	1.1	0.5	1.0	0.8	0.7	1.0	1.0	1.5	0.7	1.0	0.4	0.9	0.2	1.6	0.7	4.7	9.6	30.5	14.7	6.0	8.5	9.0	6.0	17.7	3.4
DIRAS3	"ARHI, NOEY2"	ENSG00000162595	"DIRAS family GTPase 3"	O95661	1	68045896-68051631	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 49.9;ovary: 33.2;pituitary gland: 35.2"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.3;HSkMC: 15.3;TIME: 9.5;U-251 MG: 7.7;U-87 MG: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 49.9"	"Group enriched"	"Detected in some"	18	"plasmacytoid DC: 2.1;T-reg: 1.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.1;T-cells: 1.8"					"Low region specificity"	"Detected in all"			"HPA028483, HPA028557, HPA029384"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	"Nuclear membrane, Cytosol"	"HPA028483: AB_10599599, HPA028557: AB_10602091, HPA029384: AB_10601343"	"prognostic favourable (9.21e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.33e-1)"	"prognostic favourable (9.21e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.07e-3)"	1.0	10.2	2.0	0.2	49.9	0.0	2.4	0.9	2.9	2.3	1.6	1.0	0.0	3.4	1.2	5.4	1.3	1.3	5.9	5.7	1.3	8.7	3.2	4.5	2.3	0.0	1.3	1.1	33.2	9.9	8.8	35.2	0.0	17.3	2.3	0.1	2.4	1.3	1.1	1.0	1.1	1.2	0.3	1.7	1.2	1.9	2.4	0.5	0.0	1.6	0.3	0.1	1.2	1.9	0.0	2.1	0.0	0.0	0.0	1.8	0.0	0.0	1.3	1.4	0.0	4.7	3.5	0.5	4.0	1.4	0.3	1.1	0.0	0.7	0.0	0.2	4.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.6	0.0	7.3	0.0	0.0	15.3	0.1	0.6	0.0	0.9	0.2	0.0	4.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.1	0.1	0.0	9.5	0.0	0.4	0.2	7.7	2.4	0.0	0.0	14.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	0.0	2.0	49.9	0.9	2.9	1.3	8.7	1.3	1.1	17.3	0.5
DMRTC1B		ENSG00000184911	"DMRT like family C1B"	Q5HYR2	X	72777009-72848802	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.1;ovary: 12.1;pituitary gland: 12.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;SK-BR-3: 1.1;U-138 MG: 1.0;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	12	"B-cells: 2.1;T-cells: 2.8"									"HPA046874, HPA046992"	Uncertain									"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (2.00e-1)"						"unprognostic (1.91e-2)"	"unprognostic (1.54e-1)"				"unprognostic (6.52e-2)"		0.3	4.6	11.0	1.7	15.1	0.1	0.7	4.5	14.3	1.7	0.6	2.2	1.4	0.5	2.2	9.6	0.3	3.3	0.6	0.2	8.6	14.2	1.6	0.2	1.1	1.4	4.9	9.1	12.1	5.2	1.5	12.1	0.2	2.2	3.8	0.8	2.4	1.0	1.9	0.2	0.5	0.5	0.6	2.2	1.3	1.2	7.1	2.9	0.7	3.9	0.2	2.1	0.3	0.2	2.1	0.0	0.0	0.0	0.2	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.4	0.0	2.1	2.1	2.8	0.0	0.2	0.0	0.0	0.0	0.2	11.0	15.1	4.5	11.4	8.6	14.2	4.9	9.1	2.2	2.9
DPPA3	"Pgc7, Stella"	ENSG00000187569	"Developmental pluripotency associated 3"	Q6W0C5	12	7711454-7717559	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.3;lung: 2.1;ovary: 1.8;testis: 3.6"	"Group enriched"	"Detected in some"	216	"BEWO: 84.5;NTERA-2: 35.5"	"Cancer enriched"	"Detected in single"	779	"testis cancer: 339.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	17	"dendritic cells: 2.3;granulocytes: 1.7"																																	"unprognostic (2.52e-1)"	"unprognostic (9.49e-2)"			0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.4	3.6	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	6	"AN3-CA: 29.4;HeLa: 15.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	Nucleoplasm	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6
EML5	"EMAP-2, HuEMAP-2"	ENSG00000165521	"Echinoderm microtubule associated protein like 5"	Q05BV3	14	88612431-88792752	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;ovary: 26.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 10.4;SH-SY5Y: 22.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054019, HPA055379"	Uncertain									"HPA054019: AB_2682345, HPA055379: AB_2682799"	"unprognostic (2.28e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.42e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.53e-3)"	0.8	9.1	5.1	1.5	9.0	0.8	1.4	23.0	5.0	0.8	1.6	1.9	0.1	1.2	1.7	0.7	1.6	1.7	1.1	0.9	5.8	2.6	1.9	1.1	1.2	1.5	1.6	4.7	26.8	2.2	6.0	13.7	0.7	3.8	7.6	0.7	4.5	1.6	0.7	0.6	1.3	1.4	1.8	1.6	1.5	1.6	4.9	2.1	0.9	3.9	0.8	1.1	1.2	0.9	0.9	0.3	0.0	0.2	0.0	2.4	0.4	2.0	1.3	1.9	1.8	0.0	0.0	3.9	1.9	0.3	0.2	0.1	0.6	1.7	1.0	0.8	0.0	4.6	3.6	0.1	0.1	3.1	2.8	1.4	1.3	1.1	0.0	2.8	0.4	0.0	0.1	0.0	0.0	0.0	1.4	10.4	0.0	2.5	3.5	1.1	1.6	2.1	2.3	2.0	1.0	0.1	4.0	5.3	22.3	2.5	4.5	1.5	2.0	1.4	0.8	2.1	0.4	0.3	2.7	4.8	1.3	4.3	0.9	1.2	0.8	0.0	0.0	0.0	0.2	0.2	2.4	0.9	0.5	0.2	0.3	0.5	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.4	5.1	9.0	23.0	5.0	5.8	2.6	1.6	4.7	3.8	2.1
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;ovary: 13.2;testis: 15.5"	"Group enriched"	"Detected in some"	6	"HEK 293: 8.0;U-266/70: 24.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1.0	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0.0	4.3	0.0	0.5	2.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.0	0.0	2.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.1	0.0	0.8	24.3	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ovary: 19.1;testis: 30.2;vagina: 14.3"	"Cell line enhanced"	"Detected in some"		"U-266/70: 10.5;U-698: 17.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.8"	CAB079300	Enhanced									"CAB079300: "	"unprognostic (7.63e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.27e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.89e-2)"	2.1	9.4	0.2	2.3	0.8	1.0	3.7	0.8	0.6	1.3	2.9	0.6	0.2	1.4	1.7	0.7	1.7	1.1	0.6	1.0	1.1	0.4	1.4	0.7	1.3	2.8	0.2	0.2	19.1	2.5	0.0	1.6	0.7	1.4	2.2	1.5	0.5	1.5	0.9	1.4	1.2	1.5	0.6	1.0	3.0	1.3	30.2	0.6	5.0	0.6	0.2	2.9	1.8	14.3	2.4	4.0	1.1	0.3	0.4	1.3	0.2	0.7	0.3	0.7	0.6	0.0	0.1	1.3	0.1	0.0	0.1	0.1	0.2	0.8	2.8	0.1	0.0	1.0	0.9	0.0	0.1	0.7	0.3	0.3	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.6	4.0	0.1	0.7	0.4	0.2	0.7	0.4	0.5	0.3	0.2	0.1	1.3	2.4	0.7	0.5	0.2	1.1	0.8	0.0	0.4	0.5	0.9	0.2	0.1	10.5	3.2	17.2	0.2	0.1	0.7	0.3	0.3	1.0	0.8	0.2	0.6	1.7	0.6	1.1	0.1	2.4	1.3	1.0	1.1	0.4	0.2	4.0	0.5	0.2	0.2	0.8	0.8	0.6	1.1	0.4	0.2	0.2	1.4	0.6
FAM153B		ENSG00000182230	"Family with sequence similarity 153 member B"	P0C7A2	5	176060689-176116015	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.2;ovary: 15.3;testis: 14.7"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.1"	"Low lineage specificity"	"Detected in many"											"HPA042585, HPA044022, HPA046691, HPA052337, HPA055498"	Uncertain									"HPA042585: AB_2678063, HPA044022: AB_2678778, HPA046691: AB_2679754, HPA052337: , HPA055498: AB_2682836"	"unprognostic (1.08e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.66e-2)"	"unprognostic (3.62e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-1)"	2.1	2.1	8.1	1.7	5.6	1.4	0.4	16.2	11.1	1.5	0.4	0.4	0.4	0.3	0.7	2.8	0.4	4.5	2.6	1.5	7.9	2.6	0.6	0.4	1.3	3.5	0.4	2.6	15.3	1.2	0.3	7.1	0.4	1.4	2.7	0.6	0.6	0.6	0.9	0.5	0.7	0.6	0.4	1.0	8.5	0.5	14.7	1.8	0.4	1.2	0.4	1.9	0.4	0.4	0.5	2.6	0.7	0.3	0.3	3.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.3	0.1	0.3	0.0	0.5	0.5	0.4	0.4	0.0	0.4	3.1	3.0	0.5	0.3	0.1	2.6	0.0	0.3	8.1	5.6	16.2	11.1	7.9	2.6	0.4	2.6	1.4	1.8
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3"	"Cell line enriched"	"Detected in single"	12	"U-87 MG: 6.3"	"Group enriched"	"Detected in some"	10	"endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.5;pons and medulla: 21.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain									"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3.0	0.3	8.0	0.0	0.3	1.3	18.2	0.2	51.3	0.4	10.0	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0.0	18.3	0.3	0.2	2.0	0.2	21.0	0.2	0.5	0.0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1.0	1.7	0.0	0.2	0.0	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0.0	21.0	1.7
FFAR1	"FFA1R, GPR40"	ENSG00000126266	"Free fatty acid receptor 1"	O14842	19	35351552-35353862	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;brain: 4.1;ovary: 4.8;pancreas: 9.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;U-698: 5.4;WM-115: 2.0"	"Cancer enriched"	"Detected in single"	13	"pancreatic cancer: 2.2"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																		"unprognostic (9.49e-2)"				"unprognostic (2.08e-1)"			"unprognostic (1.59e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.51e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (9.56e-3)"		0.0	0.0	1.2	0.2	1.6	5.7	0.0	0.0	0.6	0.0	0.0			0.8	0.1	0.0	0.0	0.8	0.0	0.0	1.9	0.9	0.0	0.0	0.1	0.7	1.7		4.8	9.6	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.2	0.5	0.0	4.1	0.3	1.6	0.1			0.0		0.2	0.0	0.0	1.2	0.5	1.9	0.3	0.7	0.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.8	0.4	0.1	0.4	0.0	0.0	0.1	0.3	0.3	0.8	0.2	0.0	0.1	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.6	0.1	0.0	1.1	0.2	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	5.4	0.1	0.2	2.0	1.6	0.3	0.7	0.4	0.2	0.4	0.3	0.3	0.2	0.0	1.2	0.3	0.4	1.9	0.7	0.2	0.5	0.2	0.0										
FGF10		ENSG00000070193	"Fibroblast growth factor 10"	O15520	5	44303544-44389706	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 26.4"	"Cell line enriched"	"Detected in some"	9	"AF22: 33.9"	"Cancer enriched"	"Detected in some"	6	"breast cancer: 5.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB010315	Uncertain				"Secreted in other tissues"					"CAB010315: AB_2262731"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.20e-1)"		"unprognostic (3.54e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.72e-2)"	"unprognostic (6.73e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.23e-4)"	10.5	1.8	0.2	3.4	1.2	0.0	13.1	0.6	1.9	15.5	6.1	0.4	2.1	0.2	3.1	17.2	3.8	5.4	5.0	4.2	0.2	0.5	0.9	0.1	2.5	1.8	1.0	0.3	26.4	5.4	0.0	5.4	7.7	1.4	11.7	2.0	3.2	6.8	4.2	0.7	0.9	2.5	11.0	1.7	0.1	4.4	6.2	0.4	0.2	5.0	8.6	0.8	9.3	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.6	1.9	0.2	0.5	1.0	0.3	1.4	0.4
FOXL2	"BPES, BPES1"	ENSG00000183770	"Forkhead box L2"	P58012	3	138944224-138947140	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 13.9;ovary: 55.5;parathyroid gland: 15.3"	"Cell line enhanced"	"Detected in some"		"A-431: 5.4;fHDF/TERT166: 6.3;HEL: 9.0;hTCEpi: 8.3;K-562: 9.2;SiHa: 6.4;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA069613	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	Nucleoplasm	"HPA069613: AB_2686160"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-2)"		"unprognostic (4.76e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.16e-4)"		"unprognostic (3.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.63e-8)"	"unprognostic (2.16e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.61e-2)"	0.0	1.5	0.3	0.0	1.2	0.0	0.0	0.3	1.0	13.9	0.0	0.6	0.0	0.0	10.0	0.4	0.1	6.4	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.4	55.5	0.6	15.3	13.1	1.4	0.8	0.2	0.0	1.7	0.0	0.4	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	2.1	0.3	3.9	0.1	0.0	1.7	0.2	0.0	0.4	0.1	0.0	0.4	0.0	2.6	6.3	1.2	0.0	0.0	0.1	0.0	0.0	9.0	1.1	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	9.2	0.0	3.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	6.4	0.0	0.0	0.0	6.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.3	1.0	0.4	0.2	0.3	0.4	0.8	0.2
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947234-138953451	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 51.6;parathyroid gland: 25.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.4;fHDF/TERT166: 10.5;HEL: 10.4;hTCEpi: 4.9;SiHa: 8.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"											"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA061017: AB_2684415, HPA071790: AB_2686447"	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.0	0.6	0.1	1.4	0.2	0.1	0.2	0.9	15.3	0.1	0.5	0.1	0.0	12.6	0.9	0.2	7.3	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.5	0.4	51.6	0.4	25.0	9.4	3.2	1.0	0.1	0.0	1.3	0.1	0.5	0.1	0.3	0.1	2.5	0.3	0.1	0.0	0.4	0.3	0.1	0.4	0.3	0.1	0.4	2.3	0.6	0.5	2.8	0.4	0.7	0.4	0.0	2.1	1.4	0.7	5.4	0.3	0.1	2.3	0.1	0.0	0.2	0.0	0.2	0.4	0.2	1.1	10.5	0.5	0.2	0.1	0.2	0.1	0.3	10.4	3.2	0.1	0.0	0.1	0.4	0.2	4.9	0.2	0.1	0.0	4.0	0.2	2.6	0.2	0.1	0.3	0.3	0.1	0.1	0.0	0.0	0.5	1.5	0.2	0.2	8.1	0.2	0.0	0.2	3.0	0.2	0.3	0.2	0.3	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.3	0.4	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.2	0.6	0.4	0.3	2.8	0.7	0.2	0.5	0.4	0.0	0.6	1.4	0.2	0.9	0.3	0.2	0.5	0.4	1.0	0.3
FRMPD3	"KIAA1817, RP5-1070B1.1"	ENSG00000147234	"FERM and PDZ domain containing 3"	Q5JV73	X	107522450-107605251	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.6;ovary: 10.3;thyroid gland: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.6;SCLC-21H: 3.3;U-698: 2.9;WM-115: 3.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"					"Cell type enhanced"	"Detected in some"		"gdTCR: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003164	Uncertain									"HPA003164: AB_1078260"	"unprognostic (1.27e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.69e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-9)"	"unprognostic (4.59e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.26e-1)"	0.0	0.5	2.5	0.7	1.8	0.1	0.5	8.6	6.7	0.2	0.1			0.0	0.9	0.0	0.1	0.4	0.4	0.0	3.1	5.0	0.0	0.0	0.2	1.3	2.6		10.3	0.1	0.0	0.4	0.0		0.6	0.2		0.4	2.6	0.0	0.0	0.0	1.1	2.2	0.2	0.0	0.5			6.0		0.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	2.1	0.7	0.0	0.0	0.0	0.8	0.0	0.4	0.2	0.0	0.5	10.6	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.3	3.3	0.2	0.6	0.2	0.0	0.4	0.0	0.0	1.0	1.2	0.1	0.0	0.0	0.0	2.9	0.1	0.0	3.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.2	1.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0										
FRRS1L	"C9orf4, CG-6"	ENSG00000260230	"Ferric chelate reductase 1 like"	Q9P0K9	9	109130293-109167295	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.0;ovary: 15.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.7;SH-SY5Y: 9.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071086	Enhanced									"HPA071086: AB_2686342"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.21e-4)"	"unprognostic (7.35e-3)"	"unprognostic (7.02e-2)"	"unprognostic (5.78e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.38e-3)"	0.9	10.9	10.2	1.1	26.6	1.2	1.1	19.3	38.0	2.4	1.2	2.3	0.1	1.3	2.7	4.4	3.2	2.2	2.0	2.0	10.5	12.5	0.8	0.9	1.0	1.0	6.1	13.1	15.2	1.5	4.4	6.0	0.8	6.6	4.9	1.2	3.0	1.1	3.0	0.9	1.1	1.4	2.5	3.5	1.0	1.1	1.7	3.4	0.0	1.0	0.0	0.9	0.9	0.3	1.3	0.8	2.7	1.6	1.3	0.8	0.3	0.1	0.5	3.7	0.2	0.2	0.2	0.4	0.1	0.0	0.1	0.3	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.1	0.2	0.2	0.2	0.5	0.4	0.2	0.0	0.1	0.3	0.5	0.0	0.2	0.0	0.0	0.1	0.5	0.2	0.1	0.2	0.7	1.6	0.1	0.3	0.1	0.2	0.1	0.3	1.5	9.1	0.0	0.2	0.0	0.2	0.3	0.4	0.2	0.4	0.2	0.1	0.3	0.1	0.1	0.1	0.2	0.2	2.6	0.9	0.6	0.6	1.2	0.5	0.8	0.6	0.5	0.3	1.3	0.8	0.7	2.7	1.3	1.6	0.8	0.4	0.3	10.2	26.6	19.3	25.8	10.5	12.5	6.1	13.1	6.6	3.4
FSHR	"FSHRO, LGR1, ODG1"	ENSG00000170820	"Follicle stimulating hormone receptor"	P23945	2	48962157-49154537	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 5.3;ovary: 6.5;testis: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.5;cerebral cortex: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"															"unprognostic (5.94e-2)"			"unprognostic (4.06e-3)"		"unprognostic (5.78e-2)"			0.1	0.1	0.1	0.0	1.5	0.1	0.1	0.1	2.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.3	5.3	1.0	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	6.5	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.1	2.9	0.1	0.4	0.1	0.1	0.5	0.0
GAGE10		ENSG00000215274	"G antigen 10"	A6NGK3	X	49303669-49319844	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 3.9;pituitary gland: 3.1;testis: 2.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.0;BJ hTERT+: 1.4;T-47d: 1.3;WM-115: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA043232: AB_2678376"					"unprognostic (2.81e-2)"					"unprognostic (2.26e-1)"						"unprognostic (3.97e-1)"		0.0	0.0	0.6	0.0	1.8	0.1	0.8	0.5	0.3	0.0	0.2			0.0	0.5	2.0	0.0	1.7	0.1	0.5	0.5	0.5	0.0	0.0	0.0	0.6	0.4		3.9	0.0	0.0	3.1	0.0		0.4	0.3		0.2	1.1	0.2	0.0	0.0	1.4	0.2	0.3	0.0	2.9			0.8		0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.5	0.3	0.0	0.0	0.6	7.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.7	0.3	0.3										
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.7"	"Cell line enhanced"	"Detected in many"		"TIME: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	830000	830000	"Plasma membrane"	"Plasma membrane"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favourable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	9.5	13.5	8.4	15.4	9.1	10.1	8.7	3.2	6.2	15.9	10.6	14.4	1.0	8.8	4.9	11.5	5.9	9.2	17.8	7.7	6.9	7.5	6.8	3.4	10.1	11.5	7.2	5.2	43.7	9.2	14.1	9.7	5.2	10.1	8.3	9.4	31.6	11.6	2.4	5.6	4.0	12.4	14.1	7.7	16.7	13.8	4.3	9.2	5.6	10.6	4.2	9.3	7.5	10.0	4.7	3.1	5.7	3.8	3.9	7.5	2.1	7.4	25.4	6.2	5.4	13.2	11.8	4.8	21.5	12.0	8.6	8.2	3.5	17.1	4.8	15.2	36.1	1.3	2.8	16.8	7.9	12.6	2.0	13.3	4.8	4.8	10.2	2.8	13.0	14.6	3.9	6.9	10.3	16.4	3.0	15.4	14.6	7.7	0.3	2.0	2.4	5.2	1.5	3.3	4.8	11.9	5.1	0.8	2.0	9.5	35.6	2.8	13.8	2.2	48.2	20.9	5.0	5.1	22.8	4.4	4.3	2.6	13.7	5.7	6.3	3.4	2.7	5.3	7.5	3.6	6.6	4.5	4.3	4.8	3.1	4.7	1.9	5.3	5.7	3.9	3.8	2.7	3.5	2.1	8.4	9.1	3.2	6.2	6.9	7.5	7.2	5.2	10.1	9.2
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 42.5;intestine: 29.9;ovary: 63.4;pancreas: 49.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 14.9;HHSteC: 17.4;SH-SY5Y: 16.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	16.8	0.1	0.0	13.4	0.5	0.4	0.1	1.0	15.4	42.5	0.0	0.0	0.0	26.5	0.1	0.8	0.0	0.0	63.4	49.9	0.0	0.1	4.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	13.8	18.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.9	17.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.3	16.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169443-22202528	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 77.2"	"Group enriched"	"Detected in many"	4	"BEWO: 27.3;CACO-2: 33.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavourable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	9.7	26.6	0.2	8.4	0.2	0.0	9.4	0.2	0.2	9.8	24.7	0.9	1.5	12.5	19.5	10.3	3.3	15.3	51.3	40.4	0.2	0.2	3.9	15.5	14.9	11.1	0.2	0.1	77.2	52.2	0.1	0.5	5.2	0.7	24.3	6.0	0.4	1.5	1.1	1.5	0.9	43.5	32.2	0.4	18.9	26.9	9.7	0.0	0.1	6.3	0.7	0.6	30.3	16.5	0.0	0.0	5.7	0.0	0.0	0.4	0.0	4.7	0.7	0.0	0.0	1.0	0.5	27.3	0.1	0.2	0.4	0.5	33.2	1.8	0.0	1.6	0.5	5.3	0.2	2.1	0.7	0.0	6.7	0.0	2.1	2.8	7.2	0.2	0.3	0.2	4.3	6.0	4.5	4.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	4.7	0.0	0.5	0.1	0.2	1.3	0.4	0.0	5.1	3.0	1.3	0.8	0.0	0.3	0.7	0.8	5.6	0.8	0.0	0.0	0.0	3.1	0.1	4.8	5.7	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.7	0.0
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.2;NTERA-2: 11.7;U-2 OS: 19.9;WM-115: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"CAB008558: AB_2111910, HPA074275: AB_2686677"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	2.1	1.6	3.6	2.9	5.3	0.2	2.3	3.1	3.4	8.0	4.4	1.9	1.5	0.9	8.6	2.6	3.9	5.8	8.8	3.3	3.7	1.0	1.7	0.8	2.9	0.7	1.3	1.5	23.3	0.8	0.7	2.6	1.7	3.6	6.2	1.4	5.9	1.8	2.4	1.6	3.7	3.2	4.5	1.6	2.0	3.9	5.4	2.1	1.7	1.6	4.7	2.6	4.3	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	19.2	3.8	2.1	4.1	0.0	7.3	1.6	3.2	2.1	0.0	0.6	0.0	0.8	3.6	0.3	5.3	0.0	1.6	0.0	3.4	0.5	4.7	0.0	4.6	0.0	1.5	2.1	0.0	10.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	11.7	5.9	0.0	2.1	1.2	0.0	0.0	0.8	3.3	3.4	0.0	0.5	0.0	0.2	5.8	0.0	19.9	2.0	0.0	0.0	0.0	0.0	7.2	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.3	3.1	3.4	3.7	1.0	1.3	1.5	3.6	2.1
GNG4		ENSG00000168243	"G protein subunit gamma 4"	P50150	1	235547687-235650754	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;ovary: 25.1;pituitary gland: 18.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 28.3;SCLC-21H: 30.0;SH-SY5Y: 42.2;U-2197: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"olfactory region: 574.6"	"Region enhanced"	"Detected in all"		"olfactory region: 427.7"												"unprognostic (1.50e-3)"	"unprognostic (8.33e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.56e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.01e-3)"	1.9	9.4	16.8	2.0	21.5	0.9	1.1	8.6	24.1	1.8	3.4	6.5	0.5	2.5	8.3	1.1	8.4	1.6	1.2	0.9	10.2	20.8	1.3	0.8	0.9	4.7	6.3	7.7	25.1	4.5	0.8	18.8	4.2	11.2	17.1	3.0	1.7	1.4	1.4	0.8	1.1	4.8	5.8	7.1	0.9	3.6	2.1	2.8	3.1	0.9	0.0	3.9	1.2	1.1	1.3	0.8	3.8	0.6	1.0	0.8	0.3	6.6	0.4	5.0	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	2.0	0.7	5.3	0.2	1.2	3.5	1.9	0.0	0.1	2.5	0.1	0.0	2.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.3	0.2	28.3	0.0	0.0	2.6	0.1	0.0	0.2	30.0	42.2	0.2	0.1	0.6	0.0	0.9	0.0	0.3	0.9	12.6	0.9	0.9	0.0	0.0	0.9	0.0	8.3	3.8	0.6	0.6	0.5	0.5	0.4	1.0	0.8	0.5	0.2	1.3	0.6	0.6	2.3	1.0	0.5	0.8	0.6	0.3	16.8	21.5	8.6	21.7	10.2	20.8	6.3	7.7	11.2	2.8
GREB1	KIAA0575	ENSG00000196208	"Growth regulation by estrogen in breast cancer 1"	Q4ZG55	2	11482341-11642788	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 74.9"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;Hep G2: 14.0;MCF7: 21.9;SH-SY5Y: 14.9;T-47d: 50.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA024616, HPA027843, HPA028416"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA024616: AB_10599728, HPA027843: AB_10601103, HPA028416: AB_10601344"	"unprognostic (1.52e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.80e-2)"	1.2	2.0	3.0	0.6	5.0	0.5	11.1	1.3	5.4	13.7	0.5	2.8	3.0	0.7	21.3	15.6	0.6	11.2	1.8	2.3	3.9	3.0	1.3	1.5	0.6	0.6	3.9	3.5	74.9	2.9	0.6	5.0	9.4	3.8	19.2	0.5	2.8	0.7	2.4	2.1	1.2	0.6	7.3	3.2	0.4	0.8	10.9	3.2	0.0	0.5	0.5	0.5	0.8	5.7	0.8	1.0	2.8	0.6	1.0	1.3	0.4	0.0	0.3	14.8	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.0	0.1	1.1	0.0	0.0	1.7	1.3	0.0	0.1	14.0	0.1	0.1	0.7	0.2	0.8	0.2	0.1	0.0	0.1	0.3	0.1	21.9	0.4	0.7	4.8	0.0	10.2	0.0	0.6	0.0	0.0	4.3	14.9	0.3	0.4	10.9	50.6	0.2	0.0	1.5	0.7	0.1	0.0	2.2	1.5	8.6	2.5	4.2	0.4	2.6	0.6	0.8	0.7	0.3	0.3	0.5	0.5	0.4	0.4	0.8	0.5	1.3	2.8	1.0	0.5	1.0	0.5	0.4	3.0	5.0	1.3	5.4	3.9	3.0	3.9	3.5	3.8	3.2
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511700-120988904	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;ovary: 8.5"	"Group enriched"	"Detected in some"	4	"HDLM-2: 6.2;HEL: 19.2;T-47d: 5.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced									"HPA074453: AB_2732255"	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	1.0	5.4	11.3	1.0	9.0	0.8	1.3	3.9	19.3	1.2	1.1	9.4	0.0	1.2	1.1	0.9	1.2	1.7	1.1	1.6	13.9	7.2	1.0	0.8	3.1	1.0	8.7	11.0	8.5	0.8	0.8	2.6	1.5	12.3	1.5	1.1	0.0	1.1	1.0	1.0	1.3	1.2	1.0	6.3	1.4	0.9	2.0	8.2	0.0	6.3	0.0	1.0	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	6.2	0.6	19.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	11.3	9.0	3.9	14.0	13.9	7.2	8.7	11.0	12.3	8.2
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 49.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	11.7	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	49.8	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3
HIST2H3PS2	p06	ENSG00000203818	"Histone cluster 2 H3 pseudogene 2"		1	143905556-143905966	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adrenal gland: 9.1;lymphoid tissue: 7.0;ovary: 8.9"	"Cell line enhanced"	"Detected in some"		"BJ: 8.4;NB-4: 9.6;SH-SY5Y: 10.2;THP-1: 9.8;U-2197: 7.2;U-87 MG: 5.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 3.5"	"Low lineage specificity"	"Detected in many"											HPA042570	Approved									"HPA042570: AB_2678056"																		0.6	9.1	0.5	0.6	0.5	0.0	0.2	1.4	0.3	0.2	0.1			0.1	0.7	0.0	1.4	1.1	1.1	0.3	0.5	0.7	0.0	0.0	0.5	1.3	0.7		8.9	0.7	0.3	0.3	0.0		2.3	0.0		0.5	0.4	0.0	0.3	0.2	1.4	1.5	7.0	4.7	0.9			1.0		0.4	2.4	0.2	1.5	1.0	0.1	3.5	2.4	0.3	0.8	0.0	0.0	0.0	0.0	3.4	0.8	0.0	8.4	1.9	1.7	1.5	0.0	1.2	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	2.1	0.0	3.3	0.0	1.9	0.3	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.2	0.0	3.0	0.0	0.0	9.8	0.0	1.0	0.0	7.2	0.4	0.2	0.0	0.0	5.4	0.0	0.2	0.0	1.2	0.0	0.0	1.7	0.0	0.7	0.1	0.3	1.0	1.5	0.0	0.1	0.1	2.4	3.5	0.6	0.0	0.8										
HOXC4	"HOX3, HOX3E"	ENSG00000198353	"Homeobox C4"	P09017	12	54016931-54056030	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;ovary: 31.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.8;HEK 293: 19.6;SH-SY5Y: 16.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	27	"pons and medulla: 29.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	24	"pons and medulla: 9.9"	"Region enriched"	"Detected in single"	13	"pons and medulla: 3.7"	HPA053910			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053910: AB_2682305"	"unprognostic (2.78e-2)"	"unprognostic (8.51e-2)"	"unprognostic (2.96e-6)"	"unprognostic (3.30e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.37e-2)"	"unprognostic (7.81e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-4)"	"unprognostic (9.82e-2)"	16.2	4.4	0.7	3.2	0.7	0.0	17.9	0.7	0.7	1.3	2.3	0.6	1.4	0.9	11.5	17.8	6.0	20.9	1.0	1.0	0.7	0.7	15.4	0.8	0.9	3.2	1.1	0.0	31.6	0.7	0.0	0.7	5.8	29.7	2.4	0.0	0.3	0.7	1.3	8.1	4.2	9.2	4.4	10.5	1.2	2.6	8.3	0.9	0.0	1.0	0.0	1.8	2.1	3.4	1.1	0.5	0.0	0.0	0.0	1.1	0.0	3.0	3.1	0.0	13.8	5.8	3.0	0.0	1.4	1.4	1.4	1.0	0.1	2.6	12.0	0.1	10.6	2.7	0.2	0.3	0.8	17.8	19.6	0.1	1.4	0.0	0.6	1.4	0.4	7.6	1.4	8.3	1.4	0.2	0.6	0.0	5.3	0.1	1.6	0.3	0.1	0.0	3.9	4.4	0.0	5.9	0.0	0.0	16.7	2.1	0.7	7.8	10.4	0.7	0.0	7.3	4.2	0.5	7.4	3.2	3.4	6.2	0.4	1.3	7.6	0.0	0.0	0.0	0.8	0.0	0.8	1.1	0.0	0.8	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.5	0.6	0.0	0.7	0.7	0.7	0.7	0.7	0.7	1.1	0.0	29.7	0.9
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;ASC TERT1: 6.1;HSkMC: 5.7;SH-SY5Y: 9.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdTCR: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.1	0.0	8.3	5.0	6.1	0.0	0.5	0.4	0.9	0.7	3.5	0.4	0.0	0.6	2.5	1.3	0.1	0.0	0.3	2.6	2.9	0.0	1.0	0.1	0.2	0.0	0.1	5.7	0.6	4.1	0.4	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.1	0.6	0.2	4.3	1.7	0.1	0.0	1.4	0.9	3.1	0.3	0.0	0.0	0.0	0.2	0.1	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 31.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.3;fHDF/TERT166: 18.6;HDLM-2: 31.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	17	"pons and medulla: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	23	"pons and medulla: 1.5"	"Not detected"	"Not detected"			HPA054981			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	10.9	11.2	0.4	1.2	0.4	0.0	16.3	0.4	0.4	0.7	1.9	0.6	0.4	0.0	3.9	14.8	3.1	13.5	0.4	2.0	0.4	0.0	11.3	0.4	0.9	3.0	0.4	0.4	31.2	0.4	0.0	0.4	4.0	7.0	0.8	0.0	0.4	0.4	0.4	11.0	7.6	8.8	6.1	8.1	1.0	0.3	3.3	0.4	0.4	0.6	0.8	0.4	0.7	2.5	0.0	0.0	0.1	0.0	0.0	0.5	0.0	2.4	1.7	0.0	37.3	13.7	13.0	0.3	1.9	1.9	3.1	2.8	1.5	2.8	1.1	2.5	18.6	4.2	1.4	0.2	2.8	31.2	10.8	1.9	4.8	0.0	1.5	0.2	4.7	12.3	2.0	6.1	2.2	0.1	1.3	0.0	10.8	0.5	0.0	1.2	0.0	1.6	0.0	1.4	0.0	9.4	0.1	0.0	4.6	2.8	2.7	7.6	6.6	0.5	0.0	3.9	8.4	4.2	2.6	0.3	0.3	0.0	1.4	0.3	7.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	7.0	0.4
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54009106-54012362	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.7;ASC TERT1: 15.5;fHDF/TERT166: 27.6;HSkMC: 18.9;LHCN-M2: 20.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Nucleoplasm	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.4	0.4	0.7	0.2	0.0	7.1	0.2	0.3	0.5	0.5	0.2	0.2	0.0	0.3	16.7	0.4	6.3	0.6	0.6	0.2	0.0	7.0	0.2	0.2	2.2	0.2	0.5	25.2	0.2	0.0	0.2	1.9	0.4	0.3	0.0	0.2	0.2	0.2	12.8	2.6	4.8	7.9	2.5	0.2	0.0	2.6	0.2	0.3	0.7	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	8.3	23.7	15.5	0.1	1.5	0.0	2.8	1.8	2.5	1.2	0.0	0.2	27.6	1.0	2.2	0.7	3.2	2.8	3.0	0.4	1.0	0.0	2.9	0.0	3.2	18.9	2.1	8.9	5.2	0.2	0.3	0.0	20.6	0.7	0.0	0.2	0.0	0.4	0.0	0.0	0.0	3.1	0.0	0.0	1.1	2.8	0.5	7.2	0.8	0.0	0.0	0.5	4.4	3.8	0.9	0.0	0.0	0.0	0.5	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.4	0.2
HS3ST1	3OST1	ENSG00000002587	"Heparan sulfate-glucosamine 3-sulfotransferase 1"	O14792	4	11393150-11429765	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;gallbladder: 31.9;ovary: 30.3"	"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 14.0;HaCaT: 4.2;RPTEC TERT1: 12.4;RT4: 10.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"cerebellum: 27.4;cerebral cortex: 9.0"	"Group enriched"	"Detected in some"	39	"memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3"	"Group enriched"	"Detected in many"	99	"B-cells: 15.8;dendritic cells: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002237	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA002237: AB_1079085"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.01e-2)"	"prognostic favourable (7.73e-4)"	"unprognostic (3.32e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (5.99e-8)"	"unprognostic (9.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (8.67e-4)"	2.3	2.9	1.6	2.8	2.2	2.8	2.0	27.4	9.0	3.3	2.7	1.1	3.6	3.5	4.3	5.0	10.2	4.3	31.9	2.2	1.7	1.8	10.4	0.9	3.4	2.1	1.9	1.5	30.3	1.1	0.7	8.9	1.0	2.4	3.2	1.7	1.7	3.7	2.4	0.7	0.8	2.9	1.7	2.2	3.0	7.0	3.0	0.3	3.8	1.8	7.0	7.4	7.3	2.4	15.8	22.3	0.1	0.1	0.0	0.1	0.6	4.4	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.0	0.0	0.4	0.0	4.2	0.0	2.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.9	1.1	1.0	0.0	0.0	12.4	10.1	3.7	0.0	0.0	0.1	0.5	0.0	0.0	2.0	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	7.3	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.6	1.6	2.2	27.4	9.0	1.7	1.8	1.9	1.5	2.4	0.3
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;kidney: 17.3;ovary: 18.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 19.3;HeLa: 13.1;RH-30: 28.0;RT4: 13.9;SH-SY5Y: 34.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 29.5"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.8"	"Low region specificity"	"Detected in all"							"HPA034625, HPA034626"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA034625: AB_10612119, HPA034626: AB_2674252"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favourable (6.03e-4)"	0.4	3.2	6.5	0.9	29.5	0.1	2.6	3.0	6.7	1.0	0.8	0.8	0.6	0.3	4.5	3.2	5.0	2.5	0.5	0.4	4.1	9.1	17.3	0.2	1.0	0.3	3.5	0.9	18.2	6.5	0.1	1.3	9.9	3.3	5.4	1.2	0.0	1.1	1.6	6.7	0.3	0.2	2.0	3.3	0.2	1.1	7.9	0.7	0.7	0.6	1.7	2.7	2.3	0.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	4.3	0.0	6.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	6.4	0.0	0.2	9.1	0.0	0.0	0.0	19.3	0.0	13.1	0.0	0.0	0.0	0.0	0.3	8.5	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.1	0.0	4.9	0.2	0.0	28.0	0.0	5.6	13.9	0.7	34.9	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.5	29.5	3.0	5.8	4.1	9.1	3.5	0.9	3.3	0.7
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937306-87016683	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;ovary: 13.3"	"Group enriched"	"Detected in some"	22	"PC-3: 2.9;SH-SY5Y: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA004931	Approved									"HPA004931: AB_1856706"					"unprognostic (2.25e-2)"					"unprognostic (1.32e-1)"		"unprognostic (6.29e-2)"			"unprognostic (4.52e-2)"	"unprognostic (1.25e-1)"		0.5	0.6	8.9	0.6	13.3	0.5	0.5	5.4	16.4	1.6	0.5	0.0	0.0	0.5	5.1	1.1	0.6	0.5	0.8	0.5	4.1	2.8	0.5	0.5	0.5	0.5	1.8	11.4	13.3	0.8	0.5	0.3	0.5	2.2	1.1	0.5	0.0	0.5	1.2	0.5	0.5	0.5	2.9	0.6	0.5	3.6	1.4	1.5	0.0	2.7	0.0	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	13.3	5.4	16.4	4.1	2.8	1.8	11.4	2.2	1.5
IGFBP4	"BP-4, HT29-IGFBP, IBP4, IGFBP-4"	ENSG00000141753	"Insulin like growth factor binding protein 4"	P22692	17	40443461-40457731	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 370.8"	"Cell line enhanced"	"Detected in many"		"A549: 109.4;ASC diff: 82.6;ASC TERT1: 81.0;BJ: 87.8;BJ hTERT+: 90.4;HSkMC: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.6;NK-cell: 20.5"	"Group enriched"	"Detected in many"	5	"NK-cells: 20.5;T-cells: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066240	Supported				"Secreted to blood"	500000000	500000000			"HPA066240: AB_2685643"	"unprognostic (1.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.00e-1)"	"prognostic favourable (5.49e-4)"	"unprognostic (4.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (2.72e-5)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.81e-2)"	79.7	23.3	2.5	36.8	5.2	0.0	198.7	1.8	3.1	115.0	57.1	3.2	41.1	9.9	88.8	126.5	67.7	67.4	117.5	119.1	2.2	1.8	72.3	255.6	88.2	101.4	3.7	2.3	370.8	21.5	6.5	19.4	99.8	5.1	66.7	17.0	46.2	24.4	38.6	36.3	22.3	36.8	80.4	6.4	68.1	38.7	53.2	2.3	4.2	81.0	50.4	22.5	89.9	123.9	3.6	0.1	0.0	0.0	20.5	12.6	0.9	0.0	109.4	5.6	0.0	82.6	81.0	0.1	87.8	90.4	16.8	13.1	4.8	1.4	0.0	47.6	41.7	0.9	1.8	0.5	7.6	0.3	0.1	0.3	8.0	7.2	51.8	0.2	0.0	172.1	0.3	22.5	3.2	29.1	1.7	0.0	24.1	3.3	0.0	20.2	3.1	14.8	5.4	0.1	0.1	0.7	3.4	1.5	4.4	39.7	0.1	1.3	40.5	2.0	43.8	23.4	1.2	73.9	0.0	0.0	0.0	0.1	13.9	0.8	6.0	0.0	0.0	0.0	1.8	0.0	12.6	0.4	3.3	4.4	0.0	3.6	0.2	0.4	0.0	20.5	0.0	0.1	0.0	0.9	2.5	5.2	1.8	3.1	2.2	1.8	3.7	2.3	5.1	2.3
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695525	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 245.3"	"Cell line enhanced"	"Detected in many"		"BJ: 77.9;BJ hTERT+: 207.2;T-47d: 50.4;U-138 MG: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	330000000	330000000	"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA059827: AB_2732640, HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	47.3	23.4	6.2	19.2	6.3	0.1	41.3	3.6	6.5	191.7	23.1	19.7	15.8	3.9	94.6	91.0	30.0	96.9	21.4	16.9	8.2	2.4	34.8	7.8	9.3	14.5	12.1	7.4	245.3	3.5	6.5	37.7	32.7	7.0	31.4	7.9	188.5	12.0	15.1	47.0	13.5	14.2	71.8	7.4	7.6	36.9	51.7	12.0	1.5	130.1	34.5	17.6	28.8	45.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.1	0.0	23.2	0.7	0.0	77.9	207.2	10.4	1.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	0.5	0.0	0.7	20.0	0.4	0.0	10.1	0.0	0.1	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.2	0.3	0.0	0.0	0.1	6.7	23.1	1.3	0.8	1.3	9.6	0.0	50.4	0.0	7.5	68.7	4.2	10.4	3.7	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.2	6.3	3.6	6.5	8.2	2.4	12.1	7.4	7.0	12.0
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.8"	"Group enriched"	"Detected in some"	5	"HeLa: 25.0;HL-60: 12.1;REH: 9.0;RPMI-8226: 29.0"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA012921	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted - unknown location"	280000	280000	"Intermediate filaments"	"Intermediate filaments"	"HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	2.5	2.9	0.6	0.1	0.4	0.0	4.5	0.0	0.2	0.3	0.5			0.0	0.7	0.8	2.0	3.4	7.3	4.1	0.7	0.8	0.0	0.0	6.7	0.5	0.3		17.8	0.1	0.7	1.5	0.0		0.0	0.6		3.7	0.0	0.0	1.2	0.7	0.7	0.3	0.2	0.4	0.3			1.3		1.6	1.5	0.1	0.2	1.5	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.2	3.9	25.0	0.0	0.9	12.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	29.0	0.0	0.0	0.5	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.1	3.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0										
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;ovary: 21.1;testis: 39.9"	"Cell line enhanced"	"Detected in some"		"A549: 5.9;HEL: 4.3;SK-MEL-30: 25.6;U-266/70: 8.9;U-266/84: 10.4"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Cell Junctions"	"Cell Junctions"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	1.1	10.5	12.5	1.4	14.6	0.9	1.2	3.4	23.9	1.3	2.6	27.8	0.0	1.1	1.6	2.3	2.0	1.6	1.9	2.2	12.3	6.0	10.6	0.9	1.0	1.0	25.2	8.9	21.1	5.1	3.8	1.4	1.1	15.3	1.3	1.8	7.0	1.4	2.0	2.9	2.6	1.6	1.5	20.5	1.0	1.4	39.9	20.7	0.0	5.0	0.0	1.1	1.1	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	5.9	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	25.6	0.5	0.1	0.0	0.0	1.0	0.0	0.0	8.9	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.6	3.4	13.6	12.3	6.0	25.2	8.9	15.3	20.7
KCNRG		ENSG00000198553	"Potassium channel regulator"	Q8N5I3	13	50015254-50020922	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 27.7;ovary: 17.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001027			Uncertain	Vesicles				Vesicles	Vesicles	"HPA001027: "	"unprognostic (1.85e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-2)"	"prognostic favourable (2.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.16e-2)"	0.4	0.2	0.3	0.3	0.3	1.1	0.6	0.9	0.3	1.8	0.3	0.5	0.3	0.3	1.0	4.8	0.6	27.7	0.3	1.0	0.3	0.5	0.6	0.3	9.1	0.3	0.3	0.3	17.1	0.3	0.4	0.4	0.3	0.5	0.5	0.8	0.3	0.3	1.7	0.4	0.8	0.4	0.4	0.3	0.4	0.3	1.7	0.3	0.3	0.4	0.3	0.6	0.3	0.3	2.7	1.2	4.4	1.1	1.3	1.4	0.4	1.0	0.9	3.1	1.0	1.0	1.5	0.5	0.2	2.4	2.0	0.1	3.6	1.0	2.0	0.6	2.9	1.2	2.3	0.8	1.5	1.4	1.5	4.0	1.5	1.6	2.9	3.3	1.1	2.0	2.2	1.5	3.7	3.9	1.6	0.4	2.5	1.2	3.6	3.2	2.1	1.4	2.6	0.0	0.0	1.8	2.6	2.6	5.6	1.1	1.9	1.8	1.5	1.1	1.3	1.8	0.8	1.1	0.8	0.2	0.5	2.1	0.6	1.3	0.4	3.2	1.1	0.7	0.5	1.1	0.7	1.5	0.7	1.0	0.9	2.7	0.8	0.9	4.4	1.3	0.8	1.2	1.4	0.4	0.3	0.3	0.9	0.3	0.3	0.5	0.3	0.3	0.5	0.3
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.1;ovary: 28.4"	"Cell line enriched"	"Detected in single"	144	"HDLM-2: 55.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.7"	"Cell type enhanced"	"Detected in many"		"gdTCR: 11.3;MAIT T-cell: 9.2;memory CD8 T-cell: 10.0"	"Lineage enriched"	"Detected in single"	56	"T-cells: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Secreted - unknown location"					"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.39e-2)"	"prognostic favourable (3.89e-4)"	"unprognostic (8.88e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.74e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.97e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavourable (4.62e-11)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	"unprognostic (8.19e-3)"	1.7	0.4	0.3	33.2	0.3	1.0	1.0	0.8	0.7	7.7	4.4	0.5	2.7	2.9	6.4	3.3	2.4	3.8	3.0	2.2	0.3	0.4	1.2	5.9	3.8	12.4	0.4	0.0	28.4	0.4	0.1	1.0	1.3	2.7	2.8	1.8	1.1	2.0	6.8	0.8	0.6	9.6	1.7	0.9	58.1	2.0	6.1	0.1	4.1	1.0	1.3	23.5	2.6	3.6	0.0	0.2	0.0	0.0	0.0	11.3	0.8	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	9.2	0.0	2.2	10.0	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.2	1.7	0.8	0.3	0.3	0.8	0.7	0.3	0.4	0.4	0.0	2.7	0.1
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 15.8;ovary: 10.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;NTERA-2: 16.4;RH-30: 6.9;U-937: 3.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	1.5	0.2	6.0	1.0	2.1	0.6	2.0	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4.0	10.0	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1.0	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0.0	0.6	0.8	1.2	1.4	0.9	0.0	0.5	7.4	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.6	1.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.3	0.0	0.4	1.8	16.4	0.2	0.8	6.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.2	0.0	0.6	1.4	0.0	0.7	0.7	3.9	1.6	7.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	6.0	2.1	4.9	3.5	15.8	1.4	2.4	4.0	3.6	5.6
LRP3	"hLRp105, LRP-3"	ENSG00000130881	"LDL receptor related protein 3"	O75074	19	33177603-33208867	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.0"	"Cell line enhanced"	"Detected in many"		"THP-1: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.8;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041658			Approved	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA041658: "	"unprognostic (3.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (6.12e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.36e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	23.5	16.6	28.3	5.1	33.1	15.3	15.6	14.2	41.2	12.1	7.8	6.6	4.4	7.1	11.2	8.8	7.4	12.4	8.2	10.9	27.6	13.0	4.2	15.5	5.3	3.2	15.4	19.4	50.0	16.8	9.8	10.3	3.8	11.0	15.5	3.4	10.0	14.4	12.7	21.9	5.0	6.6	10.6	6.3	4.8	7.0	5.6	7.7	0.0	9.5	4.7	3.1	9.0	9.1	0.0	0.0	0.6	2.8	0.5	0.1	0.7	0.0	20.4	5.6	20.2	14.1	5.4	4.2	5.2	5.1	4.8	1.8	5.8	0.2	0.0	13.7	6.4	0.0	5.4	0.5	0.4	0.0	11.0	0.0	4.6	20.4	5.4	7.3	0.7	8.0	4.8	1.3	0.7	3.9	0.0	0.0	6.1	18.8	0.0	8.2	11.5	1.0	0.0	2.6	0.0	0.0	8.1	12.4	18.7	8.4	0.0	1.5	8.6	25.8	0.0	10.0	9.0	14.9	2.9	0.0	0.0	0.1	0.0	12.3	2.9	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	2.6	0.0	0.0	0.7	28.3	33.1	14.2	41.2	27.6	13.0	15.4	19.4	11.0	7.7
LRRC17	"H_RG318M05.3, P37NB"	ENSG00000128606	"Leucine rich repeat containing 17"	Q8N6Y2	7	102912991-102944949	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 39.0"	"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 168.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 12.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073458			Approved	"Vesicles,Cytokinetic bridge"	"Secreted in other tissues"			Vesicles	Vesicles	"HPA073458: "	"unprognostic (1.77e-1)"	"unprognostic (7.73e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.76e-4)"	"unprognostic (6.09e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (4.12e-6)"	"unprognostic (8.57e-3)"	"unprognostic (4.48e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (6.30e-4)"	5.1	1.3	1.1	0.5	1.2	0.0	6.2	1.4	2.0	15.0	1.4	1.5	5.6	0.5	8.3	17.1	5.2	8.9	13.5	6.4	1.2	1.3	1.5	1.4	1.6	1.6	1.1	2.1	39.0	2.6	1.2	1.7	1.8	2.5	7.8	1.4	2.7	2.8	2.5	5.3	2.0	2.6	5.1	1.2	1.2	3.5	5.1	0.2	2.2	2.6	6.7	1.3	6.7	4.2	0.1	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.8	4.2	0.0	0.2	2.4	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	3.9	0.1	2.9	0.0	19.1	0.0	0.0	168.8	0.0	0.0	0.0	0.4	0.0	0.0	33.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.2	2.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	1.2	1.4	2.0	1.2	1.3	1.1	2.1	2.5	0.2
MCC		ENSG00000171444	"Mutated in colorectal cancers"	P23508	5	113022099-113488830	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 49.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 27.7;hTCEpi: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA037390, HPA037391"	Approved	Approved	Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA037390: AB_2675451, HPA037391: AB_10671248"	"unprognostic (6.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.70e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.90e-1)"	7.1	2.3	6.9	3.2	6.1	0.5	7.8	11.4	8.1	11.8	3.2	3.4	5.9	1.7	12.5	4.7	9.1	7.4	4.4	8.4	9.2	5.0	3.9	12.7	4.6	3.0	7.6	5.1	49.4	4.5	28.9	5.2	7.1	7.8	7.7	2.4	15.1	6.7	9.5	5.0	13.9	2.6	9.1	5.8	3.4	3.6	6.5	5.2	1.3	3.2	6.1	4.3	9.3	11.8	0.2	6.3	1.3	0.2	0.1	1.6	0.1	0.4	0.1	7.0	0.6	6.1	5.7	7.8	1.1	3.1	1.3	1.6	0.2	6.4	0.0	7.5	0.5	8.6	4.3	27.7	0.6	2.2	2.6	0.0	2.4	1.8	1.8	0.3	0.1	7.6	18.6	3.5	13.2	8.2	0.0	10.5	2.9	0.6	0.1	0.1	3.8	0.5	0.1	6.1	1.9	0.1	17.3	3.1	6.7	5.7	0.0	15.2	2.3	0.0	9.8	4.8	4.5	7.5	2.1	3.0	0.0	0.0	12.9	0.0	5.1	0.0	0.2	0.1	0.5	0.2	1.6	0.2	0.5	0.6	0.0	0.2	0.4	0.5	1.3	0.1	0.1	6.3	1.5	0.1	6.9	6.1	11.4	8.1	9.2	5.0	7.6	5.1	7.8	5.2
MDK	"FLJ27379, MK, NEGF2"	ENSG00000110492	Midkine	P21741	11	46380756-46383837	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 115.9"	"Cell line enhanced"	"Detected in many"		"AF22: 75.8;NTERA-2: 88.8;REH: 129.2;SH-SY5Y: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.6;neutrophil: 4.9"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010055, HPA057126"	Uncertain		Approved	Vesicles	"Secreted to blood"	1200000	1200000	Vesicles	Vesicles	"CAB010055: AB_627949, HPA057126: AB_2683344"	"unprognostic (8.87e-3)"	"unprognostic (6.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.15e-1)"	"prognostic unfavourable (3.06e-6)"	"unprognostic (8.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-2)"	8.0	16.2	4.7	11.9	5.6	1.7	13.5	5.3	5.9	62.5	36.3	5.3	13.9	50.6	41.0	33.9	6.5	34.6	35.0	6.4	4.0	5.9	6.1	2.0	8.0	3.6	4.9	4.4	115.9	13.1	8.9	64.8	11.5	5.5	47.7	7.4	59.0	22.2	24.5	4.7	4.1	58.4	16.6	4.0	13.9	21.0	9.3	2.1	22.5	5.2	5.5	12.4	15.3	23.0	3.6	0.2	4.9	0.6	0.2	2.0	1.5	4.8	6.5	75.8	0.2	0.5	6.4	1.8	3.8	7.6	14.6	13.0	49.2	21.6	0.3	53.4	5.6	42.2	42.7	0.0	1.3	15.0	9.0	2.1	0.6	67.3	34.6	0.1	0.3	10.2	1.3	8.9	0.0	21.3	36.4	0.3	8.2	33.5	1.8	0.9	88.8	38.5	129.2	2.8	0.4	0.1	0.1	42.1	110.3	12.6	1.1	1.0	34.6	34.0	5.8	22.5	53.9	0.3	2.6	0.2	1.0	0.4	0.6	1.3	19.5	0.0	0.1	0.0	0.3	0.5	0.0	3.6	0.2	0.5	0.1	1.1	0.2	0.0	4.9	0.2	0.6	0.2	2.0	1.5	4.7	5.6	5.3	5.9	4.0	5.9	4.9	4.4	5.5	2.1
MEX3A	"RKHD4, RNF162"	ENSG00000254726	"Mex-3 RNA binding family member A"	A1L020	1	156072013-156081998	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 7.2;ovary: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.0;NTERA-2: 22.7;SCLC-21H: 23.6;SH-SY5Y: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062703			Supported	Cytosol				Cytosol	Cytosol	"HPA062703: AB_2684840"	"unprognostic (8.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (9.23e-8)"	"unprognostic (4.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.73e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.96e-2)"	0.4	0.2	1.8	1.0	1.8	0.8	2.5	3.3	5.1	2.5	1.3	1.4	0.2	0.7	7.2	0.7	1.4	1.7	1.1	0.2	3.5	1.0	1.1	1.8	0.6	3.4	1.9	2.1	10.1	0.6	0.4	0.4	0.8	2.2	1.7	1.0	1.0	2.0	0.6	0.2	0.7	0.6	1.7	1.0	1.4	0.5	3.1	2.0	3.6	1.5	0.2	1.1	1.9	1.4	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	25.0	6.2	0.3	0.4	2.9	0.6	0.1	1.0	0.9	1.4	0.3	0.7	2.9	0.3	0.5	10.8	0.4	1.2	1.2	2.9	0.6	1.1	2.4	0.5	0.3	0.5	0.7	0.8	0.5	0.4	4.7	5.6	0.0	1.4	1.6	2.8	0.4	22.7	3.2	9.2	2.0	0.1	0.8	1.1	23.6	43.1	0.7	2.8	1.4	4.8	1.8	1.6	1.5	3.9	0.4	1.4	0.5	0.4	1.3	0.1	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	3.3	2.0	3.5	1.0	1.9	2.1	2.2	2.0
MKX	"C10orf48, IRXL1, MGC39616"	ENSG00000150051	"Mohawk homeobox"	Q8IYA7	10	27672875-27746060	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 21.3;prostate: 24.3"	"Cell line enhanced"	"Detected in some"		"BJ: 18.8;BJ hTERT+: 10.8;BJ hTERT+ SV40 Large T+: 12.4;BJ hTERT+ SV40 Large T+ RasG12V: 8.5;fHDF/TERT166: 53.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006927	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"	"Nucleoplasm, Nuclear speckles"	"HPA006927: AB_1853981"	"unprognostic (2.04e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.38e-3)"	3.7	3.2	1.6	1.4	2.1	0.3	3.0	2.6	5.9	4.9	4.3	1.4	0.9	0.5	1.8	3.4	1.8	7.1	2.7	0.8	1.4	2.5	0.6	1.9	1.2	0.5	2.7	1.4	21.3	1.0	0.3	13.9	0.3	6.7	24.3	1.5	2.9	0.9	7.7	0.5	1.0	0.7	10.6	2.7	0.8	3.4	1.3	0.1	0.0	4.5	0.5	0.3	8.7	1.6	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.8	10.8	12.4	8.5	0.0	0.0	0.0	0.0	53.9	0.0	0.1	0.0	3.3	0.0	1.2	0.0	3.4	0.0	0.5	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.1	2.6	5.9	1.4	2.5	2.7	1.4	6.7	0.1
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632095-1635263	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 51.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;HHSteC: 8.1;NTERA-2: 3.6;PC-3: 3.5;U-266/70: 6.4"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 12.3"	"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Not detected"	"Not detected"														"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	4.7	2.4	0.3	3.9	0.3	2.1	2.3	0.5	0.4	19.6	3.2	0.1	4.2	3.9	17.3	20.1	4.7	6.4	28.5	14.4	0.2	0.3	3.6	2.3	11.0	3.3	0.1	0.0	51.8	0.7	0.0	3.1	10.5	0.1	32.1	0.2	1.2	1.4	6.3	0.9	2.5	2.7	11.7	0.2	4.1	4.3	13.5	0.0	0.4	1.2	0.9	2.8	13.9	7.0	0.2	12.3	0.1	0.2	2.2	1.8	1.3	1.0	0.0	0.3	3.3	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.7	0.9	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.7	2.6	1.0	0.3	2.1	8.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	0.0	0.6	3.6	3.5	1.3	0.1	1.6	0.0	0.1	0.6	0.2	0.5	0.0	0.2	0.9	0.0	0.7	0.5	0.3	0.7	0.0	6.4	0.3	1.1	0.1	0.4	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.0	0.4	1.1	0.0	0.2	0.1	0.9	0.1	2.2	0.1	12.3	0.2	1.3	0.3	0.3	0.5	0.4	0.2	0.3	0.1	0.0	0.1	0.0
MOB3B	"C9orf35, FLJ13204, MOB1D, MOBKL2B"	ENSG00000120162	"MOB kinase activator 3B"	Q86TA1	9	27325209-27529781	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.2;ovary: 29.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 10.0;HAP1: 10.2;K-562: 29.2;SK-BR-3: 12.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.8;myeloid DC: 4.6;naive B-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA057744			Uncertain	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"	"Intermediate filaments, Cytosol"	"HPA057744: "	"unprognostic (6.96e-3)"	"unprognostic (9.60e-2)"	"unprognostic (5.10e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"prognostic favourable (2.33e-10)"	"unprognostic (1.55e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (7.99e-2)"	6.0	2.3	6.2	4.2	18.0	1.0	7.0	5.0	13.9	7.8	13.2	32.6	2.8	19.0	10.9	6.1	4.3	9.4	5.8	2.0	9.8	6.4	8.6	1.9	7.5	4.2	19.7	6.2	29.9	4.5	0.9	1.8	5.3	17.2	2.8	14.9	5.7	3.9	3.8	8.5	7.1	16.6	7.5	33.2	8.6	6.2	3.7	17.5	0.6	7.0	2.9	6.2	4.0	5.2	5.9	4.6	0.0	1.4	0.0	0.1	0.5	2.0	1.5	4.7	0.0	1.2	0.1	10.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	2.0	0.0	6.6	10.2	8.0	0.0	4.6	1.6	2.9	6.2	0.0	0.0	0.0	0.6	2.1	8.5	0.0	1.5	0.0	29.2	0.1	0.0	0.0	0.0	0.0	6.0	0.5	1.9	0.4	0.0	2.8	3.9	0.0	1.5	1.6	12.3	2.8	0.8	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.9	0.0	0.0	1.4	0.0	4.8	0.0	0.0	4.6	5.9	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.5	6.2	18.0	5.0	12.0	9.8	6.4	19.7	6.2	17.2	17.5
MUM1L1	FLJ33516	ENSG00000157502	"MUM1 like 1"	Q5H9M0	X	106168305-106208956	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 79.4;thyroid gland: 26.9"	"Cell line enhanced"	"Detected in some"		"AF22: 5.1;HHSteC: 2.8;HSkMC: 5.2;LHCN-M2: 9.4;NTERA-2: 3.6;T-47d: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000168, HPA020464"	Enhanced									"HPA000168: AB_1079431, HPA020464: AB_1854209"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.12e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (3.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.11e-5)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.53e-2)"	1.5	1.8	5.2	0.2	1.3	0.2	0.6	0.1	8.8	7.3	0.2	0.0	2.0	0.2	7.3	4.2	0.3	6.7	0.7	1.9	2.9	2.3	1.0	0.8	0.4	0.2	0.5	4.9	79.4	11.4	0.2	12.8	4.8	4.8	2.3	0.2	0.0	0.2	1.7	4.1	0.2	0.2	1.5	0.3	0.2	0.6	17.0	0.8	0.0	26.9	1.5	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.0	2.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.1	3.6	0.0	0.0	1.5	0.0	0.0	0.7	0.0	0.0	0.0	1.2	0.0	3.2	0.0	0.0	0.4	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.1	8.8	2.9	2.3	0.5	4.9	4.8	0.8
NAV3	"KIAA0938, POMFIL1"	ENSG00000067798	"Neuron navigator 3"	Q8IVL0	12	77324641-78213008	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.2;ovary: 29.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 23.4;THP-1: 20.5;U-138 MG: 15.7;WM-115: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032111, HPA061392"	Approved		Approved	"Nuclear membrane,Cytosol"				"Nuclear membrane"	"Nuclear membrane"	"HPA032111: AB_10603881, HPA061392: "	"unprognostic (3.51e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.68e-7)"	"unprognostic (6.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.29e-3)"	6.2	8.5	17.8	2.4	14.2	1.5	7.1	14.7	25.2	2.8	2.1	9.7	2.6	1.2	4.1	5.8	3.8	3.6	8.6	3.7	14.2	7.5	1.4	2.3	3.8	1.6	7.8	13.0	29.6	1.4	2.2	9.3	4.3	7.1	4.5	2.0	12.3	2.2	5.1	2.6	4.1	1.3	4.6	10.6	12.7	1.6	5.0	8.3	0.0	1.7	0.0	1.4	3.9	2.3	0.3	0.1	3.8	0.2	0.1	0.0	0.0	1.8	4.3	0.3	0.1	4.5	9.3	0.1	13.1	10.3	5.4	2.8	1.2	0.3	0.1	1.0	10.5	1.4	3.8	2.0	9.6	0.0	0.0	0.0	1.8	0.1	3.5	0.0	0.1	3.4	0.0	23.4	5.9	8.0	0.0	0.0	13.2	0.1	0.0	5.9	1.5	1.2	0.6	1.1	0.0	0.9	0.0	0.3	0.0	0.9	0.1	1.8	0.0	20.5	6.9	15.7	4.4	6.7	9.0	0.7	0.0	0.4	4.7	0.2	19.4	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.1	0.2	0.1	0.0	0.0	17.8	14.2	14.7	20.5	14.2	7.5	7.8	13.0	7.1	8.3
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 40.3"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.9	0.0	0.1	1.0	0.7	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	40.3	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2
NPHP3-ACAD11		ENSG00000274810	"NPHP3-ACAD11 readthrough (NMD candidate)"		3	132558142-132722459	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"ovary: 6.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.50e-1)"	"unprognostic (1.82e-1)"			"unprognostic (1.04e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.63e-5)"	"unprognostic (4.17e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.59e-2)"	2.1	0.4		0.0		0.6	1.7		1.2	0.5	1.2			0.0	2.5	0.0	0.2	0.8	0.3	0.0			0.0	0.2	1.7	0.4			6.0	0.0	0.0		0.0		0.0	0.1		1.1	0.0	3.5	0.0	0.0	0.0		0.6	0.1	0.8			0.0		0.3	0.0		0.6	0.7	1.0	1.1	0.1	2.0	0.0	1.5	0.0	2.7	0.4	1.8	10.5	1.6	3.0	2.6	0.5	1.2	0.0	1.0	0.5	1.3	2.8	0.4	0.3	0.8	1.5	0.0	0.6	0.0	0.0	1.8	1.0	0.0	3.5	4.9	1.7	0.6	1.5	0.0	0.4	0.9	0.7	0.0	0.0	1.1	0.5	0.0	0.0	2.0	0.6	0.2	0.0	0.3	2.4	2.0	0.4	3.1	0.5	1.6	5.5	3.2	2.4	1.4	0.0	1.6	0.0	0.5	3.3	0.0	2.0	0.3	0.0	1.0	0.1	1.1	0.1	0.6	0.0	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.0	0.7	2.0	0.0										
NRK	DKFZp686A17109	ENSG00000123572	"Nik related kinase"	Q7Z2Y5	X	105822543-105958610	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 42.2;placenta: 64.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 32.4;HSkMC: 6.2;RH-30: 7.3;RPTEC TERT1: 19.9"	"Cancer enriched"	"Detected in some"	8	"testis cancer: 6.1"	"Region enriched"	"Detected in single"	10	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	28	"cerebellum: 16.0"	"Low region specificity"	"Detected in many"			HPA017238	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA017238: AB_1854645"	"unprognostic (2.64e-4)"	"unprognostic (9.82e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.52e-2)"		"unprognostic (3.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.28e-2)"	"unprognostic (6.80e-3)"	2.6	12.7	0.4	2.7	0.4	0.0	0.8	4.3	0.3	3.5	1.5	0.1	4.6	0.0	4.3	15.6	1.6	1.3	7.5	2.9	0.4	0.4	9.9	0.4	0.5	0.0	0.3	0.0	42.2	0.5	0.0	2.9	64.8	0.2	22.0	0.1	0.0	2.1	1.6	0.4	0.4	0.5	2.8	0.4	0.3	0.9	10.6	0.0	0.0	0.5	3.1	0.3	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	7.3	0.0	19.9	0.4	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	4.3	0.3	0.4	0.4	0.3	0.0	0.2	0.0
NXNL2	"C9orf121, RdCVF2"	ENSG00000130045	"Nucleoredoxin like 2"	Q5VZ03	9	88535101-88584274	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 15.0"	"Group enriched"	"Detected in some"	7	"breast cancer: 1.7;endometrial cancer: 4.0;ovarian cancer: 7.2;renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045526	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA045526: AB_10961044"	"prognostic favourable (6.53e-4)"	"unprognostic (9.70e-2)"	"unprognostic (4.78e-3)"	"prognostic favourable (3.83e-8)"	"unprognostic (2.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.56e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-3)"	"unprognostic (5.58e-2)"	"prognostic favourable (9.60e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-2)"	7.2	0.4	1.6	1.0	1.6	4.4	3.2	0.6	1.1	6.7	0.5	2.0	0.4	0.6	6.2	9.7	0.8	6.6	0.7	0.5	1.8	2.9	4.4	5.1	0.4	0.4	1.3	1.0	11.7	0.5	0.0	0.7	3.9	1.2	0.8	0.0	2.0	1.4	3.7	1.0	1.3	0.5	0.4	1.8	0.8	0.5	2.2	0.4	0.4	1.2	0.4	0.4	1.2	1.5	1.2	1.1	4.8	1.0	1.7	2.4	0.7	1.9	4.1	1.7	1.5	0.1	1.1	1.2	3.8	1.0	0.5	0.7	0.8	1.3	1.0	1.6	0.4	2.0	0.6	0.2	1.3	0.6	1.2	1.9	4.0	1.3	0.8	1.1	1.4	0.8	0.3	0.4	0.4	0.0	1.3	4.1	1.0	0.9	1.1	1.8	2.1	0.9	0.8	0.8	1.4	15.0	1.4	1.1	0.7	2.3	1.2	0.7	1.7	1.0	1.4	1.4	2.8	2.1	0.8	1.4	1.2	1.1	1.2	1.6	1.0	4.8	1.0	2.3	2.1	0.5	2.1	0.8	1.2	2.4	0.3	1.2	2.1	2.4	2.8	1.7	0.5	1.1	2.0	0.7	1.6	1.6	0.6	1.1	1.8	2.9	1.3	1.0	1.2	0.4
OBSL1	KIAA0657	ENSG00000124006	"Obscurin like 1"	O75147	2	219550729-219571859	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 82.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.2;SK-BR-3: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.8;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.7;granulocytes: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036404, HPA036405"	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA036404: AB_10670437, HPA036405: AB_2675104"	"unprognostic (2.36e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (6.41e-4)"	"unprognostic (7.27e-3)"	"unprognostic (2.89e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.16e-1)"	10.7	26.9	13.4	7.0	11.5	1.2	11.7	18.0	16.2	17.6	8.7	10.3	10.5	3.8	18.2	23.3	7.3	19.9	14.5	30.7	12.8	8.2	19.6	14.5	9.3	3.4	5.5	10.9	82.2	35.6	23.5	16.6	19.3	11.5	15.1	2.3	19.1	25.5	19.1	21.0	14.8	4.8	10.5	8.8	8.2	10.3	15.5	11.5	0.8	34.1	12.4	2.6	10.1	12.1	0.1	2.7	6.8	0.4	0.1	0.2	0.0	9.5	6.5	11.9	24.8	8.3	6.1	45.2	7.2	10.6	9.2	8.6	5.6	15.0	0.0	15.3	9.8	9.8	9.2	5.4	1.9	0.0	16.1	20.8	6.2	28.4	6.2	0.5	0.1	16.5	4.5	2.1	3.5	1.0	8.5	0.2	6.5	23.7	0.0	5.9	28.3	6.7	10.6	10.5	0.0	16.7	9.1	5.2	17.9	8.2	43.9	16.5	4.0	18.0	2.4	9.8	10.6	3.1	2.8	0.0	0.0	0.0	5.7	0.0	9.7	6.8	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.8	0.1	0.4	2.7	0.0	0.0	13.4	11.5	18.0	16.2	12.8	8.2	5.5	10.9	11.5	11.5
OR51B4		ENSG00000183251	"Olfactory receptor family 51 subfamily B member 4"	Q9Y5P0	11	5301014-5301946	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"ovary: 1.6"	"Group enriched"	"Detected in some"	7	"K-562: 7.0;U-2197: 9.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (6.16e-2)"	"unprognostic (5.01e-1)"		0.3	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.7	0.1			0.0	0.6	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0		1.6	0.2	0.0	0.3	0.7		0.4	0.2		0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	1.0			0.2		0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.7	9.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52B6		ENSG00000187747	"Olfactory receptor family 52 subfamily B member 6"	Q8NGF0	11	5580877-5581884	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"ovary: 1.4;pancreas: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			"unprognostic (1.57e-1)"				0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1			0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0		1.4	1.8	0.0	0.2	0.0		0.2	0.0		0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2			0.2		0.0	0.2	0.4	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0										
OR8S1		ENSG00000284723	"Olfactory receptor family 8 subfamily S member 1"	Q8NH09	12	48525632-48528103	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"intestine: 1.2;ovary: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CAPAN-2: 1.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA045595	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA045595: AB_10964447"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.1	0.0	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0			1.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PABPC5	PABP5	ENSG00000174740	"Poly(A) binding protein cytoplasmic 5"	Q96DU9	X	91434595-91438584	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HSkMC: 4.0;LHCN-M2: 2.6;RH-30: 11.6;U-2 OS: 2.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000164, HPA000165"	Approved									"HPA000164: AB_1079551, HPA000165: AB_1079552"	"unprognostic (1.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.55e-2)"	"unprognostic (8.07e-2)"	4.3	14.1	5.3	1.9	4.3	0.4	7.3	2.2	6.2	8.1	4.0	5.7	1.3	1.2	10.3	5.2	2.8	3.9	2.9	3.6	3.7	3.7	2.0	1.0	2.4	1.8	5.1	2.4	20.9	1.3	1.5	11.7	1.8	4.9	5.5	1.9	3.8	1.9	4.3	1.3	1.3	1.9	5.8	5.2	3.4	2.3	3.3	4.9	0.0	4.5	2.1	1.4	4.9	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.0	0.0	1.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.2	0.1	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.3	2.2	5.9	3.7	3.7	5.1	2.4	4.9	4.9
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.0;ASC TERT1: 37.9;BJ hTERT+: 47.0;fHDF/TERT166: 32.7;HHSteC: 27.4;HSkMC: 68.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	150000	150000	"Nucleoplasm, Plasma membrane, Cell Junctions"	"Nucleoplasm, Plasma membrane, Cell Junctions"	"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favourable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	81.0	37.9	0.1	4.2	47.0	0.0	0.1	11.2	0.0	0.1	0.1	32.7	0.1	3.2	0.0	0.0	0.4	0.1	0.1	0.1	0.2	27.4	0.0	0.0	68.9	0.0	5.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.6	0.0	0.1	0.0	0.1	0.0	0.1	14.8	0.5	16.2	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3
PEG3	"KIAA0287, ZKSCAN22, ZNF904, ZSCAN24"	ENSG00000198300	"Paternally expressed 3"	Q9GZU2	19	56810083-56840728	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.0;ovary: 106.4;placenta: 49.8"	"Group enriched"	"Detected in some"	5	"BEWO: 31.4;Hep G2: 63.9;RH-30: 21.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.3;plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.3"	"Low region specificity"	"Detected in all"							HPA026070	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA026070: AB_10603328"	"unprognostic (1.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.48e-5)"	"unprognostic (6.92e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (6.68e-3)"	2.0	29.8	10.1	1.0	51.0	0.5	4.5	9.8	22.4	4.1	2.4	5.9	0.0	0.7	9.1	2.6	1.7	5.8	1.2	2.3	9.7	9.6	1.8	2.1	1.7	0.7	3.5	16.0	106.4	1.9	7.3	24.6	49.8	21.3	1.8	1.2	0.4	2.3	2.5	1.7	1.8	1.7	4.1	4.8	1.6	2.0	12.3	7.3	0.0	2.7	0.0	2.7	2.6	2.0	0.0	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	21.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	10.1	51.0	9.8	22.4	9.7	9.6	3.5	16.0	21.3	7.3
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451264-6556494	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;HeLa: 8.6;hTCEpi: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.1	2.4	17.9	1.2	18.8	0.5	1.7	18.7	23.0	2.4	4.5	0.7	3.4	1.5	1.9	3.4	9.4	4.3	3.8	0.8	7.2	5.2	1.5	1.6	3.1	0.6	2.9	11.9	24.2	0.9	1.9	0.7	0.6	2.5	2.7	3.6	2.3	1.9	8.3	1.1	14.3	1.4	3.8	0.9	43.3	3.2	2.4	1.5	0.0	2.4	0.7	2.1	1.3	2.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.4	0.5	0.4	0.2	0.0	0.1	0.4	0.4	0.1	0.5	0.3	0.3	3.9	0.1	2.1	0.1	11.1	0.2	2.3	0.2	0.2	0.4	0.1	8.6	0.1	0.6	0.2	0.3	0.1	32.3	0.6	1.8	0.3	0.1	0.0	0.3	0.5	0.0	0.1	0.6	1.6	0.1	1.2	0.0	0.8	0.1	0.3	0.3	5.0	2.4	0.1	0.8	0.0	0.2	0.3	2.1	0.4	1.3	0.3	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	17.9	18.8	18.7	23.0	7.2	5.2	2.9	11.9	2.5	1.5
PLCXD3		ENSG00000182836	"Phosphatidylinositol specific phospholipase C X domain containing 3"	Q63HM9	5	41306954-41510628	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.4;heart muscle: 36.6;ovary: 27.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;PC-3: 5.5;SH-SY5Y: 25.7;TIME: 13.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 33.4"	"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046849	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA046849: AB_2679838"	"unprognostic (1.71e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.12e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.15e-3)"	"unprognostic (5.91e-5)"	"unprognostic (5.11e-2)"	"unprognostic (6.75e-2)"	7.0	15.3	6.9	1.2	4.5	0.8	4.5	33.4	6.5	4.5	1.4	2.0	1.4	1.3	1.6	1.7	1.4	2.5	3.4	36.6	4.8	8.1	7.3	2.2	2.0	7.9	4.2	4.2	27.6	4.8	1.3	13.7	0.8	9.0	1.9	1.5	0.5	1.2	2.0	0.9	0.9	1.7	2.1	5.8	0.9	5.9	1.1	2.1	0.0	1.4	0.0	1.0	1.4	6.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	25.7	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	6.9	4.5	33.4	5.5	4.8	8.1	4.2	4.2	9.0	2.1
PNMA6E		ENSG00000214897	"PNMA family member 6E"	A0A0J9YXQ4	X	153395640-153401420	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 8.0;ovary: 6.5;testis: 26.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.7;THP-1: 1.1;U-937: 2.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (5.82e-2)"						"unprognostic (1.71e-1)"		"unprognostic (2.99e-2)"			"unprognostic (1.77e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512538-83525704	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.1;ovary: 16.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 42.1;RPTEC TERT1: 12.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 4.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	9	"MAIT T-cell: 17.1"	"Lineage enriched"	"Detected in single"	172	"T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"					"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	2.0	3.8	7.7	1.3	11.3	0.0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2.0	3.0	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0.0	0.7	0.4	0.2	2.0	0.9	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	5.1	0.5	1.0	42.1	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.1	0.0	0.0	0.0	12.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	17.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3
RASGRF2	"GRF2, Ras-GRF2"	ENSG00000113319	"Ras protein specific guanine nucleotide releasing factor 2"	O14827	5	80960672-81230156	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.8;ovary: 24.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.8;CACO-2: 14.4;EFO-21: 7.5;Hep G2: 19.1;HHSteC: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdTCR: 2.8;MAIT T-cell: 7.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 2.2;naive CD4 T-cell: 6.4;naive CD8 T-cell: 4.3"	"Lineage enriched"	"Detected in single"	78	"T-cells: 7.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 41.1;cerebral cortex: 118.3;hippocampal formation: 72.9;olfactory region: 58.3"	HPA018679	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA018679: AB_1856089"	"unprognostic (1.32e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-1)"	13.3	1.6	11.6	4.3	14.0	1.5	5.4	1.5	23.8	3.8	2.7	18.7	1.5	2.7	3.9	1.6	2.1	2.6	7.1	4.3	11.1	6.6	6.6	1.0	3.8	4.5	8.5	5.5	24.6	1.4	6.8	3.4	13.2	8.9	5.3	2.3	17.1	1.9	2.4	3.1	1.5	2.9	3.8	15.2	3.0	2.3	2.9	5.6	0.0	4.3	1.1	3.9	4.1	2.4	0.0	0.0	0.0	0.0	0.0	7.7	1.5	0.0	1.3	0.3	0.1	0.0	0.0	23.8	0.4	5.7	0.2	0.3	14.4	0.0	0.2	7.5	0.0	0.4	0.0	0.0	0.8	0.3	2.4	0.1	0.1	19.1	13.2	0.0	0.0	0.6	0.0	5.5	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	2.8	0.0	0.1	2.8	0.0	0.9	0.0	0.2	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	2.8	0.0	7.7	0.0	3.8	2.2	0.0	0.0	6.4	4.3	0.0	0.0	0.0	0.0	0.8	1.5	11.6	14.0	1.5	23.8	11.1	6.6	8.5	5.5	8.9	5.6
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862290-52866835	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 38.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.7;CACO-2: 7.6;NTERA-2: 10.4;RPTEC TERT1: 6.5;SH-SY5Y: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	1.1	1.6	9.2	0.6	3.8	0.2	0.7	9.8	11.5	2.2	0.4	0.1	12.5	0.1	5.3	2.7	0.3	2.9	2.4	12.4	2.7	1.9	8.5	0.5	0.7	0.7	0.7	5.5	38.0	0.8	19.9	0.4	8.8	0.4	2.2	0.3	1.3	0.8	20.2	0.3	2.0	0.5	1.9	0.5	15.2	2.5	3.9	0.0	0.0	0.6	0.0	1.0	1.2	2.8	0.2	0.9	0.0	0.1	2.2	1.3	0.2	0.2	0.0	3.8	0.0	3.5	1.6	9.7	0.1	0.0	0.2	0.0	7.6	0.0	0.0	0.3	0.0	0.0	0.5	2.2	0.0	0.0	0.9	0.3	0.0	0.0	0.7	0.0	0.3	1.6	4.0	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.7	0.0	10.4	0.1	0.0	4.5	0.0	6.5	1.0	2.2	26.4	0.1	1.7	0.8	0.9	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.9	0.0	2.2	0.0	0.9	0.0	0.2	9.2	3.8	9.8	11.5	2.7	1.9	0.7	5.5	0.4	0.0
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 134.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	8.6	0.0	0.0	6.0	0.1	0.0	0.0	0.7	0.0	0.4	11.0	25.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	5.1	0.0	0.0	0.0	3.1	134.2	5.5	0.0	0.0	0.5	0.1	0.0	0.0	19.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3
RNF122	FLJ12526	ENSG00000133874	"Ring finger protein 122"	Q9H9V4	8	33547755-33567125	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"ovary: 66.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 38.8;Karpas-707: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003888	Uncertain									"HPA003888: AB_1079822"	"unprognostic (2.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.46e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.95e-2)"	"prognostic favourable (5.37e-4)"	"prognostic unfavourable (4.50e-7)"	"unprognostic (4.45e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.88e-4)"	"unprognostic (7.15e-2)"	23.6	14.6	2.3	15.9	5.9	6.5	13.4	16.7	4.4	8.3	8.2	3.2	3.1	2.5	8.8	10.3	9.3	20.0	13.3	28.5	6.7	2.1	4.4	7.1	25.0	10.1	4.3	0.7	66.3	5.6	3.4	3.2	2.8	12.3	12.8	5.1	5.5	5.1	5.8	31.9	6.4	8.3	14.4	14.4	13.3	7.9	9.6	2.5	8.1	4.3	17.3	11.4	20.6	11.8	5.0	14.2	7.4	9.9	1.8	1.6	0.3	0.3	2.0	10.4	4.3	0.9	0.3	1.4	0.6	0.9	1.3	2.1	0.3	0.4	4.8	3.2	1.6	0.3	2.2	0.9	0.7	0.3	38.8	1.0	0.5	2.7	0.6	0.3	7.9	1.0	0.8	0.7	0.5	4.1	0.9	25.1	1.0	0.9	4.2	3.2	5.7	1.1	4.6	2.0	3.7	1.5	0.6	2.0	11.7	0.7	0.2	1.5	0.4	1.3	2.4	1.8	1.6	3.2	0.7	10.1	5.7	8.8	1.1	1.3	0.2	4.6	0.9	7.4	1.5	4.5	1.3	2.9	0.9	1.1	0.8	5.0	1.5	1.6	6.7	1.8	9.9	14.2	0.6	0.3	2.3	5.9	16.7	4.4	6.7	2.1	4.3	0.7	12.3	2.5
SCUBE1		ENSG00000159307	"Signal peptide, CUB domain and EGF like domain containing 1"	Q8IWY4	22	43197283-43343388	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 35.8;retina: 48.1"	"Group enriched"	"Detected in some"	4	"HMC-1: 32.1;THP-1: 12.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003190	Approved				"Secreted to blood"	130000	130000			"HPA003190: AB_1079882"	"unprognostic (5.29e-2)"	"unprognostic (7.15e-6)"	"unprognostic (6.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (3.65e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.87e-3)"	3.3	5.3	0.4	1.1	2.0	0.1	3.5	0.3	2.3	1.3	5.5	0.9	1.3	5.9	1.3	0.7	14.8	1.2	0.8	1.0	0.5	0.7	3.4	4.6	7.5	0.1	3.4	1.9	35.8	0.4	0.3	3.8	3.5	1.9	6.4	2.0	48.1	5.3	0.5	8.0	0.6	7.6	1.0	3.5	6.9	7.3	8.5	0.1	0.0	3.1	0.5	0.1	4.2	6.3	0.3	0.3	2.4	0.3	0.5	0.3	0.1	0.0	0.0	1.4	5.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	32.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	12.7	0.0	0.2	0.1	0.3	0.0	1.4	2.5	0.0	0.3	0.0	0.1	2.4	0.2	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.1	0.3	0.3	0.3	1.0	0.5	0.3	0.3	0.2	0.1	0.4	2.0	0.3	2.3	0.5	0.7	3.4	1.9	1.9	0.1
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 29.3;testis: 41.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	Nucleoplasm	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavourable (2.32e-6)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	3.1	15.1	5.4	5.0	3.9	2.0	3.3	10.2	5.4	7.5	4.5	2.0	2.9	3.9	8.0	6.8	3.1	9.3	5.3	2.0	6.2	4.4	1.8	5.1	3.1	3.5	2.5	3.0	29.3	3.4	4.2	7.6	3.3	3.4	6.1	4.9	4.0	3.8	4.7	5.5	2.3	5.1	6.2	3.0	5.5	5.1	41.5	3.7	4.5	2.1	2.7	3.4	4.4	5.4	7.1	8.1	10.5	5.3	10.8	6.3	3.5	1.8	5.0	16.2	12.9	8.5	8.3	8.2	6.9	6.8	7.2	8.9	17.4	5.4	0.0	8.6	8.0	1.7	17.5	12.3	9.0	3.1	13.1	8.7	3.3	2.2	19.0	9.6	6.8	5.6	5.1	4.8	8.6	6.6	21.9	8.4	8.5	8.5	9.3	7.6	5.9	5.5	13.9	10.8	12.0	4.7	3.7	10.6	11.6	7.5	1.1	6.6	4.4	18.3	4.7	8.8	4.7	7.9	5.9	2.1	2.3	13.7	3.5	6.4	5.0	7.0	5.3	10.5	5.2	5.2	6.3	7.1	6.3	4.0	8.1	6.9	5.3	4.1	0.7	10.8	4.0	3.9	4.1	3.5	5.4	3.9	10.2	5.4	6.2	4.4	2.5	3.0	3.4	3.7
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627327-219641980	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.6;ovary: 30.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"myeloid DC: 2.3;plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.12e-4)"	1.8	5.4	11.8	1.6	22.5	1.2	2.0	8.8	22.0	2.8	1.3	3.0	0.4	1.4	3.4	2.6	2.9	2.7	2.3	103.6	10.4	8.2	1.6	1.0	1.3	1.4	6.5	9.0	30.2	2.7	4.5	9.9	2.5	24.1	4.2	1.1	4.9	3.1	4.3	1.2	1.6	1.3	3.1	1.6	2.6	1.4	4.2	3.5	0.0	1.5	0.0	1.3	1.6	0.9	0.0	8.9	0.0	0.1	0.0	0.0	0.0	6.8	0.3	2.5	7.1	0.4	0.5	4.9	4.3	4.5	5.8	4.1	5.0	4.0	0.0	1.7	1.6	4.0	1.2	7.7	1.7	0.0	1.1	0.0	0.0	0.1	1.2	0.1	0.4	3.4	7.4	0.0	2.3	0.0	0.2	0.0	1.7	2.3	0.0	0.0	4.0	5.8	0.0	0.0	0.0	4.0	1.6	1.5	7.0	2.7	7.5	3.7	0.7	1.8	0.0	3.6	6.3	0.0	3.4	0.0	0.0	0.0	3.0	0.0	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	11.8	22.5	8.8	22.0	10.4	8.2	6.5	9.0	24.1	3.5
SNCAIP	SYPH1	ENSG00000064692	"Synuclein alpha interacting protein"	Q9Y6H5	5	122311354-122464219	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 22.6;ovary: 32.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;BJ hTERT+: 7.4;HBF TERT88: 4.8;RPMI-8226: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 9.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064687	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"				"Cytoplasmic bodies"	"Cytoplasmic bodies"	"HPA064687: AB_2685324"	"unprognostic (7.28e-3)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-1)"	3.9	1.2	2.2	2.1	5.8	0.7	4.1	15.4	6.4	16.0	1.6	3.7	4.0	1.6	22.6	4.3	0.9	4.5	2.4	1.5	3.4	2.2	1.6	0.4	1.4	4.5	1.6	2.4	32.3	0.7	0.3	1.6	2.1	3.2	2.6	1.1	2.3	0.8	2.7	0.7	1.9	1.1	10.6	1.5	6.1	1.2	11.6	2.1	0.5	1.2	3.3	1.4	4.6	4.1	0.4	0.4	9.9	0.3	0.1	0.4	0.0	0.0	0.1	7.7	0.2	0.0	0.5	0.5	3.5	7.4	1.3	0.4	0.5	0.6	0.1	0.3	3.4	0.2	3.0	0.5	4.8	2.8	1.0	0.0	0.6	0.4	0.1	0.0	0.4	0.6	0.1	0.6	0.4	2.3	0.0	2.0	0.0	0.0	0.2	0.1	3.7	0.6	0.2	0.0	7.9	0.3	1.0	1.5	0.3	0.0	0.7	0.0	0.6	0.2	0.8	0.4	1.0	0.5	0.8	0.2	0.2	0.3	0.4	0.0	0.5	9.9	0.3	0.0	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.4	0.2	0.4	1.7	0.1	0.1	0.4	0.1	0.0	2.2	5.8	15.4	4.3	3.4	2.2	1.6	2.4	3.2	2.1
STXBP5L	"KIAA1006, LLGL4"	ENSG00000145087	"Syntaxin binding protein 5 like"	Q9Y2K9	3	120908072-121424761	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.2;ovary: 19.7"	"Cell line enhanced"	"Detected in some"		"AF22: 8.1;HeLa: 5.9;MOLT-4: 7.7;RH-30: 4.0;SCLC-21H: 11.1;SH-SY5Y: 4.9;U-937: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.42e-1)"	"unprognostic (9.47e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.89e-2)"		"unprognostic (7.01e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.61e-3)"	0.9	4.3	9.1	0.9	15.4	0.8	0.8	55.2	22.6	1.8	1.6	1.3	1.3	1.3	2.6	0.8	1.4	1.1	0.9	0.8	13.9	3.4	0.8	0.8	0.9	0.8	3.1	17.1	19.7	1.2	0.8	12.6	0.9	22.4	5.2	1.2	0.0	0.9	7.4	0.8	0.8	1.4	2.5	2.1	0.8	1.7	4.3	2.5	0.0	16.1	0.0	0.8	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	5.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.0	4.0	0.8	0.0	4.0	0.0	0.0	0.8	11.1	4.9	0.0	0.0	0.1	1.1	2.9	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.0	2.2	4.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	15.4	55.2	22.6	13.9	3.4	3.1	17.1	22.4	2.5
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.9;HMC-1: 30.9;RT4: 20.3;TIME: 17.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 5.1"	"Region enriched"	"Detected in single"	5	"hypothalamus: 35.1"	"Not detected"	"Not detected"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		6100000	6100000	Vesicles	Vesicles	"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	3.8	3.1	9.1	2.8	9.5	1.6	4.4	4.3	8.4	18.1	5.3	6.6	4.8	1.7	36.2	5.4	2.6	10.0	2.9	2.1	11.9	6.0	4.2	7.1	3.0	0.7	9.8	2.7	47.3	8.8	1.3	41.9	2.6	9.4	9.2	6.8	1.3	3.8	6.0	4.5	1.4	3.0	22.5	7.8	2.3	5.3	7.8	9.5	0.0	6.2	1.1	1.4	4.3	9.4	0.5	0.3	5.1	0.3	0.5	0.4	2.3	0.1	3.0	0.8	0.0	4.4	2.5	0.0	3.8	2.5	4.1	7.4	0.3	3.8	0.0	1.0	2.7	3.4	14.9	1.3	4.4	0.0	1.3	0.0	5.1	0.2	1.1	0.0	30.9	0.9	0.3	3.7	0.2	10.4	1.4	0.0	1.9	1.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	3.7	20.3	7.5	0.3	1.5	5.9	0.8	3.6	0.3	17.5	2.1	4.7	10.7	0.9	0.0	0.0	0.0	2.7	0.0	2.4	1.1	0.3	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.5	0.4	0.2	5.1	0.5	0.2	0.3	0.1	2.3	9.1	9.5	4.3	8.4	11.9	6.0	9.8	2.7	9.4	9.5
TCEAL2	"my048, MY0876G05, WEX1"	ENSG00000184905	"Transcription elongation factor A like 2"	Q9H3H9	X	102125688-102127711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;ovary: 46.5"	"Group enriched"	"Detected in some"	4	"HAP1: 7.2;SCLC-21H: 7.9;U-2 OS: 14.2"	"Cancer enhanced"	"Detected in many"		"glioma: 22.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.1"									HPA076317			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA076317: AB_2686794"	"unprognostic (2.34e-3)"	"unprognostic (1.35e-2)"	"unprognostic (7.59e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.47e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.11e-3)"	2.4	19.6	34.1	2.6	44.6	1.1	2.4	40.9	84.0	5.8	7.0	8.5	1.8	3.1	19.5	8.6	5.3	7.3	6.4	5.1	30.0	37.9	8.2	1.3	4.4	1.6	25.4	26.5	46.5	3.7	2.8	38.3	1.1	30.1	19.4	3.8	6.6	16.4	21.6	1.2	1.7	3.2	14.0	16.1	2.9	4.2	19.7	9.6	0.0	25.6	0.0	2.1	4.3	2.6	0.1	0.1	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.1	0.0	0.0	7.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.8	0.1	1.7	0.0	0.1	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.1	0.4	34.1	44.6	40.9	41.8	30.0	37.9	25.4	26.5	30.1	9.6
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889138-133895553	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lung: 74.4;ovary: 61.6"	"Cell line enriched"	"Detected in some"	12	"HHSteC: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013189	Uncertain									"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	4.7	2.2	0.2	11.6	0.5	0.0	0.4	0.2	0.2	12.7	16.8	0.4	9.6	5.2	12.9	9.6	19.1	2.2	14.6	13.2	0.2	0.2	17.0	4.1	74.4	1.0	0.2	0.0	61.6	1.9	0.0	2.4	48.4	1.2	57.8	5.3	0.0	0.2	16.0	0.8	0.3	13.9	21.1	0.2	52.2	5.7	5.9	0.0	0.0	0.5	0.0	0.0	19.6	24.6	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.0	1.2	0.0
TCF23	"bHLHa24, OUT"	ENSG00000163792	"Transcription factor 23"	Q7RTU1	2	27149004-27156974	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 28.0;endometrium 1: 56.4;ovary: 49.9"	"Cell line enriched"	"Detected in single"	10	"THP-1: 8.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044596			Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA044596: "	"unprognostic (1.04e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.41e-5)"	"unprognostic (7.58e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.58e-4)"	"unprognostic (2.64e-2)"	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	28.0	0.5	0.0	0.5	0.0	56.4	7.2	0.1	14.0	0.4	0.6	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	49.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	16.7	0.1	6.2	0.1	7.5	0.0	0.0	0.1	0.0	0.0	0.7	1.5	1.8	1.4	4.4	1.0	1.3	1.2	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.0	0.5	0.1	0.6	0.3	0.1	0.8	0.1	0.7	0.0	0.3	0.2	0.1	0.2	0.3	0.0	0.3	8.6	0.0	0.2	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.0	4.4	1.0	0.9	1.0	0.5	0.8	1.1	1.1	0.8	0.2	1.8	1.2	1.0	3.9	1.3	0.5	1.4	0.6	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
TDGF1	"CR, CRIPTO, Cripto-1"	ENSG00000241186	"Teratocarcinoma-derived growth factor 1"	P13385	3	46574534-46582463	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7"	"Cell line enriched"	"Detected in some"	5	"NTERA-2: 45.5"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 6.4;testis cancer: 27.1"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 12.5;pons and medulla: 9.1"	"Low region specificity"	"Detected in single"			HPA051928			Uncertain	Vesicles,Cytosol	"Secreted in other tissues"			Vesicles	Vesicles	"HPA051928: "	"unprognostic (7.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.76e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-1)"	0.6	3.9	0.6	0.6	0.8	0.0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0.0	0.6	0.6	1.0	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0.0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1.0	0.0	0.6	0.8	1.0	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1.0	0.7	3.7	0.6	1.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	10.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1.0	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1.0	0.6	0.9	0.6	0.6	0.6
TENM4	"KIAA1302, ODZ4, Ten-M4"	ENSG00000149256	"Teneurin transmembrane protein 4"	Q6N022	11	78652831-79440948	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.0;parathyroid gland: 44.4"	"Cell line enhanced"	"Detected in many"		"HSkMC: 8.2;PC-3: 9.4;REH: 8.9;SH-SY5Y: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019521, HPA065961"	Approved									"HPA019521: AB_2670171, HPA065961: AB_2685588"	"unprognostic (2.81e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.40e-3)"	"unprognostic (5.64e-2)"	"unprognostic (7.07e-2)"	"unprognostic (9.81e-3)"	3.2	2.8	14.7	2.2	13.0	1.0	1.6	1.4	16.9	4.4	1.4	3.6	0.0	1.1	2.7	1.2	3.1	3.7	1.5	1.3	11.4	6.3	2.9	1.0	1.4	1.5	3.3	5.7	23.0	1.3	44.4	12.0	1.1	8.3	1.4	1.4	4.8	1.5	1.3	1.4	5.1	1.2	2.2	12.5	1.3	1.5	2.9	5.7	0.6	8.2	2.1	2.5	1.6	2.3	0.3	1.4	0.6	0.6	0.3	0.1	0.0	0.0	0.0	3.0	0.0	3.4	5.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.7	1.8	4.5	4.6	0.0	3.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.2	2.1	2.2	4.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	1.6	9.4	8.9	0.0	0.0	5.9	1.0	6.4	15.7	0.0	0.0	0.0	0.0	0.1	0.4	0.1	1.1	0.1	5.2	0.0	0.0	0.1	6.2	0.0	0.0	0.5	0.6	0.0	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.3	0.0	0.0	0.6	0.3	0.3	0.3	0.1	0.0	14.7	13.0	1.4	16.9	11.4	6.3	3.3	5.7	8.3	5.7
TMEM190	MDAC1	ENSG00000160472	"Transmembrane protein 190"	Q8WZ59	19	55376836-55378244	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 63.6;ovary: 17.7;testis: 21.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 13.8;SCLC-21H: 6.9"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6"	"Region enhanced"	"Detected in some"		"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Region enriched"	"Detected in some"	6	"cerebellum: 5.6"												"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-3)"	"unprognostic (3.97e-2)"		"unprognostic (1.42e-1)"	"unprognostic (5.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.38e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.93e-1)"	0.1	0.7	0.1	0.1	0.3	0.1	0.1	0.2	0.5	5.7	0.1	0.5	0.1	0.1	1.4	1.1	0.1	63.6	0.1	0.1	0.6	2.7	0.1	0.1	11.8	0.1	0.1	0.1	17.7	0.1	0.0	3.0	0.3	1.0	0.1	0.0	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.5	21.5	0.3	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.4	2.5	0.0	0.5	0.0	0.0	0.2	0.7	0.3	0.6	0.1	1.7	1.5	2.5	0.2	0.6	4.5	0.0	0.0	0.0	4.2	0.2	0.0	2.6	13.8	0.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	3.4	0.0	2.0	0.3	0.0	0.4	0.8	0.2	1.6	1.4	0.0	1.3	6.9	1.3	1.4	1.8	0.6	0.8	0.0	0.0	0.2	1.1	0.2	0.6	0.5	3.2	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.5	0.6	2.7	0.1	0.1	1.0	0.3
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"				"Nucleoli fibrillar center, Endoplasmic reticulum"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.0	2.5	2.8	3.0	0.8	0.4	5.4	2.9	0.9	1.1	1.2	2.0	3.2	5.3	3.6	1.4	2.8	1.7	1.3	2.5	7.0	2.7	6.3	6.4	2.6	0.5	3.6	5.3	1.1	1.5	1.4	1.1	1.3	4.4	8.5	0.9	2.6	3.2	4.0	4.8	2.6	2.7	4.4	4.4	1.1	3.1	3.3	3.2	4.0	3.0	2.2	3.6	3.3	6.5	4.5	4.9	7.1	3.1	5.0	4.0	3.5	2.3	3.3	2.3	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4
TMEM221		ENSG00000188051	"Transmembrane protein 221"	A6NGB7	19	17435509-17448567	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 11.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.3;PC-3: 11.0;REH: 6.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											"HPA041580, HPA062945"	Supported		Approved	"Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA041580: AB_10795700, HPA062945: "	"unprognostic (3.60e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.51e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.14e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.47e-4)"	"unprognostic (2.37e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.23e-1)"	1.0	6.1	5.4	0.7	2.9	0.5	1.6	1.3	7.0	0.9	0.8	1.1	0.0	0.4	1.2	3.1	0.9	6.2	1.5	1.2	6.0	2.1	0.7	0.4	0.7	0.6	1.2	2.5	11.4	5.4	10.2	2.5	0.5	3.3	3.8	0.4	6.5	3.3	4.6	0.6	1.2	0.6	0.6	3.1	0.5	0.6	2.4	1.8	0.0	1.4	1.1	0.4	0.9	3.3	0.0	1.6	0.0	0.1	0.0	0.7	0.1	0.8	2.4	1.0	7.3	0.0	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.2	0.2	1.5	0.0	0.3	2.2	0.1	0.0	0.1	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.3	1.6	11.0	6.1	0.2	0.0	0.4	0.5	0.1	0.3	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.1	5.4	2.9	1.3	7.0	6.0	2.1	1.2	2.5	3.3	1.8
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.4;ovary: 29.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 16.9;RPMI-8226: 10.8;SK-MEL-30: 17.7;U-2 OS: 7.6;U-87 MG: 19.3"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdTCR: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 5.9"	"Low region specificity"	"Detected in all"							HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	3.9	5.5	6.8	3.4	14.4	1.5	5.4	6.8	7.8	11.2	3.5	12.4	1.7	1.9	3.2	2.9	4.4	6.3	2.1	2.4	5.3	25.4	2.4	1.5	4.8	5.0	30.4	4.4	29.6	1.1	0.6	6.6	0.8	18.4	3.8	3.9	7.1	1.3	3.3	2.4	4.0	2.8	2.0	13.0	2.8	2.1	0.9	7.8	6.4	0.9	1.8	5.7	1.6	8.0	0.5	0.3	0.0	0.6	0.0	5.9	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	1.1	0.4	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	16.9	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	10.8	0.0	0.0	3.4	0.1	0.3	0.0	17.7	0.0	0.2	0.0	0.0	7.6	0.0	2.8	0.0	3.2	2.4	19.3	0.0	0.0	0.0	0.6	0.0	5.9	0.2	3.3	0.5	0.4	2.2	0.3	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.9	6.8	14.4	6.8	3.9	5.3	25.4	30.4	4.4	18.4	7.8
TMSB15B		ENSG00000269226	"Thymosin beta 15B"		X	104063871-104076212	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"endometrium 1: 4.2;ovary: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 11.2;AN3-CA: 10.6;Karpas-707: 11.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (5.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.89e-2)"		"unprognostic (1.04e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.46e-2)"	"unprognostic (9.11e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.07e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.07e-2)"	0.5	0.0		1.0		0.4	0.7		1.9	1.3	0.0			0.0	4.2	0.8	0.4	0.9	1.1	0.0			0.0	0.0	0.2	1.1			6.7	0.0	0.5		0.0		1.6	0.4		0.0	1.0	0.0	0.4	0.2	1.8		0.5	0.6	0.0			0.0		1.1	0.5		2.3	1.4	2.4	0.6	3.6	2.4	0.6	0.0	0.4	11.2	10.6	2.0	2.9	0.3	3.3	1.6	1.6	2.4	0.5	0.2	2.3	1.2	0.8	0.1	0.1	0.0	2.3	1.2	2.2	0.6	0.2	0.0	1.1	0.3	1.0	1.9	0.6	1.9	0.6	3.3	0.2	11.6	2.9	0.6	7.0	0.1	3.0	1.8	6.4	2.7	1.5	2.5	1.4	1.8	7.9	0.2	0.0	0.4	0.1	1.1	6.5	3.7	1.9	1.8	2.7	0.8	0.1	2.2	1.5	0.5	1.6	2.4	0.6	0.5	1.0	0.4	0.5	2.3	1.0	0.8	0.4	1.9	2.4	2.1	1.5	3.6	0.4	1.4	0.3	0.6										
TSPAN5	"NET-4, TM4SF9, Tspan-5"	ENSG00000168785	"Tetraspanin 5"	P62079	4	98470367-98658629	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5;ovary: 38.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"B-cells: 2.5;NK-cells: 4.5;T-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.29e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (7.83e-5)"	"prognostic unfavourable (8.56e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.23e-1)"	1.9	1.5	14.1	3.1	17.1	7.0	12.7	47.5	37.5	11.8	3.8	20.9	2.1	1.6	13.4	23.4	10.4	4.9	4.3	2.9	15.5	10.1	4.4	0.9	3.7	7.4	13.7	13.8	38.2	1.0	0.9	5.7	6.3	17.3	4.7	3.5	8.6	7.9	7.5	2.6	15.3	2.4	13.2	16.7	7.5	7.2	9.7	13.9	5.7	14.8	2.9	7.2	4.9	5.9	2.5	0.1	0.1	0.0	4.5	6.9	1.2	7.6	3.0	3.2	0.2	12.1	36.1	1.1	31.7	34.6	11.4	14.1	2.6	4.1	0.0	0.3	11.2	2.0	2.7	14.7	25.7	9.5	1.5	4.6	0.4	0.1	12.5	2.5	0.2	20.5	0.4	20.9	26.0	18.4	1.8	8.3	27.2	0.2	7.7	0.0	2.0	14.1	2.4	3.0	1.1	0.9	2.2	22.5	4.3	0.5	10.0	0.0	0.3	0.4	18.7	24.0	10.8	8.6	11.0	5.8	8.5	0.0	9.4	6.2	8.2	0.0	0.0	0.0	4.6	0.0	5.0	1.3	6.4	6.4	0.1	2.5	3.2	2.2	0.1	4.5	0.0	0.0	6.9	1.2	14.1	17.1	47.5	24.9	15.5	10.1	13.7	13.8	17.3	13.9
TXNRD3NB	"TR2IT1, TXNRD3IT1, TXNRD3NT1"	ENSG00000206483	"Thioredoxin reductase 3 neighbor"	Q6F5E7	3	126571789-126572636	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"ovary: 1.4;testis: 2.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;HL-60: 2.1;NTERA-2: 1.5;PC-3: 1.0;U-937: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058257	Uncertain									"HPA058257: AB_2683655"																		0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.6	0.1	0.4	0.0			0.0	0.3	0.7	0.8	0.8	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0		1.4	0.0	0.0	0.1	0.0		0.1	0.0		0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2			0.3		0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.8	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.2	0.0	0.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583586	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.2;ovary: 48.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					6400000	6400000			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	18.3	4.1	18.7	2.1	16.6	1.5	7.7	27.3	39.2	2.3	1.8	25.6	1.2	2.3	5.0	4.2	12.7	11.7	3.1	2.5	15.1	7.8	6.4	1.6	3.2	1.9	19.6	18.2	48.2	9.5	1.3	0.8	5.9	14.0	3.3	1.7	1.7	2.4	6.7	1.4	13.0	2.9	4.8	23.1	5.4	3.6	17.9	16.6	0.0	1.8	2.2	4.1	2.9	2.8	1.2	1.0	5.0	0.9	1.0	0.8	0.2	4.7	3.1	9.9	10.8	9.3	6.4	33.5	6.9	4.4	6.9	6.4	17.6	1.6	0.1	8.9	5.6	11.2	11.1	1.7	3.2	2.7	7.4	1.4	10.0	8.3	6.6	2.4	0.2	2.0	3.5	5.2	1.8	5.1	8.7	2.0	3.7	4.5	1.1	0.4	22.9	3.2	14.7	9.0	1.7	0.6	9.2	11.9	3.4	6.5	10.3	7.7	8.5	2.8	3.9	13.7	6.0	10.1	10.4	0.8	1.6	1.4	8.3	15.8	8.2	2.6	0.9	0.8	0.6	0.5	0.6	0.7	0.6	0.8	0.3	1.2	0.7	0.7	5.0	1.0	0.5	1.0	0.5	0.2	18.7	16.6	27.3	32.7	15.1	7.8	19.6	18.2	14.0	16.6
UBE2Q2L		ENSG00000259511	"Ubiquitin conjugating enzyme E2 Q2 like"	H0YL09	15	84172490-84182234	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ovary: 6.5;testis: 8.1"	"Cell line enhanced"	"Detected in some"		"K-562: 5.7;Karpas-707: 4.7;RPMI-8226: 1.7;RPTEC TERT1: 1.6;U-266/70: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.37e-2)"			"unprognostic (1.48e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.00e-1)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.16e-2)"				0.8	1.8	0.3	1.0	0.2	0.7	0.8	0.0	2.3	1.2	1.2			0.0	1.3	0.0	0.3	0.8	1.3	2.4	0.4	0.5	0.1	0.0	0.2	0.0	0.3		6.5	3.0	2.2	0.9	0.0		0.7	0.0		0.1	1.7	0.0	0.5	0.2	0.0	0.5	0.0	0.7	8.1			0.1		0.2	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.3	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30732247-30767006	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 30.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA017725: AB_1847462, HPA077538: AB_2686844"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	5.0	5.3	3.9	1.4	4.8	1.4	4.3	1.5	9.2	3.0	3.5	4.0	6.7	3.1	3.8	14.3	4.1	3.6	3.8	2.8	5.7		8.2	21.5	2.1	3.9	7.6	4.0	30.6	10.3	6.2	3.5	6.2	6.2	4.8	4.7	1.6	1.8	6.1	1.7	4.1	2.9	2.9	7.1	5.7	3.3	11.5	6.1	0.9	9.1	2.8	2.3	2.9	3.7	6.0	8.2	1.0	6.1	3.3	8.4	3.4	7.6	7.7	5.6	5.8	9.1	12.2	6.2	13.7	8.0	7.5	9.2	12.2	2.7	12.2	11.3	11.1	6.8	1.1	7.6	11.6	6.4	12.5	34.3	6.3	14.9	13.6	7.8	19.4	9.5	7.9	12.0	5.9	6.5	33.4	9.2	16.5	7.2	7.9	6.0	10.8	5.8	9.5	5.4	8.5	12.8	10.0	3.2	8.1	3.8	11.3	24.7	8.4	13.6	8.3	8.5	3.7	3.8	12.7	4.0	12.5	9.2	7.6	12.6	12.1	0.0	6.0	0.7	8.4	6.1	7.3	6.0	4.5	8.0	6.7	2.9	4.4	7.4	1.0	3.3	3.0	8.2	4.3	3.4										
VLDLR	"CARMQ1, CHRMQ1, VLDLRCH"	ENSG00000147852	"Very low density lipoprotein receptor"	P98155	9	2621834-2660053	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 27.6;THP-1: 28.3;U-87 MG: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"eosinophil: 14.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032462, HPA051312"	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Centriolar satellite"		180000	180000	"Vesicles, Cytokinetic bridge, Centriolar satellite"	"Vesicles, Cytokinetic bridge, Centriolar satellite"	"CAB032462: AB_2216805, HPA051312: "	"unprognostic (5.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.92e-2)"	"prognostic favourable (5.95e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.34e-2)"	11.3	13.7	7.2	3.7	9.6	1.3	11.2	8.7	7.3	6.9	3.9	12.8	6.5	1.2	12.1	4.3	11.6	15.1	5.5	38.0	7.6	4.5	8.8	2.5	6.9	0.9	13.2	5.3	50.5	20.8	43.6	5.9	9.4	7.7	5.7	2.9	12.3	7.5	4.4	21.2	3.4	1.6	15.7	10.1	5.5	5.8	5.6	10.3	0.0	8.8	12.5	3.9	11.9	6.1	0.1	0.8	14.1	0.1	0.1	1.1	0.0	0.0	3.0	19.1	0.9	2.8	0.2	27.6	8.6	2.8	2.3	6.6	4.8	0.3	0.0	9.3	5.3	0.2	5.3	5.8	7.4	10.1	2.0	0.1	2.5	2.2	3.1	12.0	2.1	1.2	4.2	0.8	0.4	1.1	0.0	16.9	1.3	0.8	2.2	1.6	9.6	1.2	0.2	0.6	0.0	11.0	1.2	4.3	3.0	0.6	1.0	11.9	0.5	28.3	0.3	3.1	5.9	0.0	5.7	12.9	5.2	3.0	20.5	10.0	1.2	0.1	0.1	14.1	0.2	0.0	1.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	2.0	0.1	0.0	0.8	0.0	0.0	7.2	9.6	8.7	7.3	7.6	4.5	13.2	5.3	7.7	10.3
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;Hep G2: 18.9;HSkMC: 11.1;REH: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	1300000	1300000	Nucleoplasm	Nucleoplasm	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.7	0.0	0.2	5.6	0.0	0.3	0.0	0.4	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	18.9	1.0	0.0	0.1	11.1	0.5	0.5	0.0	1.7	0.2	0.3	0.3	0.0	4.1	0.0	1.6	0.0	10.6	0.1	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.5	0.7	0.0	0.4	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5
WIPF3	"CR16, FLJ36931"	ENSG00000122574	"WAS/WASL interacting protein family member 3"	A6NGB9	7	29806486-29917066	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6;ovary: 44.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 18.1;HEK 293: 4.1;K-562: 6.2;NTERA-2: 5.1;RPMI-8226: 10.9;SK-MEL-30: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 234.6"					"HPA041145, HPA041211"	Uncertain		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA041145: AB_10795001, HPA041211: AB_10795003"	"prognostic favourable (7.93e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.12e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.41e-1)"	1.8	6.6	13.4	1.6	40.6	1.1	1.9	5.5	15.1	1.2	1.4	3.8	1.0	3.6	4.2	21.8	2.1	9.9	3.5	4.6	30.0	5.1	3.3	1.3	1.3	1.4	4.0	12.1	44.7	2.4	1.6	5.6	1.0	1.5	5.5	1.3	0.8	4.5	5.9	23.0	1.7	3.5	5.2	1.7	1.7	6.3	27.6	7.8	0.0	2.8	2.9	2.3	3.2	0.8	0.8	2.1	2.6	1.2	0.9	1.3	0.2	0.3	1.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	18.1	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.1	5.1	3.5	0.0	0.0	10.9	0.0	0.0	1.8	1.5	0.1	0.1	4.4	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.6	0.5	0.9	0.3	0.7	0.6	0.7	0.9	0.3	0.3	0.8	1.3	0.8	1.2	0.9	1.2	2.1	0.5	0.2	13.4	40.6	5.5	15.1	30.0	5.1	4.0	12.1	1.5	7.8
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780678-42796936	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1;ovary: 14.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.4;K-562: 21.7;TIME: 21.0;WM-115: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved									"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.1	0.0	0.8	5.8	0.2	0.0	2.6	0.6	0.3	0.7	12.9	0.4	0.4	2.1	0.2	2.8	8.7	0.5	1.0	0.2	2.6	0.0	28.1	0.2	0.4	0.1	0.1	0.3	14.6	1.0	0.0	2.4	0.0	1.7	11.1	11.7	12.2	1.4	1.2	0.0	0.5	3.3	0.4	0.8	0.1	2.6	0.4	0.2	0.0	0.0	0.2	2.0	0.3	0.4	0.4	0.0	0.0	0.3	0.0	1.0	0.0	1.2	0.6	0.2	0.0	0.2	0.1	2.9	7.2	2.8	2.7	0.8	0.4	0.5	0.2	4.3	19.4	0.0	0.1	0.2	4.7	0.4	0.9	0.0	0.0	2.8	4.6	0.0	0.4	2.5	0.4	3.9	1.2	0.2	21.7	0.7	0.0	0.6	0.0	0.5	0.2	4.9	0.3	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.9	1.4	1.5	21.0	0.2	1.9	0.2	0.1	3.5	3.0	0.6	0.0	1.2	14.1	0.0	0.3	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.3	2.6	0.0	0.1	0.3	1.7	0.2
WNT4	WNT-4	ENSG00000162552	"Wnt family member 4"	P56705	1	22117305-22143969	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 34.3;skin 1: 28.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 10.0;SCLC-21H: 12.2;SK-BR-3: 10.3;T-47d: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Low region specificity"	"Detected in many"							HPA011397	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles	Vesicles	"HPA011397: "	"unprognostic (1.85e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.75e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (2.14e-2)"	"prognostic favourable (4.90e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.49e-2)"	0.5	6.5	1.0	0.3	1.0	0.0	1.4	0.6	1.7	4.3	1.7	1.1	1.0	2.0	3.1	6.6	6.9	6.4	6.4	0.6	1.5	3.1	1.1	1.2	1.4	0.3	1.0	1.7	34.3	1.9	0.0	3.7	11.8	1.7	7.7	1.0	1.7	3.0	1.8	2.7	28.6	4.1	1.2	1.5	0.3	2.8	0.9	0.8	1.4	2.2	5.4	2.8	2.0	3.5	0.0	0.0	2.8	0.0	0.0	0.4	0.0	1.5	0.1	3.0	0.1	0.1	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.1	10.0	0.0	0.8	0.0	0.3	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	1.8	12.2	0.0	0.1	10.3	0.7	4.1	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.6	1.7	1.5	3.1	1.0	1.7	1.7	0.8
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"Wilms tumor 1"	P19544	11	32387775-32435630	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4"	"Cell line enhanced"	"Detected in some"		"HEL: 13.2;HMC-1: 17.0;K-562: 11.9;NB-4: 31.9;THP-1: 15.3"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 0.5"	"Low region specificity"	"Detected in single"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: "	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	10.3	0.0	0.2	1.8	0.6	0.0	0.2	0.2	0.5	20.3	1.5	0.2	3.7	0.0	69.0	9.3	0.4	34.5	0.8	2.1	0.9	0.0	5.3	0.2	0.8	0.5	0.2	0.2	53.4	0.2	0.0	0.2	6.9	0.3	0.9	0.0	0.2	0.2	4.2	0.2	0.0	0.4	23.7	0.2	14.6	0.0	24.5	0.2	0.2	0.3	0.2	0.2	1.3	4.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.0	6.1	0.0	0.0	0.0	4.6	13.2	0.0	1.1	3.7	8.8	17.0	0.0	0.0	2.7	0.0	0.0	11.9	0.1	2.7	0.0	7.7	31.9	0.7	3.7	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	15.3	0.1	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.2	0.5	0.9	0.0	0.2	0.2	0.3	0.2
ZCCHC18	"PNMA7B, SIZN2"	ENSG00000166707	"Zinc finger CCHC-type containing 18"	P0CG32	X	104112131-104115846	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 9.6;ovary: 9.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.5;Karpas-707: 8.4;SH-SY5Y: 5.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"B-cells: 3.0;T-cells: 2.2"					"Low region specificity"	"Detected in all"			"HPA034940, HPA078516"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA034940: AB_10671098, HPA078516: "	"unprognostic (7.20e-2)"	"unprognostic (7.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.34e-1)"	"unprognostic (4.44e-6)"	"unprognostic (4.05e-2)"	"unprognostic (1.02e-6)"	"unprognostic (3.82e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.14e-3)"	0.9	2.3	3.4	3.3	9.4	1.1	2.6	9.6	9.2	1.7	0.9	1.2	0.5	1.1	3.6	1.1	1.0	1.6	1.4	1.2	3.1	7.7	0.5	0.3	1.0	4.9	3.8	4.9	9.4	2.6	0.3	2.3	0.7	4.7	1.5	1.1	1.2	0.5	1.8	1.0	0.5	2.6	1.9	2.5	3.4	1.4	2.2	2.2	0.0	0.4	0.2	5.1	2.0	1.1	3.0	0.0	0.0	0.0	0.1	2.2	0.3	0.0	0.2	3.5	2.4	0.3	0.0	0.2	0.7	0.1	0.6	0.6	0.1	0.0	4.5	0.1	0.2	0.0	2.1	0.0	0.3	1.3	1.7	0.8	0.2	0.0	0.4	2.5	0.8	0.2	0.0	0.4	0.0	0.7	0.0	8.4	0.2	0.0	0.0	0.1	1.9	0.6	3.0	0.8	0.0	0.5	0.3	2.4	5.7	0.2	0.0	0.0	0.0	0.3	1.5	0.1	1.1	0.2	1.0	0.2	0.0	2.2	0.1	2.5	0.7	0.0	0.0	0.0	1.4	0.0	2.2	2.5	1.1	1.7	0.0	3.0	1.2	1.6	0.0	0.1	0.0	0.0	0.8	0.3	3.4	9.4	9.6	7.2	3.1	7.7	3.8	4.9	4.7	2.2
ZFP92	ZNF897	ENSG00000189420	"ZFP92 zinc finger protein"	A6NM28	X	153418322-153426481	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 6.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;HMC-1: 5.8;U-937: 9.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.2"					"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"hypothalamus: 10.3"	"Low region specificity"	"Detected in all"			HPA003030	Uncertain									"HPA003030: AB_2666758"	"unprognostic (6.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.57e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.51e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.49e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.66e-3)"	2.0	2.8	1.1	0.4	1.5	4.0	0.8	3.6	2.5	1.1	0.5			0.1	1.8	4.3	0.0	5.4	0.4	0.7	0.9	1.9	0.8	0.2	2.3	0.3	0.9		6.7	0.8	1.3	1.8	0.8		0.5	0.0		0.0	2.5	0.0	0.0	0.6	1.5	0.2	0.6	0.4	0.7			0.4		0.4	0.0	0.0	0.4	0.0	0.1	1.8	0.0	0.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.8	1.4	1.3	1.3	0.7	0.1	0.0	0.8	0.9	0.7	0.6	0.7	1.1	6.0	0.0	2.2	0.0	0.0	2.5	0.7	5.8	0.4	0.9	0.0	0.0	2.3	1.8	0.0	0.0	0.0	1.4	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.0	0.0	1.5	0.1	3.8	0.0	0.0	2.9	0.0	0.0	1.4	0.0	1.5	0.0	9.9	0.6	0.0	0.7	0.0	0.9	1.8	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.3										
ZFPM2	"FOG2, hFOG-2, ZC2HC11B, ZNF89B"	ENSG00000169946	"Zinc finger protein, FOG family member 2"	Q8WW38	8	104590733-105804532	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.0;ovary: 37.8"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;BJ hTERT+: 13.6;HHSteC: 9.9;HUVEC TERT2: 10.4;K-562: 5.6;TIME: 6.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 67.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004094	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA004094: AB_1859058"	"unprognostic (4.48e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-6)"	"unprognostic (4.10e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.63e-4)"	"unprognostic (2.61e-2)"	10.7	3.8	7.9	3.9	2.7	0.6	15.4	67.0	8.2	8.4	4.2	0.7	2.0	1.1	16.6	7.3	5.5	14.2	6.8	11.2	14.8	3.5	1.8	3.5	5.6	8.2	3.4	4.9	37.8	1.4	1.2	2.5	5.0	9.3	3.3	2.9	0.9	1.5	2.9	23.3	2.0	2.3	19.8	3.5	3.5	3.5	4.9	2.0	0.0	8.0	6.5	2.1	7.6	9.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.3	0.0	5.5	1.8	0.0	0.5	13.6	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	4.9	1.6	0.0	0.0	9.9	0.0	0.0	0.5	0.0	5.5	0.0	10.4	5.6	0.0	1.3	0.0	1.4	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.3	0.0	6.3	0.3	0.9	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	2.7	67.0	8.2	14.8	3.5	3.4	4.9	9.3	2.0
ZIM2	ZNF656	ENSG00000269699	"Zinc finger imprinted 2"	Q9NZV7	19	56774552-56840729	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;ovary: 35.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;Hep G2: 9.6;NTERA-2: 2.8;RH-30: 2.9;U-2 OS: 2.0;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071856			Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nuclear speckles"	"HPA071856: AB_2686460"	"unprognostic (9.01e-4)"				"unprognostic (8.77e-2)"		"unprognostic (5.09e-2)"			"unprognostic (4.60e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.00e-1)"		1.6	13.1	8.5	1.6	44.0	1.4	2.5	8.2	19.1	2.2	1.7	4.8	0.0	1.6	3.2	1.2	1.7	2.8	1.4	2.6	8.1	6.5	2.0	1.7	1.4	1.5	3.0	13.7	35.4	1.5	1.8	21.1	18.3	18.2	2.0	1.5	0.1	3.7	2.0	1.3	1.4	1.8	2.2	3.9	1.7	1.5	11.4	6.1	0.0	2.2	0.0	2.0	1.9	1.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.9	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	44.0	8.2	19.1	8.1	6.5	3.0	13.7	18.2	6.1
ZNF331	"RITA, ZNF361, ZNF463"	ENSG00000130844	"Zinc finger protein 331"	Q9NQX6	19	53520981-53580269	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 66.4;ovary: 86.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 36.6;RT4: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063157			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063157: AB_2684951"	"unprognostic (2.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.24e-1)"	"unprognostic (8.16e-2)"	"unprognostic (7.62e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (7.43e-4)"	"unprognostic (6.74e-2)"	19.1	66.4	6.8	9.0	8.2	18.6	10.5	11.4	9.5	9.4	5.3	8.4	8.9	2.1	9.5	11.6	4.9	19.5	23.8	15.5	5.1	7.7	6.6	6.1	15.6	4.0	6.8	5.5	86.4	9.9	11.3	29.0	23.3	7.2	10.2	4.2	9.9	4.7	31.5	6.3	5.2	4.8	8.5	9.1	4.5	6.3	8.1	6.0	3.8	7.8	4.4	4.8	25.7	9.2	8.1	4.1	6.5	7.4	4.6	14.7	5.2	0.1	5.1	10.3	11.9	8.0	6.0	17.3	7.4	6.5	5.6	10.3	5.5	2.6	4.1	1.9	4.3	3.0	7.5	5.5	10.1	0.0	36.6	5.2	8.7	3.4	5.9	3.2	7.2	6.0	3.6	6.2	3.0	2.5	0.2	1.6	5.5	3.6	7.3	6.8	4.6	7.7	9.0	6.5	4.2	3.4	28.0	7.4	7.5	3.5	9.7	2.4	1.7	2.9	2.6	7.9	7.0	4.6	4.8	20.4	13.3	7.8	0.1	0.4	6.2	0.5	4.9	6.5	8.7	3.8	13.4	8.1	9.4	8.8	3.6	8.1	14.7	9.7	0.7	4.6	7.4	4.1	9.4	5.2	6.8	8.2	11.4	9.5	5.1	7.7	6.8	5.5	7.2	6.0
ZNF556	FLJ11637	ENSG00000172000	"Zinc finger protein 556"	Q9HAH1	19	2867335-2883445	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.6;brain: 22.3;ovary: 11.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.1;HBEC3-KT: 7.6;Hep G2: 11.8;RH-30: 17.6;THP-1: 6.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	16	"cerebellum: 22.3"	"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 14.6"									HPA060593			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060593: AB_2684328"	"unprognostic (1.36e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.23e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.54e-3)"	0.3	0.2	0.5	0.3	0.5	1.0	0.5	22.3	0.5	0.7	0.3	0.0	1.7	0.1	1.6	0.7	3.1	4.2	0.8	0.2	0.4	0.3	2.6	0.1	0.4	0.3	0.4	0.1	11.3	2.6	0.4	1.6	0.8	1.3	0.4	0.1	0.1	1.0	0.1	4.5	0.7	0.2	0.3	0.5	0.3	0.3	3.5	0.0	0.6	0.2	8.7	0.9	0.2	0.2	0.4	14.6	1.2	0.2	0.6	0.2	0.1	1.8	0.3	0.0	3.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	7.1	0.1	2.3	1.2	0.1	0.1	0.0	7.6	0.0	0.1	0.0	0.1	3.1	11.8	0.1	0.2	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.2	0.0	0.1	0.0	17.6	1.5	0.0	0.3	0.1	2.9	0.0	0.3	0.0	3.6	6.4	0.0	0.1	0.1	4.6	0.1	2.1	3.8	0.1	0.2	0.1	0.1	1.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.6	0.1	14.6	0.1	0.1	0.5	0.5	22.3	0.5	0.4	0.3	0.4	0.1	1.3	0.0
ZNF648	FLJ46813	ENSG00000179930	"Zinc finger protein 648"	Q5T619	1	182054570-182061712	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;liver: 1.7;ovary: 3.0;testis: 2.2"	"Cell line enriched"	"Detected in single"	80	"HMC-1: 28.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053897	Uncertain									"HPA053897: AB_2682297"	"unprognostic (3.52e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.30e-1)"		"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.16e-6)"	"unprognostic (4.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.83e-1)"	0.0	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.3	0.2	0.0			0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0		3.0	0.4	0.0	1.0	0.0		0.0	0.0		0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZP4	ZPB	ENSG00000116996	"Zona pellucida glycoprotein 4"	Q12836	1	237877864-237890922	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 8.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA008547	Supported				"Secreted in female reproductive system"					"HPA008547: AB_1080766"						"unprognostic (7.12e-2)"			"unprognostic (2.70e-1)"						"unprognostic (4.59e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		2.3	0.0	0.0	0.0	1.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
